{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting openai\n",
      "  Downloading openai-0.27.8-py3-none-any.whl (73 kB)\n",
      "     ---------------------------------------- 0.0/73.6 kB ? eta -:--:--\n",
      "     ---------------------------------------- 73.6/73.6 kB 4.0 MB/s eta 0:00:00\n",
      "Requirement already satisfied: tqdm in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from openai) (4.65.0)\n",
      "Requirement already satisfied: requests>=2.20 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from openai) (2.31.0)\n",
      "Requirement already satisfied: aiohttp in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from openai) (3.8.4)\n",
      "Requirement already satisfied: urllib3<3,>=1.21.1 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from requests>=2.20->openai) (2.0.2)\n",
      "Requirement already satisfied: certifi>=2017.4.17 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from requests>=2.20->openai) (2023.5.7)\n",
      "Requirement already satisfied: charset-normalizer<4,>=2 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from requests>=2.20->openai) (3.1.0)\n",
      "Requirement already satisfied: idna<4,>=2.5 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from requests>=2.20->openai) (3.4)\n",
      "Requirement already satisfied: frozenlist>=1.1.1 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (1.3.3)\n",
      "Requirement already satisfied: multidict<7.0,>=4.5 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (6.0.4)\n",
      "Requirement already satisfied: aiosignal>=1.1.2 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (1.3.1)\n",
      "Requirement already satisfied: async-timeout<5.0,>=4.0.0a3 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (4.0.2)\n",
      "Requirement already satisfied: attrs>=17.3.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (23.1.0)\n",
      "Requirement already satisfied: yarl<2.0,>=1.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from aiohttp->openai) (1.9.2)\n",
      "Requirement already satisfied: colorama in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from tqdm->openai) (0.4.6)\n",
      "Installing collected packages: openai\n",
      "Successfully installed openai-0.27.8\n"
     ]
    }
   ],
   "source": [
    "!pip install openai"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "from bs4 import BeautifulSoup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "# api_key = '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'  # API key from personal account (gregorio.pique+causal-llms@gmail.com)\n",
    "api_key = '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'  # API key from AA.idsia account"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<OpenAIObject list at 0x27fd5b5f290> JSON: {\n",
       "  \"object\": \"list\",\n",
       "  \"data\": [\n",
       "    {\n",
       "      \"id\": \"whisper-1\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1677532384,\n",
       "      \"owned_by\": \"openai-internal\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-KlsZlfft3Gma8pI6A8rTnyjs\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1683912666,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"whisper-1\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649358449,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-49FUp5v084tBB49tC4z8LPH5\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669085501,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"davinci\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649359874,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-U6ZwlyAd0LyMk4rcMdz33Yc3\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066355,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"davinci\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-davinci-edit-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649809179,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-otmQSS0hmabtVGHI9QB3bct3\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1679934178,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-davinci-edit-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage-code-search-code\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-4qRnA3Hj8HIJbgo0cGbcmErn\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669085863,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage-code-search-code\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-similarity-babbage-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-48kcCHhfzvnfY84OtJf5m8Cz\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669081947,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-similarity-babbage-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"code-davinci-edit-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649880484,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-Foe5Y4TvaKveYxt74oKMw8IB\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1679934178,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"code-davinci-edit-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-davinci-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364042,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-MVM5NfoRjXkDve3uQW3YZDDt\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066355,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-davinci-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649357491,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-u0nKN4ub7EVQudgMuvCuvDjc\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1675997661,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage-code-search-text\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-Lftf8H4ZPDxNxVs0hHPJBUoe\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669085863,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage-code-search-text\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage-similarity\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-mS20lnPqhebTaFPrcCufyg7m\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669081947,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage-similarity\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"code-search-babbage-text-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-EC5ASz4NLChtEV1Cwkmrwm57\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669085863,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"code-search-babbage-text-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-curie-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364043,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-8InhPV3CZfN3F5QHKoJd4zRD\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1679310997,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-curie-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"code-search-babbage-code-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-64LWHdlANgak2rHzc3K5Stt0\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669085864,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"code-search-babbage-code-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"gpt-3.5-turbo-0613\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1686587434,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-5XP2xnkaNkMxRS436DXZ8FYy\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1687913317,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"gpt-3.5-turbo-0613\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-ada-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364042,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-KN5dRBCEW4az6gwcGXkRkMwK\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669088497,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-ada-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-similarity-ada-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-DdCqkqmORpqxqdg4TkFRAgmw\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092759,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-similarity-ada-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"curie-instruct-beta\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364042,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-bsg59MlOi88CMf1MjnIKrT5a\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1680267269,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"curie-instruct-beta\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"gpt-3.5-turbo-0301\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1677649963,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-v60zSOg6kSqrIjHyLT3wC4Io\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1688063670,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"gpt-3.5-turbo-0301\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"gpt-3.5-turbo\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1677610602,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-LeYYAMp5mu0Qkfui5StsNiib\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1687914041,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"gpt-3.5-turbo\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada-code-search-code\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-wa8tg4Pi9QQNaWdjMTM8dkkx\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669087421,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada-code-search-code\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada-similarity\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-LtSIwCEReeDcvGTmM13gv6Fg\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092759,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada-similarity\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"code-search-ada-text-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-JBssaJSmbgvJfTkX71y71k2J\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669087421,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"code-search-ada-text-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-ada-query-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-1YiiBMYC8it0mpQCBK7t8uSP\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092640,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-ada-query-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"davinci-search-document\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-M43LVJQRGxz6ode34ctLrCaG\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066355,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"davinci-search-document\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada-code-search-text\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172510,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-kFc17wOI4d1FjZEaCqnk4Frg\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669087421,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada-code-search-text\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-ada-doc-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-kbHvYouDlkD78ehcmMOGdKpK\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092640,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-ada-doc-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"davinci-instruct-beta\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364042,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-k9kuMYlfd9nvFiJV2ug0NWws\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066356,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"davinci-instruct-beta\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-similarity-curie-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-6dgTTyXrZE7d53Licw4hYkvd\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669079883,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-similarity-curie-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"code-search-ada-code-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-8soch45iiGvux5Fg1ORjdC4s\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669087421,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"code-search-ada-code-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada-search-query\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-b753xmIzAUkluQ1L20eDZLtQ\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092640,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada-search-query\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-davinci-query-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-9McKbsEYSaDshU9M3bp6ejUb\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066353,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-davinci-query-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"curie-search-query\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-sIbfSwzVpVBtymQgOQSLBpxe\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1677273417,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"curie-search-query\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"davinci-search-query\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-lYkiTZMmJMWm8jvkPx2duyHE\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066353,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"davinci-search-query\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage-search-document\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172510,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-5qFV9kxCRGKIXpBEP75chmp7\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669084981,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage-search-document\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"ada-search-document\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172507,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-8qUMuMAbo4EwedbGamV7e9hq\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669092640,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"ada-search-document\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-curie-query-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-Iion0NCpsXPNtIkQ0owQLi7V\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1677273417,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-curie-query-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-babbage-doc-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-ao2r26P2Th7nhRFleHwy2gn5\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669084981,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-babbage-doc-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"curie-search-document\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172508,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-LDsN5wW8eKVuh1OsyciHntE9\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1677273417,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"curie-search-document\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-curie-doc-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-taUGRSku7bQLa24SNIwYPEsi\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1677273417,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-curie-doc-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"babbage-search-query\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-wSs1hMXDKsrcErlbN8HmzlLE\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669084981,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"babbage-search-query\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-babbage-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649364043,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-a3Ph5FIBbJxsoA4wvx7VYC7R\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1675105935,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-babbage-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-davinci-doc-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-qhSf1j2MJMujcu3t7cHnF1DN\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066353,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-davinci-doc-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-search-babbage-query-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-Kg70kkFxD93QQqsVe4Zw8vjc\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669084981,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-search-babbage-query-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"curie-similarity\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172510,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-zhWKExSloaQiJgzjVHFmh2wR\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1675106290,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"curie-similarity\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"gpt-3.5-turbo-16k-0613\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1685474247,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-wzYEyRA76GfGVQ40hnRtOrPX\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1687993477,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"gpt-3.5-turbo-16k-0613\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"curie\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649359874,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-oPaljeveTjEIDbhDjzFiyf4V\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1675106503,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"curie\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-embedding-ada-002\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1671217299,\n",
       "      \"owned_by\": \"openai-internal\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-3nA9lRH2BRk4nbMOp5RUC5Pl\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1687981941,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-embedding-ada-002\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"gpt-3.5-turbo-16k\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1683758102,\n",
       "      \"owned_by\": \"openai-internal\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-1lio0GT8TXWtxj9U96NQ32HD\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1687993477,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"gpt-3.5-turbo-16k\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-similarity-davinci-001\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172505,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-OvmcfYoq5V9SF9xTYw1Oz6Ue\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066356,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-similarity-davinci-001\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-davinci-002\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1649880484,\n",
       "      \"owned_by\": \"openai\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-l4EU6QlN1HcS0so0jU16kyg8\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1679355287,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-davinci-002\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"text-davinci-003\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1669599635,\n",
       "      \"owned_by\": \"openai-internal\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-OCpZQfjQpoXnuT1DcEr3TtVy\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1686222972,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": false,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"text-davinci-003\",\n",
       "      \"parent\": null\n",
       "    },\n",
       "    {\n",
       "      \"id\": \"davinci-similarity\",\n",
       "      \"object\": \"model\",\n",
       "      \"created\": 1651172509,\n",
       "      \"owned_by\": \"openai-dev\",\n",
       "      \"permission\": [\n",
       "        {\n",
       "          \"id\": \"modelperm-lYYgng3LM0Y97HvB5CDc8no2\",\n",
       "          \"object\": \"model_permission\",\n",
       "          \"created\": 1669066353,\n",
       "          \"allow_create_engine\": false,\n",
       "          \"allow_sampling\": true,\n",
       "          \"allow_logprobs\": true,\n",
       "          \"allow_search_indices\": true,\n",
       "          \"allow_view\": true,\n",
       "          \"allow_fine_tuning\": false,\n",
       "          \"organization\": \"*\",\n",
       "          \"group\": null,\n",
       "          \"is_blocking\": false\n",
       "        }\n",
       "      ],\n",
       "      \"root\": \"davinci-similarity\",\n",
       "      \"parent\": null\n",
       "    }\n",
       "  ]\n",
       "}"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "import openai\n",
    "# openai.organization = \"org-RY44H5bLJgwQ3lmzGXItPi7R\"  # SUPSI org. ID from personal account (gregorio.pique+causal-llms@gmail.com)\n",
    "openai.organization = \"org-7abaI2EwtASEC0rg7mDiDMYf\"  # SUPSI org. ID from AA.idsia account\n",
    "# openai.api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "openai.api_key = api_key\n",
    "openai.Model.list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "def gpt_request(system_msg, user_msg, model='gpt-3.5-turbo'):\n",
    "    if not system_msg or not user_msg:\n",
    "        return None\n",
    "    try:\n",
    "        response = openai.ChatCompletion.create(model=model,\n",
    "                                            messages=[{\"role\": \"system\", \"content\": system_msg},\n",
    "                                                {\"role\": \"user\", \"content\": user_msg}])\n",
    "        return response\n",
    "    except:\n",
    "        return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Retinal ischemia/reperfusion (I/R) injury is a common pathological process responsible for cellular damage in glaucoma, diabetic retinopathy and hypertensive retinopathy. Metformin is a biguanide drug that exerts strong effects on multiple diseases. This study aims to evaluate the protective effect of metformin against retinal I/R injury and its underlying mechanism. I/R induced reduction in retina thickness and cell number in ganglion cell layer, and metformin alleviated I/R-induced retinal injury. Both retinal I/R and simulated ischemia/reperfusion (SIR) in R28\\u202fcells down-regulated expression of mitochondrial fusion protein Mfn2 and OPA1, which led to mitochondrial fission. Metformin also alleviated damage in R28\\u202fcells, and reversed the alteration in Mfn2 and OPA1, mitochondrial fission and mitochondrial membrane potential (MMP) disruption-induced by I/R or SIR as well. Intriguingly, inhibition of AMPK by compound C or siRNA prevented metformin-mediated up-regulation of Mfn2 and OPA1. Compound C and knockdown of Mfn2 or OPA1 dramatically alleviated the protective effect of metformin against intracellular ROS generation, MMP disruption, mitochondrial fission and loss of RGCs in ganglion cell layer-induced by SIR or I/R. Moreover, scavenging mitochondrial ROS (mito-ROS) by mito-TEMPO exerted the similar protection against I/R-induced retinal injury or SIR-induced damage in R28\\u202fcells as metformin. Our data show for the first time that metformin protects against retinal I/R injury through AMPK-mediated mitochondrial fusion and the decreased mito-ROS generation. These findings might also repurpose metformin as a therapeutic agent for retinal I/R injury.'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "df = pd.read_csv('../data/pubmed_data.csv') \n",
    "\n",
    "text = df['abstract'][0]\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def gpt_ner(text):\n",
    "    system_msg = 'You are a helpful assistant for medical Named Entity Recognition' \n",
    "    user_msg = f'Given the following text, please identify the named entities, especially diseases, medications, treatments, symptoms. <Text>{text}</Text>. Answer within the tags <Answer><Entity>...</Entity><Entity>...</Entity></Answer>.'\n",
    "    response = gpt_request(system_msg, user_msg)\n",
    "    if not response:\n",
    "        return []\n",
    "    \n",
    "    answer_text = response.choices[0].message.content\n",
    "    \n",
    "    soup = BeautifulSoup(answer_text, 'xml')\n",
    "    entities = [entity.text for entity in soup.find_all('Entity')]\n",
    "    \n",
    "    return entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "def gpt_causal_discovery(entities, text=None, use_pretrained_knowledge=False, reverse_variable_check=False):\n",
    "\n",
    "    graph_edges = []    \n",
    "\n",
    "    system_msg = 'You are a helpful assistant for causal reasoning'\n",
    "    text_msg = ''\n",
    " \n",
    "    text_msg += ''\n",
    "    if text:\n",
    "        text_msg += f'the following medical text <Text>{text}</Text> '\n",
    "        if use_pretrained_knowledge:\n",
    "            text_msg += 'and '\n",
    "        else:\n",
    "            text_msg += ', '\n",
    "            \n",
    "    if use_pretrained_knowledge:\n",
    "        text_msg += 'your pre-trained knowledge, '\n",
    "\n",
    "\n",
    "    for i1, e1 in enumerate(entities):\n",
    "        for i2, e2 in enumerate(entities):\n",
    "            if i1 == i2:\n",
    "                continue\n",
    "            if not reverse_variable_check and i1 >= i2:\n",
    "                continue\n",
    "            print(f'{i1} = {e1}, {i2} = {e2}')\n",
    "\n",
    "            # user_msg = f'{text_msg}Which cause-and-effect relationship is more likely? A. {e1} cause {e2}; B. {e2} cause {e1}; C. {e1} and {e2} are independent; D. {e1} and {e2} are mutually exclusive;  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>A/B/C/D</Answer>.'\n",
    "            # user_msg = f'{text_msg}Which cause-and-effect relationship is more likely? A. {e1} cause {e2}; B. {e2} cause {e1}; C: No causal relationship exists between {e2} and {e1};  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>A/B/C/D</Answer>.'\n",
    "            # user_msg = f'{text_msg}Which cause-and-effect relationship is more likely? A. \"{e1}\" causes \"{e2}\"; B. \"{e2}\" causes \"{e1}\"; C: \"{e1}\" and \"{e2}\" are independent;  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>A/B/C/D</Answer>.'\n",
    "            # user_msg = f'{text_msg}Which cause-and-effect relationship is more likely? A. \"{e1}\" causes \"{e2}\"; B. \"{e2}\" causes \"{e1}\"; C: \"{e1}\" and \"{e2}\" are not causally related;  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>A/B/C/D</Answer>.'\n",
    "            user_msg = f'Given {text_msg}the entities \"{e1}\" and \"{e2}\", Which cause-and-effect relationship is more likely? A. \"{e1}\" causes \"{e2}\"; B. \"{e2}\" causes \"{e1}\"; C: \"{e1}\" and \"{e2}\" are not causally related; D: there is a common factor that is the cause for both \"{e1}\" and \"{e2}\";  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>[answer]</Answer>, (e.g. <Answer>C</Answer>).'\n",
    "            # user_msg = f'{text_msg}Which cause-and-effect relationship is more likely? A. \"{e1}\" causes \"{e2}\"; B. \"{e2}\" causes \"{e1}\"; C: \"{e1}\" and \"{e2}\" are not causally related; D: an external counfounding variable is the cause of both the \"{e1}\" and \"{e2}\" entity;  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>A/B/C/D</Answer>.'\n",
    "            response = gpt_request(system_msg, user_msg)\n",
    "            if response:\n",
    "                graph_edges.append(((e1, e2), response.choices[0].message.content))\n",
    "            \n",
    "                print(graph_edges[-1])\n",
    "    \n",
    "    return graph_edges"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "arrows = {'A':'->', 'B':'<-', 'C':' ', 'D':'<->'}\n",
    "\n",
    "answer_pattern = re.compile(r'^([A-Z])\\.')\n",
    "\n",
    "def get_edge_answer(text):\n",
    "    soup = BeautifulSoup(text, 'html.parser')\n",
    "    answer = soup.find('answer').text\n",
    "\n",
    "    if answer in arrows:\n",
    "        return arrows[answer]\n",
    "\n",
    "    match = answer_pattern.match(answer)\n",
    "    if match:\n",
    "        answer = match.group(1)\n",
    "\n",
    "    if answer in arrows:\n",
    "        return arrows[answer]\n",
    "    \n",
    "    return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "def print_edges(graph_edges):\n",
    "    for (e1, e2), answer in graph_edges:\n",
    "        try:\n",
    "            print(f'{e1} {get_edge_answer(answer)} {e2}')\n",
    "        except:\n",
    "            print(f'{e1} ? {e2}')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "arrows = {'A':'->', 'B':'<-', 'C':' ', 'D':'<->'}\n",
    "\n",
    "\n",
    "def check_edge_direction(e1, e2, answer):\n",
    "    if answer in arrows:\n",
    "        if answer == 'A':\n",
    "            return [(e1, e2)]\n",
    "        elif answer == 'B':\n",
    "            return [(e2, e1)]\n",
    "        elif answer == 'D':\n",
    "            return [(e2, e1), (e1, e2)]\n",
    "        else: \n",
    "            return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "def optimize_entities(entities, text=None):\n",
    "    system_msg = 'You are a helpful assistant for medical Named Entity Recognition'\n",
    "    \n",
    "    user_msg = f'Given the following named entities <Entities>'\n",
    "    for entity in entities:\n",
    "        user_msg += f'<Entity>{entity}</Entity>'\n",
    "\n",
    "    user_msg += '</Entities> extracted from '\n",
    "    \n",
    "    if text:\n",
    "        user_msg += f'this medical text <Text>{text}</Text>, '\n",
    "    else:\n",
    "        user_msg += f'a medical text, '\n",
    "    \n",
    "    user_msg += f'please optimize them by removing redundant or not particularly useful ones, that are not diseases, medications, treatments, or symptoms (e.g. \"lung cancer\" is a valid entity, \"lungs\" is not). Answer within the tags <Answer><Entity>...</Entity><Entity>...</Entity></Answer>.'\n",
    "    response = gpt_request(system_msg, user_msg)\n",
    "    \n",
    "    print(user_msg)\n",
    "    \n",
    "    if response: \n",
    "        answer_text = response.choices[0].message.content\n",
    "        \n",
    "        soup = BeautifulSoup(answer_text, 'xml')\n",
    "        opt_entities = [entity.text for entity in soup.find_all('Entity')]\n",
    "\n",
    "        return opt_entities\n",
    "    \n",
    "    return entities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "def correct_invalid_edges(invalid_edges, text, use_pretrained_knowledge=False):\n",
    "    graph_edges = []\n",
    "\n",
    "    if not invalid_edges:\n",
    "        return []\n",
    "    \n",
    "    system_msg = 'You are a helpful assistant for causal reasoning'\n",
    "    base_msg = f'Given the following medical text <Text>{text}</Text>,  '\n",
    "        \n",
    "    if use_pretrained_knowledge:\n",
    "        base_msg += 'your pre-trained knowledge, '\n",
    "\n",
    "    for n1, n2 in invalid_edges:\n",
    "        user_msg = f'{base_msg}and the two entities \"{n1}\" and \"{n2}\", which cause-and-effect relationship is more likely? A. \"{n1}\" causes \"{n2}\"; B. \"{n2}\" causes \"{n1}\"; C: \"{n1}\" and \"{n2}\" are not causally related; D: there is a common factor that is the cause for both \"{n1}\" and \"{n2}\";  Lets work this out in a step by step way to be sure that we have the right answer. Then provide your final answer within the tags <Answer>[answer]</Answer>, (e.g. <Answer>C</Answer>).'\n",
    "        response = gpt_request(system_msg, user_msg)\n",
    "        if response:\n",
    "            graph_edges.append(((n1, n2), response.choices[0].message.content))\n",
    "            \n",
    "    \n",
    "    return graph_edges"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyvis.network import Network\n",
    "\n",
    "def plot_interactive_graph(nodes, edges, name='mygraph.html'):\n",
    "    net = Network(directed=True, notebook=True)\n",
    "\n",
    "    node_ids = {}\n",
    "\n",
    "    for i, node in enumerate(nodes):\n",
    "        net.add_node(i, label=node)\n",
    "        node_ids[node] = i\n",
    "    \n",
    "    for e1, e2 in edges:\n",
    "        net.add_edge(node_ids[e1],node_ids[e2])\n",
    "\n",
    "    net.show(f'../graphs/{name}.html')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Warning: When  cdn_resources is 'local' jupyter notebook has issues displaying graphics on chrome/safari. Use cdn_resources='in_line' or cdn_resources='remote' if you have issues viewing graphics in a notebook.\n",
      "mygraph.html\n"
     ]
    }
   ],
   "source": [
    "nodes = ['a', 'b', 'c', 'd']\n",
    "edges = [('a', 'b'), ('b', 'c'), ('c', 'd'), ('d', 'a'), ('a', 'd')]\n",
    "\n",
    "plot_interactive_graph(nodes, edges)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "def plot_graph(nodes, edges):\n",
    "\n",
    "    if not nodes:\n",
    "        return None\n",
    "    \n",
    "    # Create a graph\n",
    "    G = nx.DiGraph()\n",
    "\n",
    "    # Add nodes\n",
    "    for node in nodes:\n",
    "        G.add_node(node)\n",
    "\n",
    "    # Add edges\n",
    "    for e1, e2 in edges:\n",
    "        G.add_edge(e1, e2)\n",
    "\n",
    "    # Plot the graph\n",
    "    pos = nx.spring_layout(G)  # Determine the positions of nodes\n",
    "    nx.draw_networkx_nodes(G, pos)\n",
    "    nx.draw_networkx_edges(G, pos, arrows=True)\n",
    "    nx.draw_networkx_labels(G, pos)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting pyvis\n",
      "  Downloading pyvis-0.3.2-py3-none-any.whl (756 kB)\n",
      "     ---------------------------------------- 0.0/756.0 kB ? eta -:--:--\n",
      "     -- ---------------------------------- 41.0/756.0 kB 653.6 kB/s eta 0:00:02\n",
      "     ------ ------------------------------- 122.9/756.0 kB 1.4 MB/s eta 0:00:01\n",
      "     ----------- -------------------------- 225.3/756.0 kB 1.4 MB/s eta 0:00:01\n",
      "     -------------- ----------------------- 286.7/756.0 kB 1.5 MB/s eta 0:00:01\n",
      "     ------------------ ------------------- 368.6/756.0 kB 1.4 MB/s eta 0:00:01\n",
      "     -------------------- ----------------- 399.4/756.0 kB 1.3 MB/s eta 0:00:01\n",
      "     ---------------------- --------------- 450.6/756.0 kB 1.3 MB/s eta 0:00:01\n",
      "     ------------------------ ------------- 491.5/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     --------------------------- ---------- 542.7/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     ---------------------------- --------- 573.4/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     ------------------------------- ------ 624.6/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     ---------------------------------- --- 696.3/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     -------------------------------------  737.3/756.0 kB 1.2 MB/s eta 0:00:01\n",
      "     -------------------------------------- 756.0/756.0 kB 1.1 MB/s eta 0:00:00\n",
      "Collecting jsonpickle>=1.4.1\n",
      "  Downloading jsonpickle-3.0.1-py2.py3-none-any.whl (40 kB)\n",
      "     ---------------------------------------- 0.0/40.5 kB ? eta -:--:--\n",
      "     ---------------------------------------- 40.5/40.5 kB 2.0 MB/s eta 0:00:00\n",
      "Requirement already satisfied: networkx>=1.11 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from pyvis) (3.1)\n",
      "Requirement already satisfied: ipython>=5.3.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from pyvis) (8.12.0)\n",
      "Requirement already satisfied: jinja2>=2.9.6 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from pyvis) (3.1.2)\n",
      "Requirement already satisfied: backcall in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.2.0)\n",
      "Requirement already satisfied: matplotlib-inline in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.1.6)\n",
      "Requirement already satisfied: pygments>=2.4.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (2.15.1)\n",
      "Requirement already satisfied: decorator in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (5.1.1)\n",
      "Requirement already satisfied: pickleshare in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.7.5)\n",
      "Requirement already satisfied: prompt-toolkit!=3.0.37,<3.1.0,>=3.0.30 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (3.0.36)\n",
      "Requirement already satisfied: colorama in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.4.6)\n",
      "Requirement already satisfied: traitlets>=5 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (5.7.1)\n",
      "Requirement already satisfied: stack-data in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.2.0)\n",
      "Requirement already satisfied: jedi>=0.16 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from ipython>=5.3.0->pyvis) (0.18.1)\n",
      "Requirement already satisfied: MarkupSafe>=2.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from jinja2>=2.9.6->pyvis) (2.1.2)\n",
      "Requirement already satisfied: parso<0.9.0,>=0.8.0 in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from jedi>=0.16->ipython>=5.3.0->pyvis) (0.8.3)\n",
      "Requirement already satisfied: wcwidth in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from prompt-toolkit!=3.0.37,<3.1.0,>=3.0.30->ipython>=5.3.0->pyvis) (0.2.5)\n",
      "Requirement already satisfied: executing in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from stack-data->ipython>=5.3.0->pyvis) (0.8.3)\n",
      "Requirement already satisfied: asttokens in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from stack-data->ipython>=5.3.0->pyvis) (2.0.5)\n",
      "Requirement already satisfied: pure-eval in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from stack-data->ipython>=5.3.0->pyvis) (0.2.2)\n",
      "Requirement already satisfied: six in c:\\users\\grego\\onedrive\\desktop\\progetto diploma\\.conda\\lib\\site-packages (from asttokens->stack-data->ipython>=5.3.0->pyvis) (1.16.0)\n",
      "Installing collected packages: jsonpickle, pyvis\n",
      "Successfully installed jsonpickle-3.0.1 pyvis-0.3.2\n"
     ]
    }
   ],
   "source": [
    "!pip install pyvis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "arrows = {'A':'->', 'B':'<-', 'C':' ', 'D':'<->'}\n",
    "answer_pattern = re.compile(r'^([A-Z])\\.')\n",
    "\n",
    "def extract_edge_answers(edges):\n",
    "    edges_with_answers = []\n",
    "\n",
    "    for (e1, e2), text in edges:\n",
    "        try:\n",
    "            soup = BeautifulSoup(text, 'html.parser')\n",
    "            answer = soup.find('answer').text\n",
    "            \n",
    "            if answer in arrows:\n",
    "                edges_with_answers.append(((e1, e2), answer))\n",
    "                continue\n",
    "\n",
    "            match = answer_pattern.match(answer)\n",
    "            if match:\n",
    "                if match.group(1) in arrows:\n",
    "                    edges_with_answers.append(((e1, e2), match.group(1)))\n",
    "                    continue\n",
    "\n",
    "        except:\n",
    "            continue\n",
    "\n",
    "    return edges_with_answers\n",
    "\n",
    "\n",
    "\n",
    "def check_edge_compatibility(answer1, answer2):\n",
    "    return (answer1 == 'A'and answer2 == 'B') or (answer1 == 'B'and answer2 == 'A') or (answer1 == 'C'and answer2 == 'C') or (answer1 == 'D'and answer2 == 'D')\n",
    "\n",
    "def check_invalid_answers(directed_edges):\n",
    "    invalid_edges = []\n",
    "    valid_edges = []\n",
    "    temp_edges = []\n",
    "    answers = {}\n",
    "    for (n1, n2), answer in directed_edges:\n",
    "\n",
    "        if (n1, n2) not in temp_edges and (n2, n1) not in temp_edges:\n",
    "            temp_edges.append((n1, n2))\n",
    "            answers[(n1, n2)] = answer\n",
    "        elif (n1, n2) in temp_edges:\n",
    "            if answers[(n1, n2)] != answer:\n",
    "                invalid_edges.append((n1, n2))\n",
    "            else:\n",
    "                valid_edges.append(((n1, n2), answer))\n",
    "            \n",
    "            temp_edges.remove((n1, n2))\n",
    "        elif (n2, n1) in temp_edges:\n",
    "            if check_edge_compatibility(answers[(n2, n1)], answer):\n",
    "                valid_edges.append(((n1, n2), answer))\n",
    "            else:\n",
    "                invalid_edges.append((n1, n2))\n",
    "            \n",
    "            temp_edges.remove((n2, n1))\n",
    "\n",
    "    for n1, n2 in temp_edges:\n",
    "        if (n1, n2) not in invalid_edges:\n",
    "            invalid_edges.append((n1, n2))\n",
    "    \n",
    "    return valid_edges, invalid_edges\n",
    "\n",
    "def preprocess_edges(edges):\n",
    "    nodes = []\n",
    "    processed_edges = []\n",
    "\n",
    "    for (n1, n2), answer in edges:\n",
    "\n",
    "        if n1 not in nodes:\n",
    "            nodes.append(n1)\n",
    "        if n2 not in nodes:\n",
    "            nodes.append(n2)\n",
    "\n",
    "        direction = check_edge_direction(n1, n2, answer)\n",
    "        if direction:\n",
    "            processed_edges.extend(direction)\n",
    "            \n",
    "    return nodes, processed_edges"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "def causal_discovery_pipeline(text_title, text, use_text_in_causal_discovery=False, use_LLM_pretrained_knowledge_in_causal_discovery=False, reverse_edge_for_variable_check=False, optimize_found_entities=True, use_text_in_entity_optimization=True, verbose=False):\n",
    "    if verbose:\n",
    "        print('Text:')\n",
    "        print(text)\n",
    "        print('--')\n",
    "\n",
    "    entities = gpt_ner(text)\n",
    "\n",
    "    if verbose:\n",
    "        print(f'Entities: ({len(entities)})')\n",
    "        print(entities)\n",
    "        print('--')\n",
    "\n",
    "    if optimize_found_entities:\n",
    "        if use_text_in_entity_optimization:\n",
    "            entities = optimize_entities(entities, text)\n",
    "        else:\n",
    "            entities = optimize_entities(entities)\n",
    "\n",
    "        if verbose:\n",
    "            print(f'Optimized Entities: ({len(entities)})')\n",
    "            print(entities)\n",
    "            print('--')\n",
    "\n",
    "    if use_text_in_causal_discovery:\n",
    "        graph_edges = gpt_causal_discovery(entities, text, use_pretrained_knowledge=use_LLM_pretrained_knowledge_in_causal_discovery, reverse_variable_check=reverse_edge_for_variable_check)\n",
    "    else:\n",
    "        graph_edges = gpt_causal_discovery(entities, use_pretrained_knowledge=use_LLM_pretrained_knowledge_in_causal_discovery, reverse_variable_check=reverse_edge_for_variable_check)\n",
    "\n",
    "\n",
    "    edges = extract_edge_answers(graph_edges)\n",
    "    if verbose:\n",
    "        print('Edges:')\n",
    "        print(edges)\n",
    "        print('--')\n",
    "\n",
    "    if reverse_edge_for_variable_check:\n",
    "        valid_edges, invalid_edges = check_invalid_answers(edges)\n",
    "        if verbose:\n",
    "            print('Valid Edges:')\n",
    "            print(valid_edges)\n",
    "            print('--')\n",
    "            print('Invalid Edges:')\n",
    "            print(invalid_edges)\n",
    "            print('--')\n",
    "        \n",
    "        edge_correction_response = correct_invalid_edges(invalid_edges, text, use_pretrained_knowledge=use_LLM_pretrained_knowledge_in_causal_discovery)\n",
    "        corrected_edges = extract_edge_answers(edge_correction_response)\n",
    "        if verbose:\n",
    "            print('Edge Correction Response:')\n",
    "            print(corrected_edges)\n",
    "            print('--')\n",
    "\n",
    "        valid_edges.extend(corrected_edges)\n",
    "        edges = valid_edges\n",
    "    \n",
    "    nodes, processed_edges = preprocess_edges(edges)\n",
    "    if verbose:\n",
    "        print('Nodes:')\n",
    "        print(nodes)\n",
    "        print('--')\n",
    "        print('Processed Edges:')\n",
    "        print(processed_edges)\n",
    "        print('--')\n",
    "\n",
    "    plot_graph(nodes, processed_edges)\n",
    "    plot_interactive_graph(nodes, processed_edges, name=text_title)\n",
    "    print_edges(graph_edges) # TODO - remove this temporary print"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Text:\n",
      "Smoking involves inhaling tobacco fumes; it can cause lung cancer and tumors.\n",
      "--\n",
      "Entities: (4)\n",
      "['Smoking', 'tobacco fumes', 'lung cancer', 'tumors']\n",
      "--\n",
      "Given the following named entities <Entities><Entity>Smoking</Entity><Entity>tobacco fumes</Entity><Entity>lung cancer</Entity><Entity>tumors</Entity></Entities> extracted from this medical text <Text>Smoking involves inhaling tobacco fumes; it can cause lung cancer and tumors.</Text>, please optimize them by removing redundant or not particularly useful ones, that are not diseases, medications, treatments, or symptoms (e.g. \"lung cancer\" is a valid entity, \"lungs\" is not). Answer within the tags <Answer><Entity>...</Entity><Entity>...</Entity></Answer>.\n",
      "Optimized Entities: (3)\n",
      "['Smoking', 'lung cancer', 'tumors']\n",
      "--\n",
      "0 = Smoking, 1 = lung cancer\n",
      "(('Smoking', 'lung cancer'), 'Step 1: Analyze the statements in the text:\\n- Text states that \"Smoking involves inhaling tobacco fumes.\"\\n- Text states that \"Smoking can cause lung cancer and tumors.\"\\n\\nStep 2: Analyze the entities and their relationships:\\n- The entities mentioned are \"Smoking\" and \"lung cancer\".\\n- The text specifically states that smoking \"can cause\" lung cancer.\\n\\nStep 3: Determine the most likely cause-and-effect relationship:\\n- Based on the statements in the text, it is more likely that \"Smoking\" causes \"lung cancer\" rather than the other way around.\\n- The text explicitly states that smoking can cause lung cancer, indicating a direct cause-and-effect relationship.\\n\\nStep 4: Final answer:\\n<Answer>A</Answer>')\n",
      "0 = Smoking, 2 = tumors\n",
      "(('Smoking', 'tumors'), 'First, let\\'s analyze the information provided in the text:\\n- It states that smoking involves inhaling tobacco fumes.\\n- It also states that smoking can cause lung cancer and tumors.\\n\\nNow, let\\'s break down the options and evaluate each one:\\n\\nA. \"Smoking\" causes \"tumors\":\\n- The text explicitly mentions that smoking can cause tumors. Therefore, option A is a valid cause-and-effect relationship.\\n\\nB. \"tumors\" cause \"Smoking\":\\n- The text does not mention that tumors cause smoking. In fact, it states that smoking involves inhaling tobacco fumes. Therefore, option B is not supported by the information provided.\\n\\nC. \"Smoking\" and \"tumors\" are not causally related:\\n- The text specifically states that smoking can cause tumors. Therefore, option C is not supported by the information provided.\\n\\nD. There is a common factor that is the cause for both \"Smoking\" and \"tumors\":\\n- The text does not mention any common factor that would cause both smoking and tumors. It only states that smoking can cause tumors. Therefore, option D is not supported by the information provided.\\n\\nBased on the information provided in the text, the most likely cause-and-effect relationship is:\\n<Answer>A</Answer> \"Smoking\" causes \"tumors\".')\n",
      "1 = lung cancer, 0 = Smoking\n",
      "(('lung cancer', 'Smoking'), 'Step 1: Identify the entities and their relationship in the text.\\n- Entities: \"lung cancer\", \"Smoking\"\\n- Relationship: \"Smoking\" can cause \"lung cancer\"\\n\\nStep 2: Evaluate the causal relationship.\\nThe text states that \"Smoking\" can cause \"lung cancer\". This suggests a cause-and-effect relationship between the two entities.\\n\\nStep 3: Consider the pre-trained knowledge.\\nBased on pre-trained knowledge, it is well-established that smoking is a major risk factor for developing lung cancer.\\n\\nStep 4: Final answer.\\nBased on the given medical text and pre-trained knowledge, the more likely cause-and-effect relationship is:\\n<Answer>B</Answer> \"Smoking\" causes \"lung cancer.\"')\n",
      "1 = lung cancer, 2 = tumors\n",
      "(('lung cancer', 'tumors'), '1. Smoking involves inhaling tobacco fumes.\\n2. Smoking can cause lung cancer and tumors.\\n\\nStep 1: Based on the information given in the text, we know that smoking is the cause and lung cancer and tumors are the effects. \\n\\nStep 2: Lung cancer and tumors are both listed as effects of smoking.\\n\\nBased on this reasoning, it is more likely that:\\n\\nA. \"lung cancer\" causes \"tumors\";\\n\\nB. \"tumors\" causes \"lung cancer\";\\n\\nC: \"lung cancer\" and \"tumors\" are not causally related;\\n\\nD: there is a common factor that is the cause for both \"lung cancer\" and \"tumors\";\\n\\n<Answer>C</Answer>')\n",
      "2 = tumors, 0 = Smoking\n",
      "(('tumors', 'Smoking'), 'Step 1: Understand the text and identify the causal relationship mentioned:\\nThe text states that \"Smoking involves inhaling tobacco fumes; it can cause lung cancer and tumors.\" This implies that smoking is the cause and lung cancer and tumors are the effects.\\n\\nStep 2: Identify the entities mentioned:\\nThe entities mentioned are \"tumors\" and \"Smoking.\"\\n\\nStep 3: Determine the cause-and-effect relationship:\\nBased on the information provided in the text and our pre-trained knowledge, it is more likely that \"Smoking\" causes \"tumors.\" Smoking is known to be a risk factor for the development of various types of tumors, including lung cancer.\\n\\nStep 4: Final answer:\\n<Answer>B</Answer> \"Smoking\" causes \"tumors.\"')\n",
      "2 = tumors, 1 = lung cancer\n",
      "(('tumors', 'lung cancer'), '1. We are given that smoking causes both lung cancer and tumors.\\n2. Based on the information provided, we do not have any direct evidence to suggest that tumors cause lung cancer.\\n3. It is possible that tumors and lung cancer are not causally related to each other.\\n4. Additionally, there could be a common factor, such as smoking, that causes both tumors and lung cancer.\\n\\nBased on the given information and reasoning, the most likely answer is that there is a common factor that is the cause for both \"tumors\" and \"lung cancer.\" \\n\\n<Answer>D</Answer>')\n",
      "Edges:\n",
      "[(('Smoking', 'lung cancer'), 'A'), (('Smoking', 'tumors'), 'A'), (('lung cancer', 'Smoking'), 'B'), (('lung cancer', 'tumors'), 'C'), (('tumors', 'Smoking'), 'B'), (('tumors', 'lung cancer'), 'D')]\n",
      "--\n",
      "Valid Edges:\n",
      "[(('lung cancer', 'Smoking'), 'B'), (('tumors', 'Smoking'), 'B')]\n",
      "--\n",
      "Invalid Edges:\n",
      "[('tumors', 'lung cancer')]\n",
      "--\n",
      "Edge Correction Response:\n",
      "[(('tumors', 'lung cancer'), 'D')]\n",
      "--\n",
      "Nodes:\n",
      "['lung cancer', 'Smoking', 'tumors']\n",
      "--\n",
      "Processed Edges:\n",
      "[('Smoking', 'lung cancer'), ('Smoking', 'tumors'), ('lung cancer', 'tumors'), ('tumors', 'lung cancer')]\n",
      "--\n",
      "Warning: When  cdn_resources is 'local' jupyter notebook has issues displaying graphics on chrome/safari. Use cdn_resources='in_line' or cdn_resources='remote' if you have issues viewing graphics in a notebook.\n",
      "../graphs/Smoking.html\n",
      "Smoking -> lung cancer\n",
      "Smoking -> tumors\n",
      "lung cancer <- Smoking\n",
      "lung cancer   tumors\n",
      "tumors <- Smoking\n",
      "tumors <-> lung cancer\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# text = 'Smoking is a major cause of lung cancer. Tobacco smoke contains harmful substances that can lead to tumor formation in the lungs. Quitting smoking reduces the risk of lung cancer and improves overall health.'\n",
    "text = 'Smoking involves inhaling tobacco fumes; it can cause lung cancer and tumors.'\n",
    "text_title = 'Smoking'\n",
    "causal_discovery_pipeline(text_title, text, use_text_in_causal_discovery=True, use_LLM_pretrained_knowledge_in_causal_discovery=True, reverse_edge_for_variable_check=True, optimize_found_entities=True, use_text_in_entity_optimization=True, verbose=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R). A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes. In this review, we highlight the progress made in recent years regarding the role of mitochondria in liver I/R and discuss the impact of liver conditions on LIRI.\n",
      "\n",
      "Text:\n",
      "Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R). A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes. In this review, we highlight the progress made in recent years regarding the role of mitochondria in liver I/R and discuss the impact of liver conditions on LIRI.\n",
      "--\n",
      "Entities:\n",
      "['Liver ischemia-reperfusion injury']\n",
      "--\n",
      "Optimized Entities:\n",
      "['Liver ischemia-reperfusion injury (LIRI)', 'complications', 'clinical settings', 'liver resection', 'liver transplantation', 'graft rejection', 'morbidity', 'mortality', 'mechanisms', 'parenchymal', 'non-parenchymal liver cells', 'mitochondrial dysfunction', 'glucose metabolism', 'energy production', 'reactive oxygen species (ROS) signaling', 'calcium homeostasis', 'cell death', 'mitochondrial biogenesis', 'fission/fusion', 'mitophagy', 'steatosis', 'aging', 'therapeutic strategies', 'patient outcomes']\n",
      "--\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 1 = complications\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'complications'), '1. \"Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\"\\nThis statement suggests that LIRI is a cause of complications.\\n\\n2. \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\nThis statement further supports the idea that LIRI causes complications.\\n\\n3. \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\nThis statement explains that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\nThis statement suggests that protecting mitochondria can decrease susceptibility to LIRI.\\n\\nBased on the above statements, the most likely cause-and-effect relationship is:\\nA. \"Liver ischemia-reperfusion injury (LIRI)\" causes \"complications\".\\n\\n<Answer>A</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 2 = clinical settings\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'clinical settings'), '1. Identify the entities involved: \"Liver ischemia-reperfusion injury (LIRI)\" and \"clinical settings\".\\n2. Look for clues in the text about the causal relationship between these entities.\\n3. The text states that LIRI is a major cause of complications in different clinical settings such as liver resection and liver transplantation. This suggests that LIRI causes clinical settings.\\n4. Therefore, the more likely cause-and-effect relationship is: \"Liver ischemia-reperfusion injury (LIRI)\" causes \"clinical settings\".\\n5. The answer is <Answer>A</Answer>.')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 3 = liver resection\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'liver resection'), '1. Liver ischemia-reperfusion injury (LIRI) is described as a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. The text states that damage from LIRI is associated with higher morbidity and mortality after surgery, and is recognized as a hallmark of the condition that exacerbates cellular injury. \\n\\n3. It goes on to indicate that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, while mitochondrial dysfunction is a key feature of LIRI that exacerbates cellular injury. \\n\\n4. The text suggests that preserving mitochondrial health through regulation of mitochondrial biogenesis, fission/fusion, and mitophagy could ameliorate LIRI. \\n\\n5. Finally, it is mentioned that studying mitochondrial dysfunction will help develop new therapeutic strategies aimed at improving patient outcomes. \\n\\nBased on the text, it is more likely that liver resection causes Liver ischemia-reperfusion injury (LIRI), as this is mentioned as one of the clinical settings in which LIRI can arise. However, it is also possible that both conditions are caused by a common factor. Therefore, the answer is <Answer>B</Answer>.')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 4 = liver transplantation\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'liver transplantation'), '1. LIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\nThese statements suggest that LIRI is a consequence of liver transplantation, rather than the cause.\\n\\n3. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n5. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nThese statements suggest that mitochondrial dysfunction plays a major role in the development of LIRI, and that efforts to protect mitochondria during liver transplantation could help prevent LIRI.\\n\\nTherefore, it is more likely that option B is the correct answer: \"liver transplantation\" causes \"Liver ischemia-reperfusion injury (LIRI)\".<Answer>B</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 5 = graft rejection\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'graft rejection'), '1. \"Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\"\\n2. \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n\\nBased on these two statements, it can be inferred that LIRI is the cause and graft rejection is the effect. Therefore, the more likely cause-and-effect relationship is:\\n\\nA. \"Liver ischemia-reperfusion injury (LIRI)\" causes \"graft rejection\"\\n\\n<Answer>A</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 6 = morbidity\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'morbidity'), '1. \"Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\"\\n2. \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n\\nBased on these two sentences, it can be concluded that LIRI is a cause of morbidity. Therefore, the most likely cause-and-effect relationship is A. \"Liver ischemia-reperfusion injury (LIRI)\" causes \"morbidity\". \\n\\n<Answer>A</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 7 = mortality\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'mortality'), '1. Identify the cause-and-effect relationship mentioned in the text:\\n- \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n\\n2. Determine the direction of causality between the two entities:\\n- LIRI causes increased morbidity and mortality.\\n\\n3. Final answer:\\n<Answer>A</Answer>, \"Liver ischemia-reperfusion injury (LIRI)\" causes \"mortality\".')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 8 = mechanisms\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'mechanisms'), '1. The text states that \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\" This suggests that mechanisms are a contributing factor to the development of LIRI.\\n\\n2. The text also suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI. This indicates that mechanisms play a role in driving LIRI.\\n\\nBased on the information provided, it is more likely that B. \"mechanisms\" causes \"Liver ischemia-reperfusion injury (LIRI)\" is the correct answer. \\n\\n<Answer>B</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 9 = parenchymal\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'parenchymal'), '1. \"Liver ischemia-reperfusion injury (LIRI)\" is described as a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n2. \"Damage arising from LIRI\" is associated with higher morbidity and mortality after surgery.\\n3. \"Mitochondrial dysfunction\" is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. The roles of mitochondria, which include glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death, make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n5. Protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n6. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on the text and pre-trained knowledge, it is more likely that \"Liver ischemia-reperfusion injury (LIRI)\" causes \"parenchymal\" because mitochondrial dysfunction, which is recognized as a hallmark of LIRI that exacerbates cellular injury, plays a major role in glucose metabolism, energy production, ROS signaling, calcium homeostasis, and cell death. Therefore, damage to parenchymal and non-parenchymal liver cells from LIRI is likely due to mitochondrial dysfunction.\\n\\n<Answer>A</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 10 = non-parenchymal liver cells\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'non-parenchymal liver cells'), '1. Identify the entities: \"Liver ischemia-reperfusion injury (LIRI)\" and \"non-parenchymal liver cells\"\\n2. Look for causal indicators: \\n      - For \"Liver ischemia-reperfusion injury (LIRI)\": \"is a major cause of the development of complications\", \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery\"\\n      - For \"non-parenchymal liver cells\": None found \\n3. Based on the information provided in the text, which cause-and-effect relationship is more likely?\\n\\nAnswer: <Answer>C</Answer> \"Liver ischemia-reperfusion injury (LIRI)\" and \"non-parenchymal liver cells\" are not causally related. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Therefore, the damage to non-parenchymal liver cells is a consequence of LIRI rather than its cause.')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 11 = mitochondrial dysfunction\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'mitochondrial dysfunction'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" implying that mitochondrial dysfunction is a consequence or effect of LIRI.\\n2. The text further suggests that protecting mitochondria during liver I/R ameliorates LIRI, indicating that mitochondrial dysfunction is contributing to the development of LIRI.\\n3. The text also mentions \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes,\" indicating that mitochondrial dysfunction is a cause of LIRI.\\n4. Overall, the text presents evidence that suggests mitochondrial dysfunction is a contributing cause of LIRI.\\n\\n<Answer>B</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 12 = glucose metabolism\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'glucose metabolism'), '1. The text explains that Liver ischemia-reperfusion injury (LIRI) is a major cause of complications such as liver resection and transplantation. \\n2. The text also explains that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury. \\n3. The text highlights the importance of preserving mitochondrial health to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n4. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n5. The text mentions that mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death.\\n\\nBased on the information provided in the text and pre-trained knowledge, it is more likely that \"glucose metabolism\" is affected as a result of \"Liver ischemia-reperfusion injury (LIRI)\", rather than the other way around. The text explains that mitochondria play a major role in glucose metabolism and that LIRI is known to cause mitochondrial dysfunction, which exacerbates cellular injury. Therefore, it is reasonable to assume that LIRI can lead to disturbances in glucose metabolism.\\n\\n<Answer> A. \"Liver ischemia-reperfusion injury (LIRI)\" causes \"glucose metabolism\" </Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 13 = energy production\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'energy production'), 'Step 1: The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\nStep 2: The text also mentions that mitochondria play a major role in energy production.\\n\\nStep 3: The text suggests that preserving mitochondrial health and targeting mitochondria can decrease susceptibility to LIRI.\\n\\nStep 4: Based on the above, it is more likely that \"energy production\" is impacted by \"Liver ischemia-reperfusion injury (LIRI)\" and not the other way around.\\n\\nTherefore, the correct answer is <Answer>B</Answer>: \"energy production\" causes \"Liver ischemia-reperfusion injury (LIRI)\".')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 14 = reactive oxygen species (ROS) signaling\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'reactive oxygen species (ROS) signaling'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\".\\n2. The text also states that \"mitochondria play a major role in...reactive oxygen species (ROS) signaling\".\\n3. Furthermore, the text highlights the importance of protecting mitochondria during liver I/R and targeting mitochondrial dysfunction to decrease susceptibility to LIRI.\\n \\nBased on this information, it is more likely that option B is the correct answer: \"reactive oxygen species (ROS) signaling\" causes \"Liver ischemia-reperfusion injury (LIRI)\". \\n\\n<Answer>B</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 15 = calcium homeostasis\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'calcium homeostasis'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and \"mitochondria play a major role in...calcium homeostasis and cell death\".\\n2. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. Therefore, it is more likely that \"calcium homeostasis\" is a result of \"Liver ischemia-reperfusion injury (LIRI)\" rather than the cause of it. \\n\\n<Answer>A</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 16 = cell death\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'cell death'), '1. The text states that \"although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n\\n2. The text also mentions that \"Mitochondria play a major role in... cell death.\"\\n\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n\\nBased on these points, it is more likely that \"cell death\" is caused by \"Liver ischemia-reperfusion injury (LIRI)\", not the other way around. Therefore, the answer is <Answer>A</Answer>: \"Liver ischemia-reperfusion injury (LIRI)\" causes \"cell death\".')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 17 = mitochondrial biogenesis\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'mitochondrial biogenesis'), '1. The text states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. The text also states that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. This suggests that \"mitochondrial biogenesis\" can have a protective effect against LIRI, rather than causing it.\\n4. Therefore, option B, \"mitochondrial biogenesis\" causes \"Liver ischemia-reperfusion injury (LIRI)\", can be eliminated.\\n5. The text does not suggest that \"Liver ischemia-reperfusion injury (LIRI)\" causes \"mitochondrial biogenesis\", so option A can be eliminated as well.\\n6. The text clearly links mitochondrial dysfunction with LIRI, but it also suggests that other factors such as steatosis and aging can exacerbate mitochondrial dysfunction and increase susceptibility to LIRI.\\n7. Thus, the most likely scenario is that there is a common factor or factors that contribute to both LIRI and mitochondrial dysfunction.\\n8. Therefore, the correct answer is D: there is a common factor that is the cause for both \"Liver ischemia-reperfusion injury (LIRI)\" and \"mitochondrial biogenesis\". \\n\\n<Answer>D</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 18 = fission/fusion\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'fission/fusion'), '1. The text describes liver ischemia-reperfusion injury (LIRI) as a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n2. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n4. A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n5. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on the information provided in the text, it is more likely that fission/fusion is a protective mechanism against liver ischemia-reperfusion injury (LIRI). Therefore, the answer is <Answer>B</Answer>, \"fission/fusion\" causes \"Liver ischemia-reperfusion injury (LIRI)\".')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 19 = mitophagy\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'mitophagy'), '1. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. The text also suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. The text does not provide any clear indication that \"mitophagy\" causes \"Liver ischemia-reperfusion injury (LIRI)\" or vice versa.\\n4. Instead, the text suggests that LIRI and mitophagy are causally related in that mitophagy can help protect against LIRI.\\n\\nTherefore, the more likely causal relationship is: D. there is a common factor that is the cause for both \"Liver ischemia-reperfusion injury (LIRI)\" and \"mitophagy\". \\n\\n<Answer>D</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 20 = steatosis\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'steatosis'), '1. The text describes \"Liver ischemia-reperfusion injury (LIRI)\" as a major cause of complications in liver resection and liver transplantation, and a major risk factor for early graft rejection with higher morbidity and mortality after surgery. \\n\\n2. The text also indicates that damage arising from LIRI is associated with exacerbating cellular injury, but the mechanisms leading to injury are not yet fully understood. \\n\\n3. The text further explains that mitochondrial dysfunction is recognized as a hallmark of LIRI and is essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R). \\n\\n4. The text also suggests that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI. \\n\\nBased on these statements, it is more likely that the answer is D: there is a common factor that is the cause for both \"Liver ischemia-reperfusion injury (LIRI)\" and \"steatosis\", rather than A or B, which suggest a unidirectional cause-and-effect relationship between LIRI and steatosis.')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 21 = aging\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 22 = therapeutic strategies\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'therapeutic strategies'), '1. The text describes Liver ischemia-reperfusion injury (LIRI) as a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also states that protecting mitochondria during liver I/R can ameliorate LIRI and that studying mitochondrial dysfunction will help develop new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this information, it is more likely that therapeutic strategies are developed in response to LIRI, rather than the other way around. Therefore, the cause-and-effect relationship is:\\n\\nB. \"therapeutic strategies\" causes \"Liver ischemia-reperfusion injury (LIRI)\"\\n\\n<Answer>B</Answer>')\n",
      "0 = Liver ischemia-reperfusion injury (LIRI), 23 = patient outcomes\n",
      "(('Liver ischemia-reperfusion injury (LIRI)', 'patient outcomes'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n2. The text also states that \"Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n3. Based on the above, it can be concluded that LIRI has a detrimental effect on patient outcomes.\\n\\nTherefore, the most likely cause-and-effect relationship is: A. \"Liver ischemia-reperfusion injury (LIRI)\" causes \"patient outcomes\".\\n\\n<Answer>A</Answer>')\n",
      "1 = complications, 2 = clinical settings\n",
      "(('complications', 'clinical settings'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. It is also mentioned that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. However, the text does not provide evidence or suggest that \"complications\" causes \"clinical settings\" or vice versa. \\n4. Furthermore, the text suggests that the mechanisms leading to LIRI are not yet fully understood and mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n5. Therefore, it is more likely that there is a common factor that causes both \"complications\" and \"clinical settings\", which is LIRI and its associated damage to liver cells. \\n\\n<Answer>D</Answer>')\n",
      "1 = complications, 3 = liver resection\n",
      "(('complications', 'liver resection'), '1. Identify the main topic: The main topic is liver ischemia-reperfusion injury (LIRI).\\n2. Look for relevant information: The text mentions that LIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. It also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. Analyze the cause-effect relationship: The text does not provide enough information to determine a direct cause-and-effect relationship between \"complications\" and \"liver resection\". While the text does suggest that LIRI can lead to complications and that LIRI can occur during liver resection, it does not explicitly state that complications are caused by liver resection or vice versa. Therefore, option C: \"complications\" and \"liver resection\" are not causally related, is the most likely answer.\\n\\n<Answer>C</Answer>')\n",
      "1 = complications, 4 = liver transplantation\n",
      "(('complications', 'liver transplantation'), '1. What is the topic of the text?\\nThe topic of the text is liver ischemia-reperfusion injury (LIRI) and the role of mitochondria in its development.\\n\\n2. What is the relationship between \"complications\" and \"liver transplantation\"?\\nThe text mentions that LIRI is a major cause of the development of complications in liver transplantation.\\n\\n3. Based on the above information, which cause-and-effect relationship is more likely?\\nB. \"liver transplantation\" causes \"complications\"\\n\\n<Answer>B</Answer>')\n",
      "1 = complications, 5 = graft rejection\n",
      "(('complications', 'graft rejection'), 'We can infer from the given text that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications and is associated with higher morbidity and mortality after surgery, and a major risk factor for early graft rejection. Therefore, it is more likely that \"complications\" cause \"graft rejection\". \\n\\n<Answer>A</Answer> \"complications\" causes \"graft rejection\".')\n",
      "1 = complications, 6 = morbidity\n",
      "(('complications', 'morbidity'), '1. What is the main topic of the text?\\n- The main topic of the text is liver ischemia-reperfusion injury (LIRI).\\n\\n2. What is the relationship between LIRI and complications?\\n- LIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n3. What is the relationship between LIRI and morbidity/mortality?\\n- Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\n4. Is there a mention of a causal relationship between \"complications\" and \"morbidity\" in the text?\\n- No, there is no mention of a causal relationship between \"complications\" and \"morbidity\" in the text.\\n\\n5. What is the most likely cause-and-effect relationship between \"complications\" and \"morbidity\" based on the information available?\\n- It is possible that both \"complications\" and \"morbidity\" are caused by the same underlying factor, which is LIRI.\\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"complications\" and \"morbidity\".')\n",
      "1 = complications, 7 = mortality\n",
      "(('complications', 'mortality'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications and is associated with higher morbidity and mortality after surgery.\\n2. It is also mentioned that the mechanisms leading to injury are not fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Protecting mitochondria during LIRI has been shown to ameliorate the injury.\\n4. Studying mitochondrial dysfunction during LIRI is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this information, it is more likely that \"complications\" causes \"mortality\". This is because LIRI, which is a major cause of complications after surgery, is also associated with higher morbidity and mortality. Additionally, protecting mitochondria during LIRI has been shown to improve patient outcomes, suggesting that mitochondrial dysfunction and resulting cellular injury are the underlying causes of complications and mortality.\\n\\nTherefore, the answer is <Answer>A</Answer>.')\n",
      "1 = complications, 8 = mechanisms\n",
      "(('complications', 'mechanisms'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and that protecting mitochondria during liver I/R ameliorates LIRI.\\n3. There is no explicit causal relationship stated between \"complications\" and \"mechanisms\".\\n\\nTherefore, the most likely answer is <Answer>C</Answer>: \"complications\" and \"mechanisms\" are not causally related. Both \"complications\" and \"mechanisms\" are effects of LIRI, but there is no indication in the text that one causes the other.')\n",
      "1 = complications, 9 = parenchymal\n",
      "(('complications', 'parenchymal'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text mentions that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. The text highlights that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI and that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on these points, the more likely cause-and-effect relationship is that <Answer>B</Answer> \"parenchymal\" causes \"complications\", as LIRI causes injury to the cells in the liver, including the parenchymal cells, which is a major risk factor for complications and poor outcomes after surgery.')\n",
      "1 = complications, 10 = non-parenchymal liver cells\n",
      "(('complications', 'non-parenchymal liver cells'), '1. Identify the entities: \"complications\" and \"non-parenchymal liver cells\".\\n2. Look for causal linkages between the entities in the text.\\n3. If a causal linkage is found, identify the direction of causality.\\n\\nThe text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications and non-parenchymal liver cell damage in different clinical settings. The text also explains that mitochondrial dysfunction exacerbates cellular injury during LIRI. However, there is no direct causal relationship mentioned between \"complications\" and \"non-parenchymal liver cells\". Therefore, the answer is <Answer>C</Answer>: \"complications\" and \"non-parenchymal liver cells\" are not causally related.')\n",
      "1 = complications, 11 = mitochondrial dysfunction\n",
      "(('complications', 'mitochondrial dysfunction'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n3. The text goes on to say that mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death, and that protecting mitochondria during liver I/R ameliorates LIRI.\\n\\nBased on this information, it is more likely that B) \"mitochondrial dysfunction\" causes \"complications\" in the context of liver I/R injury. \\n\\n<Answer>B</Answer>')\n",
      "1 = complications, 12 = glucose metabolism\n",
      "(('complications', 'glucose metabolism'), '1. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in glucose metabolism, energy production, and cell death.\\n3. Thus, mitochondrial dysfunction during liver I/R could lead to complications, and in turn, affect glucose metabolism.\\n\\nTherefore, it is more likely that \"complications\" cause \"glucose metabolism\" rather than the other way around.\\n\\n<Answer>A. \"complications\" causes \"glucose metabolism\"</Answer>')\n",
      "1 = complications, 13 = energy production\n",
      "(('complications', 'energy production'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. The text also mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n3. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death.\\n\\n4. The text suggests that protecting mitochondria during liver ischemia/reperfusion (I/R) ameliorates LIRI.\\n\\n5. The text highlights the progress made in recent years regarding the role of mitochondria in liver I/R and discusses the impact of liver conditions on LIRI.\\n\\nBased on the above information, it is more likely that \"energy production\" causes \"complications\". Mitochondrial dysfunction in LIRI exacerbates cellular injury and affects glucose metabolism, energy production, and other cellular functions. Protecting mitochondria during liver I/R ameliorates LIRI. Therefore, mitochondrial dysfunction, and by extension, impaired energy production, is a likely cause of complications associated with LIRI. \\n\\n<Answer>B. \"energy production\" causes \"complications\"</Answer>')\n",
      "1 = complications, 14 = reactive oxygen species (ROS) signaling\n",
      "(('complications', 'reactive oxygen species (ROS) signaling'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and that mitochondria play a major role in reactive oxygen species (ROS) signaling.\\n3. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI. \\n\\nBased on this information, it is more likely that \"reactive oxygen species (ROS) signaling\" causes \"complications\" rather than the other way around. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and the mitochondria play a major role in ROS signaling. Given that complications arising from LIRI are a major risk factor for early graft rejection and are associated with higher morbidity and mortality after surgery, it is reasonable to infer that ROS signaling, which is exacerbated by mitochondrial dysfunction, plays a causal role in the development of complications. \\n\\nTherefore, the answer is <Answer>B</Answer>.')\n",
      "1 = complications, 15 = calcium homeostasis\n",
      "(('complications', 'calcium homeostasis'), '1. What is the main topic of the text? \\n\\nThe main topic of the text is liver ischemia-reperfusion injury (LIRI) and the role of mitochondria in its development. \\n\\n2. What is the relationship between \"complications\" and LIRI? \\n\\nComplications are a result of LIRI. \\n\\n3. What is the relationship between \"calcium homeostasis\" and LIRI? \\n\\nCalcium homeostasis is a function of mitochondria and is relevant to LIRI because of its impact on cellular injury, but the text does not suggest that it causes LIRI or complications. \\n\\nTherefore, the answer is <Answer>C</Answer>: \"complications\" and \"calcium homeostasis\" are not causally related.')\n",
      "1 = complications, 16 = cell death\n",
      "(('complications', 'cell death'), '1. We are given information about liver ischemia-reperfusion injury (LIRI) and its association with complications, early graft rejection, and higher morbidity and mortality after surgery. \\n2. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n3. Mitochondria play a major role in various cellular processes such as glucose metabolism, energy production, ROS signaling, calcium homeostasis, and cell death.\\n4. Protecting mitochondria during liver I/R has been shown to ameliorate LIRI, and targeting mitochondria in conditions that exacerbate mitochondrial dysfunction has been successful in decreasing their susceptibility to LIRI. \\n5. The text does not provide any explicit information about a causal relationship between \"complications\" and \"cell death\".\\n\\nBased on this information, the most likely answer is <Answer>C</Answer>: \"complications\" and \"cell death\" are not causally related. While both are associated with liver I/R injury, the text does not suggest that one causes the other. Instead, both \"complications\" and \"cell death\" are consequences of the broader phenomenon of LIRI and its associated mitochondrial dysfunction.')\n",
      "1 = complications, 17 = mitochondrial biogenesis\n",
      "(('complications', 'mitochondrial biogenesis'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Mitochondrial dysfunction can be improved by protecting mitochondria through the regulation of mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R.\\n4. The text does not provide any direct link or causal relationship between \"complications\" and \"mitochondrial biogenesis.\"\\n\\nTherefore, based on the information provided in the text and pre-trained knowledge, the correct answer is: <Answer>C</Answer> \"complications\" and \"mitochondrial biogenesis\" are not causally related.')\n",
      "1 = complications, 18 = fission/fusion\n",
      "(('complications', 'fission/fusion'), '1. The text mentions that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. The text also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. It can be inferred from the text that \"fission/fusion\" is a process in which mitochondria divide or fuse together, and it plays a role in preserving mitochondrial health during liver I/R.\\n4. The text does not suggest any causation between \"complications\" and \"fission/fusion\".\\n\\nTherefore, the answer is <Answer>C</Answer>: \"complications\" and \"fission/fusion\" are not causally related.')\n",
      "1 = complications, 19 = mitophagy\n",
      "(('complications', 'mitophagy'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\" This implies that mitochondrial dysfunction is a contributing factor to the development of complications in liver I/R.\\n2. The text also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" This suggests that promoting mitophagy (a process of removing damaged mitochondria) can help prevent complications.\\n3. However, there is no mention in the text of complications causing mitophagy. \\n\\nBased on the information provided, it is more likely that option B is correct: \"mitophagy\" causes \"complications.\" \\n\\n<Answer>B</Answer>')\n",
      "1 = complications, 20 = steatosis\n",
      "(('complications', 'steatosis'), '1. The text mentions liver ischemia-reperfusion injury (LIRI) as a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that damage arising from LIRI is associated with higher morbidity and mortality after surgery.\\n3. The text highlights mitochondrial dysfunction as a hallmark of LIRI that exacerbates cellular injury.\\n4. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI.\\n5. The text mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on the information provided, it is more likely that \"steatosis\" causes \"complications\", as steatosis is a condition that exacerbates mitochondrial dysfunction and makes the liver more susceptible to LIRI, which in turn can lead to various complications such as early graft rejection, higher morbidity, and mortality after surgery. \\n\\n<Answer>B. \"Steatosis\" causes \"complications\"</Answer>')\n",
      "1 = complications, 21 = aging\n",
      "(('complications', 'aging'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) can cause complications in different clinical settings like liver resection and transplantation.\\n\\n2. The text also states that LIRI is associated with higher morbidity and mortality after surgery.\\n\\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\n5. The text does not provide any direct evidence or statement linking \"complications\" with \"aging\".\\n\\nBased on the information presented in the text, the most likely answer is:\\n\\n<Answer>D</Answer> there is a common factor that is the cause for both \"complications\" and \"aging\".')\n",
      "1 = complications, 22 = therapeutic strategies\n",
      "(('complications', 'therapeutic strategies'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\" This suggests that complications can arise from LIRI.\\n2. The text also suggests that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\" This suggests that therapeutic strategies may be developed as a result of studying the mechanisms of cellular damage during LIRI.\\n3. However, there is no direct causal relationship stated between \"complications\" and \"therapeutic strategies\".\\n\\nTherefore, the most likely answer is: <Answer>C</Answer> \"complications\" and \"therapeutic strategies\" are not causally related.')\n",
      "1 = complications, 23 = patient outcomes\n",
      "(('complications', 'patient outcomes'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text further explains that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text does not provide any direct causal relationship between \"complications\" and \"patient outcomes.\"\\n4. However, it can be inferred that the development of complications due to LIRI can lead to worse patient outcomes such as higher morbidity and mortality after surgery.\\n\\nTherefore, the more likely cause-and-effect relationship is: A. \"complications\" causes \"patient outcomes.\"\\n\\n<Answer>A</Answer>')\n",
      "2 = clinical settings, 3 = liver resection\n",
      "(('clinical settings', 'liver resection'), '1. Identify the entities: \"clinical settings\" and \"liver resection\".\\n2. Determine the causal relationship between the two entities based on the given text and pre-trained knowledge:\\n- The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n- This suggests that \"clinical settings\" is a broader term that encompasses liver resection as one of its specific instances that can lead to LIRI. In other words, \"clinical settings\" causes \"liver resection\".\\n3. Choose the best answer option: A. \"clinical settings\" causes \"liver resection\".\\n\\n<Answer>A</Answer>')\n",
      "2 = clinical settings, 4 = liver transplantation\n",
      "(('clinical settings', 'liver transplantation'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\nBased on this information, it is more likely that \"clinical settings\" (which include liver resection and liver transplantation) cause LIRI, rather than the other way around. Therefore, the answer is <Answer>A</Answer>: \"clinical settings\" causes \"liver transplantation\".')\n",
      "2 = clinical settings, 5 = graft rejection\n",
      "(('clinical settings', 'graft rejection'), '1. What is the main topic of the text? \\n\\nThe main topic of the text is liver ischemia-reperfusion injury (LIRI) and the role of mitochondrial dysfunction in its development.\\n\\n2. What is the relation of \"clinical settings\" to LIRI? \\n\\n\"Clinical settings\" is mentioned as one of the settings in which LIRI can develop.\\n\\n3. What is the relation of \"graft rejection\" to LIRI?\\n\\n\"Early graft rejection\" is mentioned as a major risk factor associated with LIRI.\\n\\n4. Based on the information in the text, which cause-and-effect relationship is more likely?\\n\\nFrom the text, it is more likely that \"graft rejection\" causes \"clinical settings\", as the text states that early graft rejection is a major risk factor associated with LIRI, which is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n<Answer>B</Answer>')\n",
      "2 = clinical settings, 6 = morbidity\n",
      "(('clinical settings', 'morbidity'), '1. What is the context of the text?\\nThe text is about liver ischemia-reperfusion injury (LIRI) and its impact on liver transplantation and liver resection.\\n\\n2. What is the main point related to \"clinical settings\" and \"morbidity\"?\\nThe text states that damage arising from LIRI is associated with higher morbidity and mortality after surgery in different clinical settings such as liver transplantation and liver resection.\\n\\n3. Based on the information provided, which cause-and-effect relationship is more likely?\\nOption B, \"morbidity\" causes \"clinical settings\", is unlikely as the text clearly states that the damage from LIRI is associated with higher morbidity and mortality after surgery in different clinical settings. Option C, \"clinical settings\" and \"morbidity\" are not causally related, is also unlikely as the text suggests that there is a causal relationship between LIRI and morbidity/mortality in different clinical settings. Option D, there is a common factor that is the cause for both \"clinical settings\" and \"morbidity\", is also not explicitly stated in the text. Therefore, Option A, \"clinical settings\" causes \"morbidity\", is the more likely cause-and-effect relationship based on the information provided.\\n\\n<Answer>A</Answer>')\n",
      "2 = clinical settings, 7 = mortality\n",
      "(('clinical settings', 'mortality'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n2. The text also mentions that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n\\n3. Based on this information, it is more likely that \"clinical settings\" (specifically liver resection and liver transplantation) cause \"mortality\" (higher morbidity and mortality after surgery) due to the risk of LIRI. \\n\\n4. The text does not suggest that \"mortality\" causes \"clinical settings\". \\n\\n5. The text does not suggest that there is a common factor causing both \"clinical settings\" and \"mortality\". \\n\\n6. Therefore, the answer is <Answer>A</Answer> \"clinical settings\" causes \"mortality\".')\n",
      "2 = clinical settings, 8 = mechanisms\n",
      "(('clinical settings', 'mechanisms'), '1. The text states that LIRI is a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n2. It also states that the mechanisms leading to the injury of liver cells during LIRI are not yet fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. The text indicates that protecting mitochondria during liver I/R ameliorates LIRI and that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction has been successful in decreasing their susceptibility to LIRI.\\n4. The text does not provide a clear causal relationship between clinical settings and mechanisms. It suggests that both are factors contributing to the development of LIRI but does not indicate a direct causal relationship between them.\\n\\n<Answer>C</Answer>')\n",
      "2 = clinical settings, 9 = parenchymal\n",
      "(('clinical settings', 'parenchymal'), '1. Identify the cause-and-effect relationship being asked: which entity (clinical settings or parenchymal) causes the other?\\n2. Find mentions of \"clinical settings\" and \"parenchymal\" in the text and their context.\\n3. Determine if there is any evidence of causality between the two entities based on the text and pre-trained knowledge.\\n\\n1. Cause-and-effect relationship: which entity (clinical settings or parenchymal) causes the other?\\n2. \"Clinical settings\" is mentioned as a location where liver ischemia-reperfusion injury (LIRI) causes complications, and the development of early graft rejection and higher morbidity and mortality after surgery. \"Parenchymal\" is associated with cellular injury, one of the damages that LIRI causes. \\n3. There is no evidence of causality between \"clinical settings\" and \"parenchymal\". \"Clinical settings\" are the location of liver resection and liver transplantation, while \"parenchymal\" refers to the liver cells (both parenchymal and non-parenchymal) that are damaged during LIRI. LIRI is the cause of damage to liver cells, but the text does not suggest that \"clinical settings\" cause LIRI or that \"parenchymal\" cause complications in different clinical settings. \\n\\n<Answer>C</Answer>')\n",
      "2 = clinical settings, 10 = non-parenchymal liver cells\n",
      "(('clinical settings', 'non-parenchymal liver cells'), '1. Identify the causal relationship: The question asks which entity causes the other. From the text, we can see that it is not explicitly stated that either \"clinical settings\" or \"non-parenchymal liver cells\" directly cause the other. \\n\\n2. Consider contextual information: The text explains that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in clinical settings and that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. The text also states that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood. These pieces of information suggest that LIRI may be the common factor causing both \"clinical settings\" and \"non-parenchymal liver cells\". \\n\\n3. Formulate the answer: Based on the above analysis, the most likely answer is D: there is a common factor that is the cause for both \"clinical settings\" and \"non-parenchymal liver cells\".\\n\\n<Answer>D</Answer>')\n",
      "2 = clinical settings, 11 = mitochondrial dysfunction\n",
      "(('clinical settings', 'mitochondrial dysfunction'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\nBased on this information, the most likely cause-and-effect relationship is: \\n\\nA. \"Clinical settings\" cause \"mitochondrial dysfunction\" \\n\\nThis is because the text mentions that LIRI, which is caused by clinical settings such as liver resection and transplantation, leads to mitochondrial dysfunction. The text does not suggest that mitochondrial dysfunction causes clinical settings. \\n\\nTherefore, the answer is: <Answer>A</Answer>.')\n",
      "2 = clinical settings, 12 = glucose metabolism\n",
      "(('clinical settings', 'glucose metabolism'), '1. The text states that mitochondria play a major role in glucose metabolism, energy production, ROS signaling, calcium homeostasis, and cell death.\\n2. The text also states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings.\\n3. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI.\\n4. The text also suggests that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on the information provided, it can be inferred that there is no direct cause-and-effect relationship between \"clinical settings\" and \"glucose metabolism\". Instead, mitochondrial dysfunction appears to be the common factor linking the two. Therefore, the correct answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"clinical settings\" and \"glucose metabolism\".')\n",
      "2 = clinical settings, 13 = energy production\n",
      "(('clinical settings', 'energy production'), '1. The text states that mitochondria play a major role in energy production, among other functions.\\n2. The text also mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in clinical settings such as liver resection and transplantation.\\n3. The text further explains that LIRI is associated with higher morbidity and mortality after surgery.\\n4. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n5. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on the information provided, it is most likely that <Answer>B</Answer> \"energy production\" causes \"clinical settings\". Mitochondria play a major role in energy production, and LIRI is a major cause of complications in clinical settings such as liver resection and transplantation. Mitochondrial dysfunction exacerbates cellular injury during LIRI, which suggests that dysfunction in energy production by mitochondria may be a causal factor in the development of complications in clinical settings.')\n",
      "2 = clinical settings, 14 = reactive oxygen species (ROS) signaling\n",
      "(('clinical settings', 'reactive oxygen species (ROS) signaling'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that mitochondria play a major role in reactive oxygen species (ROS) signaling, which is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n4. There is no information in the text to suggest that \"clinical settings\" causes \"reactive oxygen species (ROS) signaling\" or vice versa. \\n5. The text does not suggest that there is a single common factor that is the cause for both \"clinical settings\" and \"reactive oxygen species (ROS) signaling\" \\n\\nTherefore, the answer is <Answer>C</Answer>: \"clinical settings\" and \"reactive oxygen species (ROS) signaling\" are not causally related.')\n",
      "2 = clinical settings, 15 = calcium homeostasis\n",
      "(('clinical settings', 'calcium homeostasis'), '1. The text states that liver ischemia-reperfusion injury (LIRI) can occur in different \"clinical settings\".\\n2. The text also states that mitochondrial dysfunction is a hallmark of LIRI, which can exacerbate cellular injury.\\n3. The text mentions that mitochondria play a role in \"calcium homeostasis\".\\n4. There is no direct or indirect causal relationship mentioned between \"clinical settings\" and \"calcium homeostasis\".\\n\\nTherefore, option C: \"clinical settings\" and \"calcium homeostasis\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "2 = clinical settings, 16 = cell death\n",
      "(('clinical settings', 'cell death'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and transplantation.\\n2. The text also states that mitochondrial dysfunction exacerbates cellular injury, which is recognized as a hallmark of LIRI.\\n3. Additionally, the text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fusion/fission, and mitophagy during liver I/R can ameliorate LIRI. \\n\\nBased on the above information, it is more likely that there is a common factor that is the cause for both \"clinical settings\" and \"cell death\". The common factor is liver ischemia-reperfusion injury (LIRI), which can occur in various clinical settings and leads to cellular injury, including cell death. \\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"clinical settings\" and \"cell death\".')\n",
      "2 = clinical settings, 17 = mitochondrial biogenesis\n",
      "(('clinical settings', 'mitochondrial biogenesis'), '1. \"Clinical settings\" and \"mitochondrial biogenesis\" are both mentioned in the context of liver ischemia-reperfusion injury (LIRI).\\n2. From the text, it is clear that protecting mitochondria by regulating mitochondrial biogenesis can ameliorate LIRI. \\n3. However, \"clinical settings\" is mentioned as a context in which LIRI can occur, rather than a mechanism for causing or regulating mitochondrial biogenesis.\\n4. Therefore, it is more likely that there is no causal relationship between \"clinical settings\" and \"mitochondrial biogenesis\".\\n\\n<Answer>C</Answer>')\n",
      "2 = clinical settings, 18 = fission/fusion\n",
      "(('clinical settings', 'fission/fusion'), '1. \"Clinical settings\" and \"fission/fusion\" are both mentioned in the same sentence, but there is no direct causal relationship mentioned between them.\\n2. The text states that \"regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\", suggesting that fission/fusion is a potential solution for mitigating the effects of LIRI.\\n3. The text also mentions that \"clinical settings such as liver resection and liver transplantation\" are associated with LIRI, but there is no mention of fission/fusion in relation to these clinical settings.\\n\\nTherefore, it is most likely that \"clinical settings\" and \"fission/fusion\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "2 = clinical settings, 19 = mitophagy\n",
      "(('clinical settings', 'mitophagy'), '1. \"Clinical settings\" and \"mitophagy\" are both mentioned in the text, but there is no direct causative relationship mentioned.\\n2. The text suggests that protecting mitochondria through regulation of biogenesis, fission/fusion and mitophagy during liver ischemia/reperfusion (I/R) ameliorates liver ischemia-reperfusion injury (LIRI).\\n3. The text also mentions that liver conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, make mitochondria more susceptible to LIRI.\\n\\nTherefore, option D: there is a common factor that is the cause for both \"clinical settings\" and \"mitophagy\" is the most likely answer. This common factor could be liver ischemia-reperfusion or another underlying condition affecting both clinical settings and mitophagy. \\n\\n<Answer>D</Answer>')\n",
      "2 = clinical settings, 20 = steatosis\n",
      "(('clinical settings', 'steatosis'), '1. The text states that \"Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\"\\n2. The text also states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\n\\nTherefore, it is more likely that there is a common factor that is the cause for both \"clinical settings\" and \"steatosis\" since LIRI can occur in different clinical settings and can also be exacerbated by conditions such as steatosis. \\n\\n<Answer>D</Answer>')\n",
      "2 = clinical settings, 21 = aging\n",
      "(('clinical settings', 'aging'), '1. The text mentions clinical settings and aging as conditions that exacerbate mitochondrial dysfunction in the context of liver ischemia/reperfusion injury (LIRI).\\n2. However, the text does not provide any direct causal relationship between clinical settings and aging. \\n3. Instead, the text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI and has been successful in decreasing their susceptibility to LIRI in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging. \\n4. Therefore, it is more likely that there is a common factor that is the cause for both \"clinical settings\" and \"aging\", which leads to mitochondrial dysfunction and exacerbates LIRI.\\n\\n<Answer>D</Answer>')\n",
      "2 = clinical settings, 22 = therapeutic strategies\n",
      "2 = clinical settings, 23 = patient outcomes\n",
      "(('clinical settings', 'patient outcomes'), '1. Identify the variables in the text: Liver ischemia-reperfusion injury (LIRI), clinical settings, patient outcomes.\\n2. Look for causal language: \"is a major cause of the development of complications\", \"is associated with\", \"exacerbates cellular injury\", \"ameliorates LIRI\", \"important for\", \"targeting mitochondria... has been successful in decreasing their susceptibility to LIRI\", \"new therapeutic strategies aimed at improving patient outcomes\".\\n3. Determine the direction of causality between each pair of variables:\\n- LIRI causes patient outcomes (\"associated with higher morbidity and mortality after surgery\").\\n- Clinial settings may cause LIRI (\"a major cause of the development of complications\").\\n4. Decide whether the two variables are causally related or not:\\n- There seems to be a causal relationship between clinical settings and LIRI, as the latter is a consequence of the former.\\n- There also seems to be a causal relationship between LIRI and patient outcomes, as LIRI is associated with worse outcomes.\\n5. Determine the overall relationship between the three variables:\\n- It is likely that clinical settings do cause patient outcomes, but not directly. LIRI, which is caused by clinical settings, is the intermediary factor that leads to worse patient outcomes.\\n6. Choose the best answer option:\\n- A. \"clinical settings\" causes \"patient outcomes\" is the most appropriate answer based on the information provided.\\n\\n<Answer>A</Answer>')\n",
      "3 = liver resection, 4 = liver transplantation\n",
      "(('liver resection', 'liver transplantation'), '1. The text mentions \"liver resection and liver transplantation\" as two clinical settings where liver ischemia-reperfusion injury (LIRI) can occur.\\n2. The text also states that LIRI is a major risk factor for early graft rejection and higher morbidity and mortality after surgery.\\n3. There is no indication in the text that \"liver resection\" causes \"liver transplantation\" or vice versa.\\n4. Therefore, it is most likely that \"liver resection\" and \"liver transplantation\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "3 = liver resection, 5 = graft rejection\n",
      "(('liver resection', 'graft rejection'), '1. What is the medical condition discussed in the text?\\n- Liver ischemia-reperfusion injury (LIRI)\\n\\n2. What is the major cause of complications in different clinical settings such as liver resection and liver transplantation according to the text?\\n- Liver ischemia-reperfusion injury (LIRI)\\n\\n3. What is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery?\\n- Damage arising from LIRI\\n\\n4. What is recognized as a hallmark of LIRI that exacerbates cellular injury?\\n- Mitochondrial dysfunction \\n\\n5. Does \"liver resection\" cause \"graft rejection\" or reverse? Does the text provide evidence to support any of these two scenarios?\\n- The text suggests that damage arising from LIRI, which is caused by certain clinical settings including liver resection, is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Thus, it is more likely that \"liver resection\" causes \"graft rejection\" rather than the reverse.\\n\\n<Answer>A</Answer>')\n",
      "3 = liver resection, 6 = morbidity\n",
      "(('liver resection', 'morbidity'), '1. Identify the entities: \"liver resection\" and \"morbidity\"\\n2. Look for causal language: \\n- \"Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\"\\n- \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n3. Determine the causal relationship: From the text, it is clear that LIRI is the cause of morbidity after liver resection. Therefore, the answer is A. \"liver resection\" causes \"morbidity\".\\n\\n<Answer>A</Answer>')\n",
      "3 = liver resection, 7 = mortality\n",
      "(('liver resection', 'mortality'), '1. Identify the keywords: \"liver resection\" and \"mortality\".\\n2. Look for causal relationships involving these keywords in the given text.\\n3. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. LIRI is also associated with higher morbidity and mortality after surgery. However, the text does not suggest that liver resection causes mortality. Instead, it suggests that LIRI, which can occur during liver resection, is a major risk factor for early graft rejection and higher morbidity and mortality after surgery.\\n4. Therefore, the most likely cause-and-effect relationship is that LIRI caused by liver resection is a risk factor for mortality.\\n5. Option B (\"mortality\" causes \"liver resection\") can be ruled out since the text does not suggest that mortality causes liver resection.\\n6. Option C (\"liver resection\" and \"mortality\" are not causally related) can also be ruled out since LIRI caused by liver resection can lead to mortality.\\n7. Option D (\"there is a common factor that is the cause for both \"liver resection\" and \"mortality\") is not supported by the information in the given text, which specifically mentions LIRI caused by liver ischemia/reperfusion as a major risk factor for mortality after surgery.\\n8. Therefore, the correct answer is <Answer>A</Answer>: \"liver resection\" causes \"mortality\".')\n",
      "3 = liver resection, 8 = mechanisms\n",
      "(('liver resection', 'mechanisms'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also states that the mechanisms leading to the injury of liver cells are not yet fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\nFrom these statements, it is not clear that \"liver resection\" causes \"mechanisms\" or that \"mechanisms\" cause \"liver resection\". It is possible that there is a common factor that is the cause for both \"liver resection\" and \"mechanisms\". Additionally, the text does not provide any information that \"liver resection\" and \"mechanisms\" are not causally related. \\n\\nTherefore, the most likely answer is: <Answer>D</Answer> there is a common factor that is the cause for both \"liver resection\" and \"mechanisms\".')\n",
      "3 = liver resection, 9 = parenchymal\n",
      "(('liver resection', 'parenchymal'), '1. Identify the entities: \"liver resection\" and \"parenchymal\".\\n2. Look for indications of causality between the two entities in the text.\\n\\nUpon reading the text, there is no direct indication of a cause-and-effect relationship between \"liver resection\" and \"parenchymal\". The text states that damage arising from liver ischemia-reperfusion injury (LIRI) is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery, but this applies to liver transplantation in general rather than specifically to liver resection. Furthermore, the text discusses mitochondrial dysfunction as a hallmark of LIRI that exacerbates cellular injury, without mentioning liver resection as a cause of mitochondrial dysfunction. Therefore, it is unlikely that \"liver resection\" causes \"parenchymal\", or that \"parenchymal\" causes \"liver resection\". Instead, there could be a common factor that is the cause for both. \\n\\n<Answer>D</Answer>')\n",
      "3 = liver resection, 10 = non-parenchymal liver cells\n",
      "(('liver resection', 'non-parenchymal liver cells'), '1. Identify the entities: \"liver resection\" and \"non-parenchymal liver cells\".\\n2. Look for causal indicators such as verbs like \"cause\", \"result in\", \"lead to\", etc.\\n3. Check the direction of causality indicated in the text.\\n\\n1. Entities: \"liver resection\" and \"non-parenchymal liver cells\".\\n2. No causal indicators found.\\n3. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery\", indicating that \"non-parenchymal liver cells\" are affected by LIRI which is a risk factor for complications after \"liver resection\" surgery. Therefore, the correct answer is <Answer>B</Answer>, \"non-parenchymal liver cells\" causes \"liver resection\".')\n",
      "3 = liver resection, 11 = mitochondrial dysfunction\n",
      "(('liver resection', 'mitochondrial dysfunction'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI and has been successful in decreasing susceptibility to LIRI in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging. \\n\\n4. However, there is no mention in the text that \"liver resection\" causes \"mitochondrial dysfunction\", or vice versa. \\n\\nBased on the text and pre-trained knowledge, it is more likely that \"liver resection\" and \"mitochondrial dysfunction\" are not causally related. Therefore, the answer is <Answer>C</Answer>.')\n",
      "3 = liver resection, 12 = glucose metabolism\n",
      "(('liver resection', 'glucose metabolism'), '1. Identify the cause-and-effect relationship in the given text related to the two entities \"liver resection\" and \"glucose metabolism\".\\n2. Assess the plausibility of all possible options.\\n3. Choose the most likely cause-and-effect relationship.\\n\\n1. From the given text, we can see that the text discusses the detrimental effects of Liver ischemia-reperfusion injury (LIRI) that is a major cause of complications in different clinical settings such as liver resection. This implies that liver resection is not causing glucose metabolism but rather a cause of Liver ischemia-reperfusion injury (LIRI).\\n2. A) \"liver resection\" causes \"glucose metabolism\"; This option is unlikely as there is no evidence in the text to support this statement. \\nB) \"glucose metabolism\" causes \"liver resection\"; This option is also unlikely since the text states that LIRI is a major cause of complications associated with liver resection. Glucose metabolism is not mentioned in the context of causing liver resection.\\nC) \"liver resection\" and \"glucose metabolism\" are not causally related; This option is highly likely as glucose metabolism is not mentioned as a cause or a risk factor for liver resection, and liver resection is not mentioned as a cause or a risk factor for glucose metabolism.\\nD) There is a common factor that is the cause for both \"liver resection\" and \"glucose metabolism\"; This option is not mentioned in the text.\\n3. Therefore, the correct answer is <Answer>C</Answer>, \"liver resection\" and \"glucose metabolism\" are not causally related.')\n",
      "3 = liver resection, 13 = energy production\n",
      "(('liver resection', 'energy production'), '1. Identify the context: The text is discussing liver ischemia-reperfusion injury (LIRI) and the role of mitochondria in LIRI.\\n\\n2. Look for clues: The text mentions that mitochondria play a major role in energy production and that mitochondrial dysfunction is a hallmark of LIRI.\\n\\n3. Analyze the options:\\nA. \"Liver resection\" causes \"energy production\" - This is unlikely since energy production is a basic cellular process that does not require liver resection.\\nB. \"Energy production\" causes \"liver resection\" - This is unlikely since liver resection is a surgical procedure that is not directly related to energy production.\\nC. \"Liver resection\" and \"energy production\" are not causally related - This seems to be the most likely option based on the information provided in the text.\\nD. There is a common factor that is the cause for both \"liver resection\" and \"energy production\" - This is also unlikely since energy production is a basic cellular process that does not necessarily depend on liver resection.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"Liver resection\" and \"energy production\" are not causally related.')\n",
      "3 = liver resection, 14 = reactive oxygen species (ROS) signaling\n",
      "(('liver resection', 'reactive oxygen species (ROS) signaling'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver resection and liver transplantation.\\n2. The text also states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury, and that mitochondria play a major role in reactive oxygen species (ROS) signaling.\\n3. The text suggests that protecting mitochondria during liver ischemia/reperfusion (I/R) can ameliorate LIRI, and that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing susceptibility to LIRI.\\n\\nBased on this information, it is more likely that \"reactive oxygen species (ROS) signaling\" exacerbates cellular injury in liver ischemia-reperfusion injury (LIRI), rather than \"liver resection\" causing ROS signaling. Therefore, the answer is <Answer>B</Answer>: \"reactive oxygen species (ROS) signaling\" causes \"liver resection\".')\n",
      "3 = liver resection, 15 = calcium homeostasis\n",
      "(('liver resection', 'calcium homeostasis'), '1. Identify the causal relationship: We are asked to determine the causal relationship between \"liver resection\" and \"calcium homeostasis\". The text mentions that \"mitochondria play a major role in calcium homeostasis\" and that preserving mitochondrial health can help maintain liver integrity during liver ischemia/reperfusion (I/R). However, the text does not suggest a causal relationship between \"liver resection\" and \"calcium homeostasis\". \\n\\n2. Eliminate unlikely answer options: Based on the information given in the text, we can eliminate answer options A, B and D as unlikely since they suggest a causal relationship between \"liver resection\" and \"calcium homeostasis\".\\n\\n3. Final answer: Therefore, the correct answer is <Answer>C</Answer>: \"liver resection\" and \"calcium homeostasis\" are not causally related.')\n",
      "3 = liver resection, 16 = cell death\n",
      "(('liver resection', 'cell death'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also mentions that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text further states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury and that mitochondria play a major role in cell death.\\n4. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n\\nBased on the above analysis, it is more likely that \"liver resection\" and \"cell death\" are not causally related (Option C). While the text states that liver resection is a clinical setting in which LIRI can occur, it does not suggest a direct causal relationship between liver resection and cell death. The text also states that mitochondrial dysfunction exacerbates cellular injury and plays a major role in cell death, suggesting that there are multiple factors that could cause cell death during LIRI. Additionally, the text suggests that protecting mitochondria during liver I/R can ameliorate LIRI, which further supports the idea that cell death during LIRI is not solely caused by liver resection.')\n",
      "3 = liver resection, 17 = mitochondrial biogenesis\n",
      "(('liver resection', 'mitochondrial biogenesis'), '1. Identify the causal direction: The question asks which entity causes the other, so we need to identify the direction of causality. The text describes how protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI, implying that mitochondrial biogenesis is protective against liver ischemia/reperfusion injury.\\n2. Determine the relationship between the entities: The text describes liver resection and liver transplantation as clinical settings where liver ischemia-reperfusion injury can occur, but does not mention mitochondrial biogenesis in relation to these procedures. Therefore, there is no evidence to suggest that \"liver resection\" causes \"mitochondrial biogenesis\" or vice versa.\\n3. Consider alternative explanations: The text does not provide evidence for a common cause for both \"liver resection\" and \"mitochondrial biogenesis\".\\n4. Formulate the answer: Based on the information in the text and our pre-trained knowledge, the answer is <Answer>B</Answer>: \"mitochondrial biogenesis\" causes \"liver resection\".')\n",
      "3 = liver resection, 18 = fission/fusion\n",
      "(('liver resection', 'fission/fusion'), '1. Identify the causal relationship being asked: The question is asking whether \"liver resection\" causes \"fission/fusion\" or vice versa.\\n2. Identify relevant information: The text discusses liver ischemia-reperfusion injury (LIRI) and the role of mitochondrial dysfunction in exacerbating cellular injury during liver ischemia/reperfusion (I/R). The text also mentions regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R to ameliorate LIRI.\\n3. Analyze the entities: \"Liver resection\" is a clinical setting that can cause LIRI. \"Fission/fusion\" is a process involved in regulating mitochondrial health during liver I/R to ameliorate LIRI.\\n4. Apply reasoning: There is no direct causal relationship inferred or stated between \"liver resection\" and \"fission/fusion\" in the text. Rather, \"fission/fusion\" is mentioned as a process that can be regulated to protect mitochondrial health during liver I/R and ameliorate LIRI. It is possible that both \"liver resection\" and \"fission/fusion\" are caused by a common factor, such as underlying liver conditions that exacerbate mitochondrial dysfunction. However, based on the information in the text, it is most likely that \"liver resection\" and \"fission/fusion\" are not causally related.\\n5. Final answer: <Answer>C</Answer> (\"liver resection\" and \"fission/fusion\" are not causally related)')\n",
      "3 = liver resection, 19 = mitophagy\n",
      "(('liver resection', 'mitophagy'), '1. Identify the cause-and-effect relationship in the text:\\n\\nThe text discusses the role of mitochondria in liver ischemia-reperfusion injury (LIRI), which is a major cause of complications in liver transplantation and resection. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and preserving mitochondrial health during liver I/R has been shown to ameliorate LIRI. Additionally, targeting mitochondria has been successful in decreasing susceptibility to LIRI in conditions that exacerbate mitochondrial dysfunction. The text does not specifically discuss a causative relationship between \"liver resection\" and \"mitophagy.\"\\n\\n2. Determine the likely cause-and-effect relationship between \"liver resection\" and \"mitophagy\":\\n\\nThere is no clear cause-and-effect relationship between \"liver resection\" and \"mitophagy\" in the text.\\n\\n<Answer>C</Answer>')\n",
      "3 = liver resection, 20 = steatosis\n",
      "(('liver resection', 'steatosis'), '1. Identify the entities: \"liver resection\" and \"steatosis\"\\n2. Look for causal indicators: \\n   - \"such as\" indicates that they are examples of clinical settings that lead to liver ischemia-reperfusion injury (LIRI). \\n   - \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI\" suggests that steatosis is a condition that exacerbates mitochondrial dysfunction and can lead to LIRI.\\n   - There is no indication in the text that liver resection causes steatosis. \\n3. Determine the causal relationship:\\n   - Based on the above analysis, it is more likely that \"steatosis\" causes \"liver ischemia-reperfusion injury\" rather than \"liver resection\" causing \"steatosis\".\\n4. Final answer: <Answer>B</Answer> \"steatosis\" causes \"liver resection\".')\n",
      "3 = liver resection, 21 = aging\n",
      "(('liver resection', 'aging'), '1. Liver resection and aging are both mentioned in the text as conditions that can exacerbate mitochondrial dysfunction during liver ischemia/reperfusion injury (LIRI).\\n2. However, there is no indication in the text that liver resection causes aging or that aging causes liver resection.\\n3. In fact, the text only discusses the potential impact of liver conditions and aging on LIRI, without suggesting any direct causal relationship between them.\\n4. Therefore, the most likely answer is that \"liver resection\" and \"aging\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "3 = liver resection, 22 = therapeutic strategies\n",
      "(('liver resection', 'therapeutic strategies'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. The text also states that in order to improve patient outcomes, new therapeutic strategies aimed at improving mitochondrial health should be developed.\\n3. There is no direct or indirect causal relationship given between \"liver resection\" and \"therapeutic strategies\". \\n4. It is also not stated that there is a common factor that is the cause for both \"liver resection\" and \"therapeutic strategies\".\\n\\nTherefore, the answer is <Answer>C</Answer>: \"liver resection\" and \"therapeutic strategies\" are not causally related.')\n",
      "3 = liver resection, 23 = patient outcomes\n",
      "(('liver resection', 'patient outcomes'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in clinical settings such as liver resection and liver transplantation.\\n2. The text also mentions that damage arising from LIRI is associated with higher morbidity and mortality after surgery. \\n3. However, the text does not suggest that liver resection is the cause of patient outcomes, but rather that LIRI resulting from liver resection can contribute to negative patient outcomes.\\n\\nTherefore, the most likely cause-and-effect relationship is that LIRI resulting from liver resection can cause negative patient outcomes. \\n\\n<Answer>A</Answer>')\n",
      "4 = liver transplantation, 5 = graft rejection\n",
      "(('liver transplantation', 'graft rejection'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n2. The text also states that \"Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n\\nBased on the information presented, it is more likely that graft rejection is caused by damage arising from liver ischemia-reperfusion injury and mitochondrial dysfunction, rather than liver transplantation causing graft rejection.\\n\\nTherefore, the correct answer is <Answer>A</Answer>: \"liver transplantation\" causes \"graft rejection\".')\n",
      "4 = liver transplantation, 6 = morbidity\n",
      "(('liver transplantation', 'morbidity'), '1. Identify the cause-and-effect relationship: The question asks which entity is the cause and which is the effect. The text mentions both \"liver transplantation\" and \"morbidity\" as being associated with liver ischemia-reperfusion injury (LIRI). However, the text does not provide any evidence that one causes the other. \\n\\n2. Examine the context: The text describes LIRI as a major cause of complications after liver transplantation, which can lead to higher morbidity and mortality. However, the text also notes that mitochondrial dysfunction is recognized as a hallmark of LIRI, which suggests that it is not solely caused by the transplantation itself. \\n\\n3. Consider alternative explanations: It is possible that there is a common factor that contributes to both \"liver transplantation\" and \"morbidity\", such as underlying health conditions. \\n\\n<Answer>D</Answer>')\n",
      "4 = liver transplantation, 7 = mortality\n",
      "(('liver transplantation', 'mortality'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation. \\n2. The text also states that damage from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. However, the text does not provide any evidence to suggest that liver transplantation causes mortality. \\n\\nTherefore, option C: \"liver transplantation\" and \"mortality\" are not causally related is the correct answer. \\n\\n<Answer>C</Answer>')\n",
      "4 = liver transplantation, 8 = mechanisms\n",
      "(('liver transplantation', 'mechanisms'), '1. Identify the entities: \"liver transplantation\" and \"mechanisms\".\\n2. Look for references to causality or cause-and-effect relationships between these entities in the text.\\n3. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation, which suggests that \"mechanisms\" could be a cause of \"liver transplantation\".\\n4. However, the text also states that \"mechanisms\" are not yet fully understood and that protecting mitochondria during liver ischemia/reperfusion can ameliorate LIRI, which suggests that \"liver transplantation\" is not causing \"mechanisms\".\\n5. Thus, option C: \"liver transplantation\" and \"mechanisms\" are not causally related, seems to be the most appropriate answer.\\n\\n<Answer>C</Answer>')\n",
      "4 = liver transplantation, 9 = parenchymal\n",
      "(('liver transplantation', 'parenchymal'), '1. What is LIRI? \\n- Liver ischemia-reperfusion injury is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n2. What is the role of mitochondrial dysfunction in LIRI? \\n- Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n\\n3. How can LIRI be ameliorated? \\n- Protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R can ameliorate LIRI. \\n\\n4. What is the impact of liver conditions on LIRI? \\n- Liver conditions such as steatosis and aging exacerbate mitochondrial dysfunction, making the liver more susceptible to LIRI.\\n\\nBased on the information provided, it can be concluded that:\\n- While liver transplantation is a clinical setting where LIRI can occur, there is no evidence to suggest that it causes parenchymal damage.\\n- On the other hand, mitochondrial dysfunction is recognized as a hallmark of LIRI and exacerbates cellular injury, including damage to the parenchymal and non-parenchymal liver cells.\\n- Therefore, it is more likely that \"parenchymal\" is a consequence of LIRI rather than a cause of liver transplantation.\\n\\n<Answer>B</Answer>')\n",
      "4 = liver transplantation, 10 = non-parenchymal liver cells\n",
      "(('liver transplantation', 'non-parenchymal liver cells'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n2. It also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text further explains that although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. It then highlights the importance of preserving mitochondrial health to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R) and suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n5. The text mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n6. Finally, the text emphasizes that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the text and our pre-trained knowledge, it can be concluded that there is no causal relationship between \"liver transplantation\" and \"non-parenchymal liver cells\". Therefore, the correct answer is <Answer>C</Answer>: \"liver transplantation\" and \"non-parenchymal liver cells\" are not causally related.')\n",
      "4 = liver transplantation, 11 = mitochondrial dysfunction\n",
      "(('liver transplantation', 'mitochondrial dysfunction'), '1. What is Liver Ischemia-Reperfusion Injury (LIRI)? \\n\\nLiver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n2. What is the relationship between LIRI and liver transplantation? \\n\\nLIRI is a major cause of the development of complications in liver transplantation. \\n\\n3. What is mitochondrial dysfunction? \\n\\nMitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death. \\n\\n4. What is the impact of mitochondrial dysfunction on LIRI? \\n\\nMitochondrial dysfunction exacerbates cellular injury during LIRI.\\n\\n5. Can we conclude that \"liver transplantation\" causes \"mitochondrial dysfunction\"? \\n\\nNo, there is no evidence in the text suggesting that \"liver transplantation\" causes \"mitochondrial dysfunction\".\\n\\n6. Can we conclude that \"mitochondrial dysfunction\" causes \"liver transplantation\"? \\n\\nNo, there is no evidence in the text suggesting that \"mitochondrial dysfunction\" causes \"liver transplantation\". \\n\\n7. Can we conclude that \"liver transplantation\" and \"mitochondrial dysfunction\" are not causally related? \\n\\nYes, based on the information provided in the text, there is no evidence suggesting a causal relationship between \"liver transplantation\" and \"mitochondrial dysfunction\". \\n\\n8. Can we conclude that there is a common factor that is the cause for both \"liver transplantation\" and \"mitochondrial dysfunction\"? \\n\\nNo, there is no evidence in the text suggesting that there is a common factor that is the cause for both \"liver transplantation\" and \"mitochondrial dysfunction\". \\n\\n<Answer>C</Answer>')\n",
      "4 = liver transplantation, 12 = glucose metabolism\n",
      "(('liver transplantation', 'glucose metabolism'), 'Step 1: Identify the causal entities\\n- \"liver transplantation\"\\n- \"glucose metabolism\"\\n\\nStep 2: Search for causal indicators\\n- There is no explicit statement that links \"liver transplantation\" and \"glucose metabolism\".\\n- The text mentions that mitochondria play a major role in glucose metabolism, but this is not linked to liver transplantation.\\n- The text mentions that protecting mitochondria during liver ischemia/reperfusion (I/R) ameliorates LIRI. However, this does not imply a causal relationship between \"liver transplantation\" and \"glucose metabolism\".\\n\\nStep 3: Apply background knowledge\\n- \"Liver transplantation\" and \"glucose metabolism\" are not directly related concepts.\\n- However, glucose metabolism is important for liver function and a healthy liver is crucial for successful liver transplantation. \\n\\nTherefore, the correct answer is <Answer>C</Answer>: \"liver transplantation\" and \"glucose metabolism\" are not causally related.')\n",
      "4 = liver transplantation, 13 = energy production\n",
      "(('liver transplantation', 'energy production'), '1. What is the main topic of the text?\\n- Liver ischemia-reperfusion injury and its relation to mitochondrial dysfunction, as well as new therapeutic strategies for improving patient outcomes.\\n\\n2. Which entities are we asked to consider?\\n- \"Liver transplantation\" and \"energy production\".\\n\\n3. Is there any direct causal relationship stated between these entities in the text?\\n- No, there is not.\\n\\n4. Does the text provide any information on whether \"liver transplantation\" causes \"energy production\"?\\n- No, it does not.\\n\\n5. Does the text provide any information on whether \"energy production\" causes \"liver transplantation\"?\\n- No, it does not.\\n\\n6. Is there any indication in the text that \"liver transplantation\" and \"energy production\" are not causally related?\\n- No, there is no such indication.\\n\\n7. Does the text suggest that there is a common factor that is the cause for both \"liver transplantation\" and \"energy production\"?\\n- No, it does not.\\n\\nTherefore, based on the provided text and pre-trained knowledge, the answer is <Answer>C</Answer>: \"liver transplantation\" and \"energy production\" are not causally related.')\n",
      "4 = liver transplantation, 14 = reactive oxygen species (ROS) signaling\n",
      "(('liver transplantation', 'reactive oxygen species (ROS) signaling'), '1. Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n2. Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\\n5. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n6. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the information provided in the text, it can be inferred that \"reactive oxygen species (ROS) signaling\" exacerbates cellular injury that is associated with liver resection and liver transplantation. Therefore, \"reactive oxygen species (ROS) signaling\" is a contributing factor to the development of complications in these clinical settings, rather than being caused by them. \\n\\nTherefore, the correct answer is <Answer>B</Answer>: \"reactive oxygen species (ROS) signaling\" causes \"liver transplantation\".')\n",
      "4 = liver transplantation, 15 = calcium homeostasis\n",
      "(('liver transplantation', 'calcium homeostasis'), '1. Identify the causal relationship: The text describes the role of mitochondria in liver ischemia-reperfusion injury (LIRI), which is a major cause of complications in liver transplantation and other clinical settings.\\n2. Locate the entities: \"Liver transplantation\" is mentioned as a clinical setting where LIRI can occur. \"Calcium homeostasis\" is mentioned as one of the functions regulated by mitochondria in liver cells.\\n3. Determine the causal direction: The text does not suggest any causal relationship between \"liver transplantation\" and \"calcium homeostasis\". Instead, it explains how mitochondrial dysfunction can exacerbate cellular injury during LIRI and how regulating mitochondrial health can ameliorate LIRI.\\n4. Rule out alternative explanations: The text does not suggest any common factor that could be the cause for both \"liver transplantation\" and \"calcium homeostasis\".\\n5. Final answer: <Answer>C</Answer> \"liver transplantation\" and \"calcium homeostasis\" are not causally related.')\n",
      "4 = liver transplantation, 16 = cell death\n",
      "(('liver transplantation', 'cell death'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings, such as liver resection and liver transplantation.\\n2. The text also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. The text states that mitochondria play a major role in cell death.\\n5. The text suggests that protecting mitochondria during liver ischemia/reperfusion (I/R) ameliorates LIRI.\\n\\nBased on these pieces of information, it is more likely that \"cell death\" causes \"liver transplantation\", as damage from LIRI, including cell death caused by mitochondrial dysfunction, is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after liver transplantation surgery.\\n\\nTherefore, the answer is <Answer>B</Answer>, \"cell death\" causes \"liver transplantation\".')\n",
      "4 = liver transplantation, 17 = mitochondrial biogenesis\n",
      "(('liver transplantation', 'mitochondrial biogenesis'), '1. Identify the cause-and-effect relationship: \\n\\nThe question asks which entity causes the other or if they are not causally related. The entities are \"liver transplantation\" and \"mitochondrial biogenesis.\" \\n\\n2. Look for evidence in the text:\\n\\nThe text mentions that protecting mitochondria by regulating mitochondrial biogenesis during liver I/R ameliorates LIRI. It also states that liver I/R injury is associated with complications in liver transplantation. \\n\\n3. Apply causal reasoning:\\n\\nBased on the evidence in the text, it is more likely that \"liver transplantation\" causes \"mitochondrial biogenesis.\" This is because the text suggests that protecting mitochondria during liver transplantation can improve outcomes, which implies that mitochondrial biogenesis would be initiated as a response to the transplantation. In contrast, there is no evidence to suggest that mitochondrial biogenesis causes liver transplantation. \\n\\n<Answer>A</Answer>')\n",
      "4 = liver transplantation, 18 = fission/fusion\n",
      "(('liver transplantation', 'fission/fusion'), '1. Identify the cause-and-effect relationship being questioned: Which causes which between \"liver transplantation\" and \"fission/fusion\"?\\n2. Look for evidence in the text: \\n- The text mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n- \"Liver transplantation\" is mentioned as a clinical setting where liver ischemia-reperfusion injury (LIRI) may occur.\\n3. Analyze the evidence:\\n- There is evidence of a causal relationship between fission/fusion and LIRI. Regulating fission/fusion can ameliorate LIRI. \\n- There is no direct evidence of a causal relationship between liver transplantation and fission/fusion.\\n4. Combine the analysis with pre-existing knowledge:\\n- Liver transplantation involves the removal of a diseased liver and its replacement with a healthy liver from a donor. This process may involve liver ischemia-reperfusion injury (LIRI).\\n- Fission/fusion is a biological process that occurs in cells and is related to the health of mitochondria.\\n5. Choose the most likely answer based on steps 1-4: C: \"liver transplantation\" and \"fission/fusion\" are not causally related.\\n<Answer>C</Answer>')\n",
      "4 = liver transplantation, 19 = mitophagy\n",
      "(('liver transplantation', 'mitophagy'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation.\\n2. The text also mentions that protecting mitochondria by regulating mitophagy during liver I/R ameliorates LIRI.\\n3. The text does not state or imply that liver transplantation causes mitophagy.\\n\\nBased on the information provided, it is more likely that mitophagy is a process that can be regulated to improve outcomes for liver transplantation, rather than liver transplantation causing mitophagy. Therefore, the answer is <Answer>A</Answer>: \"liver transplantation\" causes \"mitophagy\".')\n",
      "4 = liver transplantation, 20 = steatosis\n",
      "(('liver transplantation', 'steatosis'), '1. Identify the relevant information: \\n- Liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation. \\n- Mitochondrial dysfunction exacerbates cellular injury during LIRI. \\n- Protecting mitochondria during liver I/R ameliorates LIRI. \\n- Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing susceptibility to LIRI. \\n2. Determine the possible cause-and-effect relationship between \"liver transplantation\" and \"steatosis\": \\n- There is no direct causal relationship suggested in the text between \"liver transplantation\" and \"steatosis\". \\n- The text suggests that steatosis is a contributing factor to mitochondrial dysfunction, which exacerbates LIRI. \\n- There is no suggestion that \"liver transplantation\" causes steatosis. \\n3. Determine the most likely cause-and-effect relationship: \\n- Based on the information provided, the most likely cause-and-effect relationship is that \"steatosis\" causes increased susceptibility to LIRI, rather than \"liver transplantation\" causing \"steatosis\". \\n4. Select the correct answer: \\n- <Answer>B</Answer>-\"steatosis\" causes \"liver transplantation\"')\n",
      "4 = liver transplantation, 21 = aging\n",
      "(('liver transplantation', 'aging'), '1. Identify the keywords and entities:\\n- Keywords: liver ischemia-reperfusion injury, mitochondrial dysfunction, cellular injury, liver transplantation, aging.\\n- Entities: liver ischemia-reperfusion injury, complications, liver resection, liver transplantation, graft rejection, morbidity, mortality, mitochondrial dysfunction, glucose metabolism, energy production, reactive oxygen species, calcium homeostasis, cell death, mitochondrial biogenesis, fission/fusion, mitophagy, steatosis, aging.\\n\\n2. Determine the cause-and-effect relationship between \"liver transplantation\" and \"aging\":\\n- The text mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n- This suggests that \"aging\" exacerbates mitochondrial dysfunction, which in turn increases susceptibility to LIRI.\\n- The text does not mention any causal relationship between \"liver transplantation\" and \"aging\".\\n\\nTherefore, the cause-and-effect relationship that is more likely is: B. \"aging\" causes \"liver transplantation\".\\n\\n<Answer>B</Answer>')\n",
      "4 = liver transplantation, 22 = therapeutic strategies\n",
      "(('liver transplantation', 'therapeutic strategies'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. The text also states that understanding the underlying mechanisms of cellular damage during LIRI is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\n3. Therefore, it is more likely that \"liver transplantation\" is not causing \"therapeutic strategies\", but rather the development of new therapeutic strategies is a response to the need to address complications arising from liver transplantation, particularly LIRI.\\n\\n4. In other words, the causal relationship between \"therapeutic strategies\" and \"liver transplantation\" is that \"liver transplantation\" is leading to the development of \"therapeutic strategies\" to address complications such as LIRI.\\n\\n<Answer>B</Answer>')\n",
      "4 = liver transplantation, 23 = patient outcomes\n",
      "(('liver transplantation', 'patient outcomes'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation.\\n2. The text also mentions that mitochondrial dysfunction exacerbates cellular injury during LIRI and that protecting mitochondria during liver I/R can ameliorate LIRI.\\n3. The text emphasizes that studying mitochondrial dysfunction will help develop new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this, it is more likely that \"patient outcomes\" are affected by LIRI, which in turn is affected by liver transplantation. Therefore, the correct answer is <Answer>B</Answer>: \"patient outcomes\" causes \"liver transplantation\", at least in the context of LIRI and the need to protect mitochondria during liver I/R.')\n",
      "5 = graft rejection, 6 = morbidity\n",
      "(('graft rejection', 'morbidity'), 'Step 1: Identify the entities\\n\\nThe entities are \"graft rejection\" and \"morbidity.\"\\n\\nStep 2: Identify the causal direction from the text\\n\\nThe text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\" This suggests that LIRI (liver ischemia-reperfusion injury) is the cause, and \"graft rejection\" and \"morbidity\" are both effects.\\n\\nStep 3: Verify the answer with the options\\n\\nBased on the above analysis, the answer is D (there is a common factor that is the cause for both \"graft rejection\" and \"morbidity\"). However, this option is not available in the given choices. Thus, the closest answer is A ( \"graft rejection\" causes \"morbidity\"). It should be noted that although there is a causal relationship between \"graft rejection\" and \"morbidity,\" the common cause for both of them is LIRI. \\n\\n<Answer>A</Answer>')\n",
      "5 = graft rejection, 7 = mortality\n",
      "(('graft rejection', 'mortality'), '1. What is the topic of the text?\\n\\nThe topic of the text is liver ischemia-reperfusion injury (LIRI) and its impact on liver transplantation and resection.\\n\\n2. What is LIRI?\\n\\nLIRI stands for liver ischemia-reperfusion injury, a condition that occurs during liver transplantation and resection and can cause damage to both parenchymal and non-parenchymal liver cells.\\n\\n3. What is a major risk factor associated with LIRI?\\n\\nLIRI is associated with higher morbidity and mortality after surgery.\\n\\n4. What is recognized as a hallmark of LIRI that exacerbates cellular injury?\\n\\nMitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n5. How do mitochondria contribute to liver function and what are some of the ways to preserve mitochondrial health during liver I/R?\\n\\nMitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death. It is essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R) by regulating mitochondrial biogenesis, fission/fusion and mitophagy.\\n\\n6. What is the purpose of studying mitochondrial dysfunction?\\n\\nStudying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\n7. Which cause-and-effect relationship is more likely between \"graft rejection\" and \"mortality\" based on the information provided?\\n\\nThere is not enough information in the text to determine a cause-and-effect relationship between \"graft rejection\" and \"mortality\".\\n\\n<Answer>C</Answer>')\n",
      "5 = graft rejection, 8 = mechanisms\n",
      "(('graft rejection', 'mechanisms'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n4. The text states that \"Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n\\nBased on this information, it is more likely that \"mechanisms\" (specifically, mitochondrial dysfunction) cause \"graft rejection\" rather than the other way around. In other words, the damage and injury caused by LIRI (which involves mitochondrial dysfunction) increase the risk of graft rejection and adverse patient outcomes.\\n\\nTherefore, the answer is <Answer>B</Answer>: \"mechanisms\" (mitochondrial dysfunction) causes \"graft rejection\".')\n",
      "5 = graft rejection, 9 = parenchymal\n",
      "(('graft rejection', 'parenchymal'), '1. \"Graft rejection\" and \"Parenchymal\" are both mentioned in the context of liver ischemia-reperfusion injury (LIRI).\\n2. The text states that damage from LIRI is a major risk factor for early graft rejection.\\n3. The text also states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury, including injury to parenchymal liver cells.\\n4. There is no clear indication that \"parenchymal\" causes \"graft rejection.\"\\n\\nTherefore, the most likely cause-and-effect relationship is: \\n\\nB. \"Parenchymal\" causes \"graft rejection.\"\\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 10 = non-parenchymal liver cells\n",
      "(('graft rejection', 'non-parenchymal liver cells'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. The text states that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n4. The text suggests that protecting mitochondria during liver ischemia/reperfusion (I/R) ameliorates LIRI, and targeting mitochondria in conditions that exacerbate mitochondrial dysfunction has been successful in decreasing susceptibility to LIRI. \\n5. The text does not provide any explicit causal relationship between \"graft rejection\" and \"non-parenchymal liver cells\". \\n\\nTherefore, the answer is <Answer>C</Answer>: \"graft rejection\" and \"non-parenchymal liver cells\" are not causally related.')\n",
      "5 = graft rejection, 11 = mitochondrial dysfunction\n",
      "(('graft rejection', 'mitochondrial dysfunction'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and transplantation.\\n2. The text also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. Furthermore, the text indicates that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n4. Mitochondria play a major role in glucose metabolism, energy production, ROS signaling, calcium homeostasis and cell death.\\n5. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n6. Finally, the text indicates that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the information provided in the text, it is more likely that \"mitochondrial dysfunction\" causes \"graft rejection\" as mitochondrial dysfunction exacerbates cellular injury in LIRI which is a major risk factor for early graft rejection.\\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 12 = glucose metabolism\n",
      "(('graft rejection', 'glucose metabolism'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of early graft rejection and higher morbidity and mortality after surgery. \\n2. The text also states that mitochondrial dysfunction exacerbates cellular injury during LIRI. \\n3. Additionally, the text mentions that mitochondria play a major role in glucose metabolism, energy production, and cellular activity.\\n4. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI. \\n5. Finally, the text highlights that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the above analysis, the most likely cause-and-effect relationship is that \"mitochondrial dysfunction\" causes \"graft rejection\". Glucose metabolism is not mentioned in the context of graft rejection in the text. Therefore, options A, B, and D can be ruled out. Option C, \"graft rejection\" and \"glucose metabolism\" are not causally related, is also not accurate as the text highlights the important role of mitochondria in glucose metabolism and cellular activity. \\n\\n<Answer>A</Answer>')\n",
      "5 = graft rejection, 13 = energy production\n",
      "(('graft rejection', 'energy production'), '1. The text mentions that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n2. The text also mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text further states that \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n4. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n\\nBased on these statements, it is more likely that \"energy production\" causes \"graft rejection\" as mitochondrial dysfunction, which affects energy production, is recognized as a hallmark of LIRI that exacerbates cellular injury leading to graft rejection.\\n\\nTherefore, the answer is <Answer>B</Answer>.')\n",
      "5 = graft rejection, 14 = reactive oxygen species (ROS) signaling\n",
      "(('graft rejection', 'reactive oxygen species (ROS) signaling'), '1. The text states that damage arising from liver ischemia-reperfusion injury (LIRI) is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and reactive oxygen species (ROS) signaling is one of the functions of mitochondria.\\n3. Therefore, it is more likely that \"reactive oxygen species (ROS) signaling\" causes \"graft rejection\". \\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 15 = calcium homeostasis\n",
      "(('graft rejection', 'calcium homeostasis'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver resection and transplantation.\\n2. The text also states that LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text further explains that mitochondrial dysfunction is recognized as a hallmark of LIRI and exacerbates cellular injury.\\n4. The text mentions that mitochondria play a major role in calcium homeostasis, among other functions.\\n5. The text suggests that protecting mitochondria during liver ischemia/reperfusion (I/R) can ameliorate LIRI.\\n\\nBased on this information, it is more likely that \"calcium homeostasis\" causes \"graft rejection\", as opposed to the other way around. The text suggests that mitochondrial dysfunction and cellular injury caused by LIRI exacerbate the risk of graft rejection, but also recognizes that mitochondria play a major role in calcium homeostasis. Therefore, it is plausible that an imbalance in calcium regulation due to LIRI-induced mitochondrial dysfunction could lead to graft rejection.\\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 16 = cell death\n",
      "(('graft rejection', 'cell death'), '1. What is liver ischemia-reperfusion injury (LIRI)? \\n\\nLIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. \\n\\n2. What is the impact of LIRI on graft rejection?\\n\\nDamage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\n3. What is recognized as a hallmark of LIRI that exacerbates cellular injury?\\n\\nMitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. What is the role of mitochondria in liver ischemia/reperfusion (I/R)? \\n\\nMitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death. \\n\\n5. Does protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorate LIRI?\\n\\nA growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n\\n6. What would studying mitochondrial dysfunction help understand?\\n\\nStudying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the information provided, it is more likely that option B, \"cell death\" causes \"graft rejection\" is the correct answer. Mitochondrial dysfunction is recognized as a hallmark of LIRI, which exacerbates cellular injury, including cell death. Damage arising from LIRI, which includes cell death, is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Therefore, it is reasonable to conclude that cell death caused by mitochondrial dysfunction during LIRI is a major contributor to graft rejection. \\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 17 = mitochondrial biogenesis\n",
      "(('graft rejection', 'mitochondrial biogenesis'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection\".\\n2. The text also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n3. However, there is no direct statement linking \"graft rejection\" and \"mitochondrial biogenesis\".\\n4. Therefore, options A and B can be ruled out.\\n5. The text does not suggest a common cause for both \"graft rejection\" and \"mitochondrial biogenesis\".\\n6. Therefore, option D can be ruled out.\\n7. Based on the information in the text, it can be concluded that \"graft rejection\" and \"mitochondrial biogenesis\" are not causally related.\\n8. Therefore, the correct answer is <Answer>C</Answer>.')\n",
      "5 = graft rejection, 18 = fission/fusion\n",
      "(('graft rejection', 'fission/fusion'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of early graft rejection and higher morbidity and mortality after surgery.\\n2. The text also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. The text does not provide any direct causal link between \"graft rejection\" and \"fission/fusion\".\\n\\nTherefore, the most likely answer is that \"graft rejection\" and \"fission/fusion\" are not causally related. <Answer>C</Answer>.')\n",
      "5 = graft rejection, 19 = mitophagy\n",
      "(('graft rejection', 'mitophagy'), '1. \"Graft rejection\" is mentioned as a consequence of liver ischemia-reperfusion injury (LIRI).\\n2. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Protecting mitochondria ameliorates LIRI.\\n4. Mitophagy is mentioned as a mechanism for protecting mitochondria during liver I/R.\\n\\nBased on these statements, it is more likely that \"mitophagy\" causes \"graft rejection\" rather than the other way around. Mitophagy is mentioned as a mechanism for protecting mitochondria during liver I/R, and protecting mitochondria has been shown to ameliorate LIRI. In contrast, \"graft rejection\" is mentioned as a consequence of LIRI rather than a cause. \\n\\nTherefore, the answer is <Answer>B</Answer>: \"mitophagy\" causes \"graft rejection\".')\n",
      "5 = graft rejection, 20 = steatosis\n",
      "(('graft rejection', 'steatosis'), '1. In the given text, there is information on how liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also mentions that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. Additionally, it is stated that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI. \\n4. There is no information in the text that suggests that graft rejection can cause steatosis.\\n\\nTherefore, the more likely cause-and-effect relationship is: \\n\\nB. \"steatosis\" causes \"graft rejection\"\\n\\n<Answer>B</Answer>')\n",
      "5 = graft rejection, 21 = aging\n",
      "(('graft rejection', 'aging'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver transplantation and that damage from LIRI is a major risk factor for early graft rejection. \\n2. The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing susceptibility to LIRI.\\n3. However, there is no mention of graft rejection causing aging or aging causing graft rejection.\\n4. Therefore, the most likely answer is that \"graft rejection\" and \"aging\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "5 = graft rejection, 22 = therapeutic strategies\n",
      "(('graft rejection', 'therapeutic strategies'), '1. What is the medical condition discussed in the text?\\n- Liver ischemia-reperfusion injury (LIRI).\\n\\n2. What is the major cause of complications in different clinical settings such as liver resection and liver transplantation as stated in the text?\\n- Liver ischemia-reperfusion injury (LIRI).\\n\\n3. What is the major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery as stated in the text?\\n- Damage arising from LIRI.\\n\\n4. Is there a causal relationship between \"graft rejection\" and \"therapeutic strategies\" that can be inferred from the text?\\n- No direct causal relationship between \"graft rejection\" and \"therapeutic strategies\" is mentioned in the text.\\n\\n5. What is inferred to be the cause of \"graft rejection\" and the need for \"therapeutic strategies\"?\\n- Both \"graft rejection\" and the need for \"therapeutic strategies\" are effects of liver ischemia-reperfusion injury (LIRI).\\n\\nTherefore, the answer is <Answer>D</Answer>.')\n",
      "5 = graft rejection, 23 = patient outcomes\n",
      "(('graft rejection', 'patient outcomes'), '1. The text states that damage from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n2. The text also states that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n3. Both graft rejection and patient outcomes are mentioned in the text as being affected by LIRI.\\n\\nBased on this information, it is most likely that:\\n\\nD. there is a common factor that is the cause for both \"graft rejection\" and \"patient outcomes\".')\n",
      "6 = morbidity, 7 = mortality\n",
      "(('morbidity', 'mortality'), '1. We are looking for the cause-and-effect relationship between \"morbidity\" and \"mortality\" in the context of liver ischemia-reperfusion injury (LIRI).\\n2. The text states that \"Damage arising from LIRI is...associated with higher morbidity and mortality after surgery.\" This suggests that LIRI is the cause of both morbidity and mortality.\\n3. Additionally, the text states that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\" This further supports the idea that LIRI is the cause of both morbidity and mortality, as the focus is on improving patient outcomes by addressing the underlying mechanism of cellular damage.\\n4. Therefore, the most likely cause-and-effect relationship is that LIRI causes both morbidity and mortality.\\n5. <Answer>D</Answer>')\n",
      "6 = morbidity, 8 = mechanisms\n",
      "(('morbidity', 'mechanisms'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery.\\n2. The text also mentions that the mechanisms leading to the injury of liver cells during LIRI are not yet fully understood, but mitochondrial dysfunction is recognized as a major contributing factor.\\n3. There is no direct causal relationship established between \"morbidity\" and \"mechanisms\" in the text.\\n\\nTherefore, the most likely answer is <Answer>C</Answer>: \"morbidity\" and \"mechanisms\" are not causally related.')\n",
      "6 = morbidity, 9 = parenchymal\n",
      "(('morbidity', 'parenchymal'), '1. Identify the relevant sentences: \\n\\n\"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood...\"\\n\\n2. Identify the entities in question and their relationships: \\n\\n- Morbidity: associated with higher rates after surgery.\\n- Parenchymal: their injury is not fully understood. \\n\\n3. Determine the cause-and-effect relationship: \\n\\nThere is no clear cause-and-effect relationship described between \"morbidity\" and \"parenchymal\". The sentence \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood\" suggests that injury to these cells is a result of the ischemia-reperfusion injury (LIRI), but it is not clear whether one is a direct cause of the other. Additionally, the sentence \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery\" raises the possibility that both \"morbidity\" and \"parenchymal\" are effects of LIRI, but we cannot discern a direct cause-and-effect relationship between the two.\\n\\n<Answer>D</Answer>')\n",
      "6 = morbidity, 10 = non-parenchymal liver cells\n",
      "(('morbidity', 'non-parenchymal liver cells'), '1. What is the main topic of the text?\\n- Liver ischemia-reperfusion injury (LIRI) and the role of mitochondria in it.\\n\\n2. What is the definition of \"morbidity\" in the text?\\n- The state of being diseased or unwell.\\n\\n3. What is the definition of \"non-parenchymal liver cells\" in the text?\\n- Cells in the liver that are not part of the liver tissue itself, such as Kupffer cells and stellate cells.\\n\\n4. Is there any direct causality mentioned between \"morbidity\" and \"non-parenchymal liver cells\" in the text?\\n- No, there is no direct causality mentioned between the two.\\n\\n5. Are there any other factors mentioned in the text that may be causally related to both \"morbidity\" and \"non-parenchymal liver cells\"?\\n- No, there is no indication of a common factor that is the cause for both.\\n\\nTherefore, the most likely answer is:\\n\\n<Answer>C</Answer>: \"morbidity\" and \"non-parenchymal liver cells\" are not causally related.')\n",
      "6 = morbidity, 11 = mitochondrial dysfunction\n",
      "(('morbidity', 'mitochondrial dysfunction'), '1. Firstly, the text states that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. It goes on to say that damage from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. The text then mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n4. It states that mitochondria play a major role in various functions related to cellular activity and liver integrity, and protecting mitochondria during liver ischemia and reperfusion can ameliorate LIRI. \\n5. Lastly, the text emphasizes the importance of studying mitochondrial dysfunction to develop new therapeutic strategies aimed at improving patient outcomes. \\n\\nGiven this information, it is more likely that \"mitochondrial dysfunction\" causes \"morbidity\" rather than the other way around. The text highlights that mitochondrial dysfunction is a major contributing factor to LIRI and exacerbates cellular injury. Additionally, the text emphasizes the importance of protecting mitochondria during liver ischemia and reperfusion to maintain cellular activity and liver integrity. Therefore, it can be inferred that mitochondrial dysfunction plays a causal role in the development of morbidity associated with LIRI.\\n\\n<Answer>B. \"mitochondrial dysfunction\" causes \"morbidity\"</Answer>.')\n",
      "6 = morbidity, 12 = glucose metabolism\n",
      "(('morbidity', 'glucose metabolism'), '1. We are looking for the cause-and-effect relationship between \"morbidity\" and \"glucose metabolism\".\\n2. The sentence \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death\" implies that glucose metabolism is influenced by mitochondrial function.\\n3. The sentence \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery\" indicates that LIRI causes morbidity and mortality.\\n4. Therefore, the cause-and-effect relationship is: **LIRI** causes **morbidity** which may be attributed in part to compromised **glucose metabolism** due to mitochondrial dysfunction. \\n\\n<Answer>B</Answer>')\n",
      "6 = morbidity, 13 = energy production\n",
      "(('morbidity', 'energy production'), '1. The text states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in energy production.\\n3. Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\nBased on these statements, it is more likely that \"energy production\" causes \"morbidity\". If there is dysfunction in mitochondrial energy production due to LIRI, it can exacerbate cellular injury and lead to higher morbidity and mortality. Therefore, option B: \"energy production\" causes \"morbidity\" is the correct answer.\\n\\n<Answer>B</Answer>')\n",
      "6 = morbidity, 14 = reactive oxygen species (ROS) signaling\n",
      "(('morbidity', 'reactive oxygen species (ROS) signaling'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of morbidity and mortality after surgery.\\n2. The text also mentions that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury. Mitochondria play a major role in ROS signaling.\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n4. The text does not provide any direct causal relationship between \"morbidity\" and \"reactive oxygen species (ROS) signaling\".\\n\\nBased on the information provided, it is more likely that \"reactive oxygen species (ROS) signaling\" causes \"morbidity\". Mitochondrial dysfunction during liver I/R results in increased ROS signaling and cellular injury, which may lead to morbidity and mortality after surgery. Therefore, regulating and protecting mitochondria to reduce ROS signaling may improve patient outcomes.\\n\\n<Answer>B</Answer>')\n",
      "6 = morbidity, 15 = calcium homeostasis\n",
      "(('morbidity', 'calcium homeostasis'), '1. Morbidity and calcium homeostasis are both mentioned in the context of liver ischemia-reperfusion injury (LIRI).\\n2. LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury and plays a major role in calcium homeostasis.\\n4. Protecting mitochondria during liver I/R has been successful in decreasing susceptibility to LIRI.\\n\\nBased on this information, it is more likely that:\\n\\nB. \"Calcium homeostasis\" causes \"morbidity\"')\n",
      "6 = morbidity, 16 = cell death\n",
      "(('morbidity', 'cell death'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery.\\n2. The text also mentions that mitochondrial dysfunction exacerbates cellular injury during LIRI.\\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n4. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n5. Protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on these points, it is more likely that \"cell death\" causes \"morbidity\" since the text emphasizes that mitochondrial dysfunction leads to cellular injury, which can ultimately result in morbidity and mortality. \\n\\n<Answer>B</Answer>')\n",
      "6 = morbidity, 17 = mitochondrial biogenesis\n",
      "(('morbidity', 'mitochondrial biogenesis'), '1. The text mentions \"morbidity\" and \"mitochondrial biogenesis\" separately.\\n2. There is no direct causal relationship implied between \"morbidity\" and \"mitochondrial biogenesis\".\\n3. The text mentions that regulating mitochondrial biogenesis can ameliorate LIRI which is associated with higher morbidity and mortality, implying that mitochondrial biogenesis can be a protective factor against \"morbidity\". \\n\\nTherefore, the most likely cause-and-effect relationship is: \\n\\nD. There is a common factor that is the cause for both \"morbidity\" and \"mitochondrial biogenesis\", with \"mitochondrial biogenesis\" being potentially protective against \"morbidity\".')\n",
      "6 = morbidity, 18 = fission/fusion\n",
      "(('morbidity', 'fission/fusion'), '1. We are looking for a cause-and-effect relationship between \"morbidity\" and \"fission/fusion\" in the context of liver ischemia-reperfusion injury (LIRI).\\n2. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\" It also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" Thus, we can conclude that mitochondrial dysfunction plays a role in causing LIRI.\\n3. The text also mentions that \"higher morbidity and mortality after surgery\" is associated with LIRI.\\n4. There is no direct mention of a causal relationship between \"morbidity\" and \"fission/fusion\" in the text. However, since mitochondrial dysfunction is involved in both LIRI and fission/fusion, it is possible that there is a causal relationship between the two.\\n5. Therefore, the most likely cause-and-effect relationship between \"morbidity\" and \"fission/fusion\" is that mitochondrial dysfunction causes both.\\n\\n<Answer>D</Answer>')\n",
      "6 = morbidity, 19 = mitophagy\n",
      "(('morbidity', 'mitophagy'), 'Step 1: Identify the entities and their roles in the text.\\n- \"Morbidity\": a measure of the frequency or rate of a disease in a population\\n- \"Mitophagy\": a process of degrading damaged mitochondria within cells\\n\\nStep 2: Look for causal indicators or cues in the text.\\n- The text describes how protecting mitochondria by regulating mitophagy during liver I/R can ameliorate LIRI (implying that mitophagy has a protective effect).\\n- The text also mentions that LIRI is associated with higher morbidity and mortality after surgery (implying that morbidity is a negative outcome of LIRI).\\n\\nStep 3: Evaluate the causal relationship between the entities.\\n- The text suggests that mitophagy has a protective effect against LIRI while morbidity is a negative outcome of LIRI.\\n- Therefore, it is more likely that \"mitophagy\" causes \"morbidity\", since impaired mitophagy could lead to insufficient removal of damaged mitochondria and exacerbate cellular injury, which in turn could result in higher morbidity and mortality after surgery.\\n\\nFinal answer: <Answer>B</Answer> (\"mitophagy\" causes \"morbidity\").')\n",
      "6 = morbidity, 20 = steatosis\n",
      "(('morbidity', 'steatosis'), 'Step 1: Identify the entities and their roles\\n- Morbidity: associated with higher morbidity and mortality after surgery.\\n- Steatosis: conditions that exacerbate mitochondrial dysfunction.\\n- Note: while the text mentions the impact of liver conditions on LIRI, it does not directly state a cause-and-effect relationship between steatosis and morbidity.\\n\\nStep 2: Look for clues in the text\\n- The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n- Mitochondrial dysfunction exacerbates cellular injury during LIRI.\\n\\nStep 3: Determine the cause-and-effect relationship\\n- Based on the information provided, it is more likely that \"steatosis\" causes \"morbidity\" rather than the other way around.\\n- This is because steatosis exacerbates mitochondrial dysfunction, which in turn exacerbates cellular injury during LIRI, leading to higher morbidity and mortality after surgery.\\n\\nTherefore, the answer is <Answer>B</Answer>: \"steatosis\" causes \"morbidity\".')\n",
      "6 = morbidity, 21 = aging\n",
      "(('morbidity', 'aging'), '1. The text mentions \"morbidity\" and \"aging\" as factors associated with higher morbidity and mortality after liver surgery.\\n2. The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n3. There is no direct causal relationship mentioned between \"morbidity\" and \"aging\" in the text.\\n4. The most likely relationship between \"morbidity\" and \"aging\" is that there is a common factor that is the cause for both, such as the overall deterioration of cellular function and health with advanced age.\\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"morbidity\" and \"aging\".')\n",
      "6 = morbidity, 22 = therapeutic strategies\n",
      "(('morbidity', 'therapeutic strategies'), '1. The text states that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery\\n2. The text also mentions the development of new therapeutic strategies aimed at improving patient outcomes\\n3. However, the text does not provide any indication that \"morbidity\" causes \"therapeutic strategies\" or vice versa\\n4. Therefore, it can be concluded that \"morbidity\" and \"therapeutic strategies\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "6 = morbidity, 23 = patient outcomes\n",
      "(('morbidity', 'patient outcomes'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n2. The text also mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n3. Based on this information, it is likely that \"morbidity\" and \"patient outcomes\" are causally related, with LIRI causing higher morbidity and mortality and therefore worse patient outcomes.\\n\\nTherefore, the answer is <Answer>B</Answer>: \"patient outcomes\" causes \"morbidity\".')\n",
      "7 = mortality, 8 = mechanisms\n",
      "(('mortality', 'mechanisms'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery. This suggests that mortality may be a consequence of LIRI.\\n2. The text also discusses that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, but mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Therefore, \"mechanisms\" are a contributing factor to LIRI, but do not necessarily cause it. \\n3. There is no clear indication in the text that \"mortality\" causes \"mechanisms\". \\n4. There is no clear indication in the text that there is a common factor that is the cause for both \"mortality\" and \"mechanisms\". \\n\\nTherefore, the most likely cause-and-effect relationship between \"mortality\" and \"mechanisms\" is that \"mechanisms\" cause \"mortality\". \\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 9 = parenchymal\n",
      "(('mortality', 'parenchymal'), '1. Identify the main idea of the text:\\nThe text discusses liver ischemia-reperfusion injury (LIRI), which is a major cause of complications in liver surgeries. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n2. Look for clues about the causal relationship between \"mortality\" and \"parenchymal\":\\nThe text mentions that \"damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n\\n3. Analyze the direction of causality:\\nThe text suggests that parenchymal and non-parenchymal liver cell damage is a major risk factor for higher mortality rates after surgery. Therefore, it is more likely that \"parenchymal\" causes \"mortality\".\\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 10 = non-parenchymal liver cells\n",
      "(('mortality', 'non-parenchymal liver cells'), '1. Reading the given text and identifying the relevant information:\\n- Liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n- Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n- Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n2. Analyzing the entities \"mortality\" and \"non-parenchymal liver cells\":\\n- The text mentions that LIRI is associated with higher morbidity and mortality after surgery.\\n- The text also mentions that the mechanisms leading to the injury of non-parenchymal liver cells are not yet fully understood, but mitochondrial dysfunction exacerbates cellular injury.\\n\\n3. Determining the cause-and-effect relationship:\\n- Based on the information provided in the text, it is more likely that \"non-parenchymal liver cells\" cause \"mortality\" rather than the other way around.\\n- This is because LIRI, which causes damage to both parenchymal and non-parenchymal liver cells, is associated with higher morbidity and mortality after liver surgery.\\n\\nTherefore, the answer is <Answer>B</Answer>: \"non-parenchymal liver cells\" causes \"mortality\".')\n",
      "7 = mortality, 11 = mitochondrial dysfunction\n",
      "(('mortality', 'mitochondrial dysfunction'), '1. What is the main topic of the text?\\n- Liver ischemia-reperfusion injury\\n\\n2. What is the relationship between liver ischemia-reperfusion injury and mortality?\\n- Liver ischemia-reperfusion injury is associated with higher morbidity and mortality after surgery.\\n\\n3. What is the role of mitochondrial dysfunction in liver ischemia-reperfusion injury?\\n- Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. Can protecting mitochondria during liver ischemia/reperfusion ameliorate LIRI?\\n- Yes, protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on the text and pre-trained knowledge, it is more likely that \"mitochondrial dysfunction\" causes \"mortality\". Therefore, the answer is <Answer>B</Answer>.')\n",
      "7 = mortality, 12 = glucose metabolism\n",
      "(('mortality', 'glucose metabolism'), '1. The text mentions that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI) that exacerbates cellular injury.\\n2. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\\n3. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n4. A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n5. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\n- Based on the text, there is no causal relationship established between \"mortality\" and \"glucose metabolism\". \\n- Instead, the text suggests that preserving mitochondrial health by regulating mitochondrial function can ameliorate liver I/R injury, which is a risk factor for mortality after liver surgery. \\n- Therefore, it is possible that there is a common factor causing both \"mortality\" and \"glucose metabolism\" indirectly through mitochondrial dysfunction.\\n\\n<Answer>D</Answer>')\n",
      "7 = mortality, 13 = energy production\n",
      "(('mortality', 'energy production'), '1. The text highlights that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery.\\n2. The text also states that mitochondria play a major role in energy production, which is essential to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n4. The text does not provide any evidence or mention of \"mortality\" causing \"energy production\".\\n\\nTherefore, the most likely causal relationship is B. \"energy production\" causes \"mortality\", as the loss of mitochondrial function during liver I/R can lead to cellular injury, exacerbate LIRI, and ultimately result in higher morbidity and mortality after surgery.\\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 14 = reactive oxygen species (ROS) signaling\n",
      "(('mortality', 'reactive oxygen species (ROS) signaling'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery.\\n2. The text also mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Mitochondria play a major role in reactive oxygen species (ROS) signaling.\\n4. Protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on the above information, it is more likely that B. \"reactive oxygen species (ROS) signaling\" causes \"mortality\", as mitochondria play a major role in both ROS signaling and LIRI, and protecting mitochondria during liver I/R has been shown to ameliorate LIRI (which is associated with higher morbidity and mortality). Therefore, it is reasonable to suggest that ROS signaling caused by mitochondrial dysfunction aggravates LIRI and contributes to mortality. \\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 15 = calcium homeostasis\n",
      "(('mortality', 'calcium homeostasis'), '1. We are looking for the cause-and-effect relationship between \"mortality\" and \"calcium homeostasis\" based on the given medical text.\\n\\n2. Based on the text, we know that liver ischemia-reperfusion injury (LIRI) can lead to early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\n3. The text also notes that calcium homeostasis is one of the diverse roles that mitochondria play, and mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. However, the text does not provide any direct causal relationship between \"mortality\" and \"calcium homeostasis\".\\n\\n5. Therefore, the most likely cause-and-effect relationship between \"mortality\" and \"calcium homeostasis\" is that they are not causally related.\\n\\n6. <Answer>C</Answer>')\n",
      "7 = mortality, 16 = cell death\n",
      "(('mortality', 'cell death'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. The text further explains that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\n3. The text also highlights that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n4. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\\n\\n5. The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n\\n6. The text also suggests that protecting mitochondria during liver I/R ameliorates LIRI, and targeting mitochondria in conditions that exacerbate mitochondrial dysfunction has been successful in decreasing their susceptibility to LIRI.\\n\\n7. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the information in the text, it is more likely that cell death causes mortality. This is because cell death is specifically identified as exacerbating the injury caused by liver ischemia-reperfusion, and this injury is associated with higher morbidity and mortality in patients after surgery. Therefore, it is reasonable to conclude that cell death, which is triggered by mitochondrial dysfunction during liver I/R, can lead to mortality. \\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 17 = mitochondrial biogenesis\n",
      "(('mortality', 'mitochondrial biogenesis'), '1. Identify the relevant sentences and extract the causal information: \\n\"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\" and \"A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n\\n2. Identify the causal relationship:\\nThe text suggests that LIRI leads to an increased risk of mortality, and that protecting mitochondria through various mechanisms can ameliorate LIRI.\\n\\n3. Determine the direction of causality:\\n\"Mortality\" is the effect and \"mitochondrial biogenesis\" is a potential protective mechanism. Therefore, it is unlikely that \"mortality\" causes \"mitochondrial biogenesis\".\\n\\n4. Final answer: <Answer>B</Answer> \"mitochondrial biogenesis\" causes \"mortality\" is not supported by the text.')\n",
      "7 = mortality, 18 = fission/fusion\n",
      "(('mortality', 'fission/fusion'), 'Step 1: Identify the entities:\\n- \"Mortality\"\\n- \"Fission/fusion\"\\n\\nStep 2: Look for mentions of these entities:\\n- \"Mortality\" is mentioned as one of the outcomes associated with liver ischemia-reperfusion injury.\\n- \"Fission/fusion\" is mentioned as a process that can help protect mitochondrial health during liver ischemia/reperfusion.\\n\\nStep 3: Determine the relationship between the entities:\\n- The text does not provide evidence that \"mortality\" causes \"fission/fusion\".\\n- The text suggests that \"fission/fusion\" may help protect against the negative effects of liver ischemia-reperfusion injury, including \"mortality\".\\n- Therefore, \"fission/fusion\" is more likely to cause \"mortality\".\\n\\nFinal Answer: <Answer>B</Answer>')\n",
      "7 = mortality, 19 = mitophagy\n",
      "7 = mortality, 20 = steatosis\n",
      "(('mortality', 'steatosis'), 'Step 1: Identify the cause-and-effect relationships mentioned in the text.\\n\\nThe text discusses liver ischemia-reperfusion injury (LIRI) as a major cause of complications in liver resection and transplantation. LIRI is associated with higher morbidity and mortality after surgery. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R is suggested to ameliorate LIRI. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nStep 2: Identify the entities \"mortality\" and \"steatosis\" in the text.\\n\\n\"Mortality\" is mentioned as one of the outcomes associated with LIRI after surgery. \"Steatosis\" is mentioned as a condition that exacerbates mitochondrial dysfunction and increases susceptibility to LIRI.\\n\\nStep 3: Determine the cause-and-effect relationship between \"mortality\" and \"steatosis\".\\n\\nThere is no direct cause-and-effect relationship mentioned in the text between \"mortality\" and \"steatosis\". However, the text suggests that steatosis can exacerbate mitochondrial dysfunction, which in turn increases susceptibility to LIRI. LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. Therefore, it can be inferred that steatosis may indirectly contribute to mortality by increasing the risk of LIRI.\\n\\n<Answer>D</Answer>')\n",
      "7 = mortality, 21 = aging\n",
      "(('mortality', 'aging'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is associated with higher morbidity and mortality after surgery.\\n2. The text also mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Studies suggest that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing their susceptibility to LIRI.\\n4. The text does not state or imply that \"mortality\" causes \"aging\" or vice versa. \\n\\nTherefore, the most likely cause-and-effect relationship between \"mortality\" and \"aging\" is D: there is a common factor that is the cause for both \"mortality\" and \"aging\".\\n\\n<Answer>D</Answer>')\n",
      "7 = mortality, 22 = therapeutic strategies\n",
      "(('mortality', 'therapeutic strategies'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in different clinical settings such as liver resection and liver transplantation. \\n2. The text also states that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n4. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI and has been successful in decreasing their susceptibility to LIRI. \\n5. The text highlights the progress made in recent years regarding the role of mitochondria in liver I/R and discusses the impact of liver conditions on LIRI.\\n\\nBased on the information provided, it is more likely that \"therapeutic strategies\" cause a decrease in \"mortality\" by ameliorating LIRI and decreasing susceptibility to it.\\n\\nTherefore, the cause-and-effect relationship is: B. \"therapeutic strategies\" causes \"mortality\"\\n\\n<Answer>B</Answer>')\n",
      "7 = mortality, 23 = patient outcomes\n",
      "(('mortality', 'patient outcomes'), '1. The given text talks about liver ischemia-reperfusion injury (LIRI) and how it is a major cause of complications in liver resection and transplantation surgeries. \\n2. It also states that LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery. \\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury and plays a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death. \\n4. Protecting mitochondria during liver I/R has been successful in decreasing susceptibility to LIRI. \\n5. The review highlights the progress made in recent years regarding the role of mitochondria in liver I/R and discusses the impact of liver conditions on LIRI.\\n\\nBased on the given information, it seems likely that \"mortality\" and \"patient outcomes\" are causally related, with mortality being a consequence of LIRI, which is a major risk factor for patient outcomes (complications, morbidity, and mortality) after liver surgery. Therefore, the cause-and-effect relationship is B. \"patient outcomes\" causes \"mortality\".\\n\\n<Answer>B</Answer>')\n",
      "8 = mechanisms, 9 = parenchymal\n",
      "(('mechanisms', 'parenchymal'), '1. We are given that \"the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood\".\\n2. However, we are also given that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\". Mitochondria are present in both parenchymal and non-parenchymal liver cells.\\n3. This suggests that \"mechanisms\" are causing injury to both parenchymal and non-parenchymal liver cells, with mitochondrial dysfunction being a key contributing factor.\\n4. From the text, there is no indication that \"parenchymal\" causes \"mechanisms\".\\n5. There is no indication from the text that there is a common factor causing both \"mechanisms\" and \"parenchymal\".\\n6. Therefore, the correct answer is <Answer>A</Answer>: \"mechanisms\" causes \"parenchymal\".')\n",
      "8 = mechanisms, 10 = non-parenchymal liver cells\n",
      "(('mechanisms', 'non-parenchymal liver cells'), '1. The text states that \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood\", which implies that there are unknown factors causing the injury of these cells.\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\", implying that mitochondrial dysfunction is a causal factor in the development of liver ischemia-reperfusion injury.\\n3. While the text mentions non-parenchymal liver cells as being affected by LIRI, it does not explicitly state that non-parenchymal liver cells are causally related to the mechanisms of LIRI.\\n4. Therefore, the most likely cause-and-effect relationship is that the \"mechanisms\" of LIRI cause mitochondrial dysfunction, which in turn exacerbates injury to both parenchymal and non-parenchymal liver cells.\\n\\n<Answer>A</Answer>')\n",
      "8 = mechanisms, 11 = mitochondrial dysfunction\n",
      "(('mechanisms', 'mitochondrial dysfunction'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n2. The text also states that \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n3. The text suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n4. The text emphasizes the importance of studying mitochondrial dysfunction to understand the underlying mechanisms of cellular damage during LIRI.\\n\\nBased on the information provided in the text, it is more likely that \"mitochondrial dysfunction\" causes \"mechanisms\". Therefore, Option B: \"mitochondrial dysfunction\" causes \"mechanisms\" is the correct answer.\\n\\n<Answer>B</Answer>')\n",
      "8 = mechanisms, 12 = glucose metabolism\n",
      "(('mechanisms', 'glucose metabolism'), 'Step 1: The text mentions that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\nStep 2: The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\nStep 3: The text suggests that protecting mitochondria during liver I/R ameliorates LIRI, which indicates that mitochondrial dysfunction is a cause of LIRI.\\nStep 4: The text does not provide clear evidence that \"mechanisms\" cause \"glucose metabolism\" or vice versa.\\n\\nTherefore, the answer is: <Answer>C</Answer>, \"mechanisms\" and \"glucose metabolism\" are not causally related.')\n",
      "8 = mechanisms, 13 = energy production\n",
      "(('mechanisms', 'energy production'), 'Step 1: Identify the two entities in the text.\\n- \"mechanisms\"\\n- \"energy production\"\\n\\nStep 2: Determine the directionality of the relationship between the two entities based on the information in the text.\\n- The text states that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n- It also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n- Therefore, it is more likely that \"energy production\" is impacted by \"mechanisms,\" specifically mitochondrial dysfunction, rather than the other way around.\\n- Option B can be eliminated.\\n\\nStep 3: Consider the possibility of other relationships.\\n- The text does not indicate that \"mechanisms\" and \"energy production\" are not causally related.\\n- The text does not suggest that there is a common causal factor for both \"mechanisms\" and \"energy production.\"\\n- Therefore, options C and D can be eliminated.\\n\\nFinal answer: <Answer>A</Answer>. \"mechanisms\" causes \"energy production\".')\n",
      "8 = mechanisms, 14 = reactive oxygen species (ROS) signaling\n",
      "(('mechanisms', 'reactive oxygen species (ROS) signaling'), '1. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\".\\n2. The text also mentions that \"mitochondria play a major role in... reactive oxygen species (ROS) signaling\".\\n3. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI.\\n\\nBased on this information, it is more likely that \"mechanisms\" (i.e. mitochondrial dysfunction) cause \"reactive oxygen species (ROS) signaling\" rather than the other way around. \\n\\nTherefore, the answer is <Answer>A</Answer>: \"mechanisms\" causes \"reactive oxygen species (ROS) signaling\".')\n",
      "8 = mechanisms, 15 = calcium homeostasis\n",
      "(('mechanisms', 'calcium homeostasis'), '1. The text mentions that mitochondria play a major role in calcium homeostasis and cell death.\\n2. The text also states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n4. The text does not provide any direct evidence that \"mechanisms\" cause \"calcium homeostasis\" or vice versa.\\n\\nBased on the given information, it is most likely that \"mechanisms\" and \"calcium homeostasis\" are not causally related. Therefore, the answer is <Answer>C</Answer>.')\n",
      "8 = mechanisms, 16 = cell death\n",
      "(('mechanisms', 'cell death'), '1. The text states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in cell death.\\n3. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on these points, it is more likely that \"mechanisms\" (specifically, mitochondrial dysfunction) causes \"cell death\", as opposed to the other way around. \\n\\nTherefore, the answer is <Answer>A</Answer>: \"mechanisms\" causes \"cell death\".')\n",
      "8 = mechanisms, 17 = mitochondrial biogenesis\n",
      "(('mechanisms', 'mitochondrial biogenesis'), 'Step 1: Identify the entities and their relationships:\\n- \"mechanisms\" (unclear what specific mechanisms are being referred to)\\n- \"mitochondrial biogenesis\"\\n- Relationship: The sentence states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" Therefore, regulating mitochondrial biogenesis is presented as a way to protect mitochondria and reduce liver ischemia-reperfusion injury (LIRI).\\n\\nStep 2: Determine the causal relationship:\\n- Option A: \"mechanisms\" causes \"mitochondrial biogenesis\" - There is no evidence in the text to support this option.\\n- Option B: \"mitochondrial biogenesis\" causes \"mechanisms\" - There is no evidence in the text to support this option.\\n- Option C: \"mechanisms\" and \"mitochondrial biogenesis\" are not causally related - There is evidence in the text to support this option. The two entities are not directly connected in a cause-and-effect relationship.\\n- Option D: there is a common factor that is the cause for both \"mechanisms\" and \"mitochondrial biogenesis\" - There is no evidence in the text to support this option.\\n\\nTherefore, the correct answer is <Answer>C</Answer>: \"mechanisms\" and \"mitochondrial biogenesis\" are not causally related.')\n",
      "8 = mechanisms, 18 = fission/fusion\n",
      "(('mechanisms', 'fission/fusion'), '1. The text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" This suggests that both \"mitochondrial biogenesis\" and \"fission/fusion\" play a role in protecting mitochondria and reducing LIRI.\\n2. The text does not provide any further information linking \"mechanisms\" to either \"fission/fusion\" or LIRI.\\n3. Therefore, the most likely answer is that \"mechanisms\" and \"fission/fusion\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "8 = mechanisms, 19 = mitophagy\n",
      "(('mechanisms', 'mitophagy'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n2. The text also suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n3. Therefore, it is likely that \"mitophagy\" is a protective mechanism used to preserve mitochondrial health during liver I/R and ameliorate LIRI, rather than the cause of mechanisms related to mitochondrial dysfunction.\\n\\n<Answer>B</Answer>')\n",
      "8 = mechanisms, 20 = steatosis\n",
      "(('mechanisms', 'steatosis'), '1. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death\".\\n2. The text also mentions that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI\".\\n3. Therefore, there is a relationship between steatosis and mitochondrial dysfunction in the development of LIRI.\\n\\n<Answer>B</Answer>')\n",
      "8 = mechanisms, 21 = aging\n",
      "8 = mechanisms, 22 = therapeutic strategies\n",
      "(('mechanisms', 'therapeutic strategies'), '1. The text discusses that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI) that exacerbates cellular injury.\\n2. The text also mentions that protecting mitochondria through regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R can ameliorate LIRI.\\n3. The text further discusses the importance of studying mitochondrial dysfunction to understand the mechanisms of cellular damage during LIRI and develop new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the above information, it can be inferred that \"mechanisms\" (i.e. the mechanisms underlying cellular damage during LIRI) are the cause for \"therapeutic strategies\" (i.e. the development of new therapeutic strategies aimed at improving patient outcomes). Therefore, the answer is <Answer>A</Answer> \"mechanisms\" causes \"therapeutic strategies\".')\n",
      "8 = mechanisms, 23 = patient outcomes\n",
      "(('mechanisms', 'patient outcomes'), '- The text states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury, and that protecting mitochondria during liver I/R ameliorates LIRI.\\n- The text also mentions that studying mitochondrial dysfunction is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nTherefore, it is more likely that the \"mechanisms\" (mitochondrial dysfunction) cause \"patient outcomes\" (complications, morbidity, and mortality after liver surgery). \\n\\n<Answer>A</Answer>')\n",
      "9 = parenchymal, 10 = non-parenchymal liver cells\n",
      "(('parenchymal', 'non-parenchymal liver cells'), '1. The text mentions that both parenchymal and non-parenchymal liver cells can be injured during liver ischemia-reperfusion injury (LIRI).\\n2. However, the text does not provide any indication that one type of cell directly causes damage to the other type of cell.\\n3. Therefore, it is most likely that option C is the correct answer, and that parenchymal and non-parenchymal liver cells are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "9 = parenchymal, 11 = mitochondrial dysfunction\n",
      "(('parenchymal', 'mitochondrial dysfunction'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n2. The text also states that \"although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood.\"\\n3. The text then goes on to suggest that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n4. Further, the text mentions that \"targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\n\\nBased on the above information, it is more likely that option B: \"mitochondrial dysfunction\" causes \"parenchymal\" as the text states that mitochondrial dysfunction exacerbates cellular injury and that protecting mitochondria during liver I/R ameliorates LIRI. This indicates that mitochondrial dysfunction is causing or contributing to the injury of parenchymal and non-parenchymal liver cells.')\n",
      "9 = parenchymal, 12 = glucose metabolism\n",
      "(('parenchymal', 'glucose metabolism'), 'First, we need to understand what \"parenchymal\" and \"glucose metabolism\" are in the context of the given text. Parenchymal cells are cells that make up the functional tissue of an organ, in this case, the liver. Glucose metabolism refers to the process by which the body breaks down glucose to produce energy. \\n\\nThe text states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Mitochondria play a major role in glucose metabolism, energy production, ROS signaling, calcium homeostasis, and cell death. Therefore, it is more likely that the relationship between \"parenchymal\" and \"glucose metabolism\" is that the dysfunction of mitochondria (which affects glucose metabolism) is responsible for the injury of parenchymal cells during LIRI. \\n\\n<Answer>B</Answer>')\n",
      "9 = parenchymal, 13 = energy production\n",
      "(('parenchymal', 'energy production'), '1. The medical text mentions that mitochondria play a major role in energy production.\\n2. It also mentions that damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text further notes that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\nBased on this information, we can infer that the relationship between \"parenchymal\" and \"energy production\" is not straight forward and there are other factors affecting both of them. Therefore, the correct answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"parenchymal\" and \"energy production\".')\n",
      "9 = parenchymal, 14 = reactive oxygen species (ROS) signaling\n",
      "(('parenchymal', 'reactive oxygen species (ROS) signaling'), '1. Identify the two entities: \"parenchymal\" and \"reactive oxygen species (ROS) signaling\"\\n2. Look for any statements in the text that indicate a causal relationship between the two entities.\\n3. The statement \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" suggests that mitochondrial dysfunction is a cause of injury to both parenchymal and non-parenchymal liver cells, but it does not specify a direct causal relationship between \"parenchymal\" and \"reactive oxygen species (ROS) signaling\".\\n4. The statement \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death\" indicates that mitochondria are involved in ROS signaling, but it does not specify a causal relationship between \"parenchymal\" and \"reactive oxygen species (ROS) signaling\".\\n5. Therefore, the most likely answer is C: \"parenchymal\" and \"reactive oxygen species (ROS) signaling\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "9 = parenchymal, 15 = calcium homeostasis\n",
      "(('parenchymal', 'calcium homeostasis'), 'Step 1: Identify the relevant sentences and entities in the medical text:\\n- \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n- \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n\\nRelevant entities: \"parenchymal\" and \"calcium homeostasis\"\\n\\nStep 2: Determine the relationship between the entities:\\n- The text does not specify a clear cause-and-effect relationship between \"parenchymal\" and \"calcium homeostasis\". \\n- The text states that mitochondria are involved in both \"parenchymal\" and \"calcium homeostasis\", but it does not indicate which entity causes or affects the other.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"parenchymal\" and \"calcium homeostasis\" are not causally related.')\n",
      "9 = parenchymal, 16 = cell death\n",
      "(('parenchymal', 'cell death'), '1. The text mentions that LIRI (liver ischemia-reperfusion injury) is a major cause of complications in different clinical settings and that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n\\n2. The text also states that the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood.\\n\\n3. While the text highlights a growing body of studies that suggest protecting mitochondria during liver I/R (ischemia/reperfusion) ameliorates LIRI, it does not provide any direct evidence of a causal relationship between \"parenchymal\" and \"cell death\".\\n\\n4. Therefore, it is not possible to determine a cause-and-effect relationship between \"parenchymal\" and \"cell death\" based on the information provided in the text.\\n\\n<Answer>C</Answer>')\n",
      "9 = parenchymal, 17 = mitochondrial biogenesis\n",
      "(('parenchymal', 'mitochondrial biogenesis'), '1. We are asked about the causal relationship between \"parenchymal\" and \"mitochondrial biogenesis\" based on the given text.\\n2. The text mentions that mitochondrial dysfunction is a hallmark of LIRI and exacerbates cellular injury. It also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI. Therefore, it is plausible that impaired mitochondrial biogenesis could lead to mitochondrial dysfunction and cellular injury during LIRI.\\n3. However, there is no direct mention in the text of a causal relationship between \"parenchymal\" and \"mitochondrial biogenesis\". Parenchymal cells are mentioned as being damaged during LIRI, but there is no indication that impaired mitochondrial biogenesis is the cause of this damage.\\n4. Therefore, we can conclude that option C: \"parenchymal\" and \"mitochondrial biogenesis\" are not causally related is the most likely answer. \\n<Answer>C</Answer>')\n",
      "9 = parenchymal, 18 = fission/fusion\n",
      "(('parenchymal', 'fission/fusion'), '1. Identify the entities: \"parenchymal\" and \"fission/fusion\"\\n2. Look for clues in the text about a causal relationship between these entities.\\n3. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\" It also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" This suggests that mitochondrial dysfunction is a causal factor in LIRI, and that regulating fission/fusion can protect against mitochondria dysfunction and therefore reduce the risk of LIRI. \\n4. Based on this analysis, it is more likely that \"fission/fusion\" causes \"parenchymal.\"\\n\\n<Answer> B </Answer>')\n",
      "9 = parenchymal, 19 = mitophagy\n",
      "(('parenchymal', 'mitophagy'), '1. What is parenchymal?\\n- Parenchymal cells are the main functional cells of an organ, in this case, the liver.\\n\\n2. What is mitophagy?\\n- Mitophagy is the process by which damaged or dysfunctional mitochondria are removed by the cell.\\n\\n3. What does the text say about the relationship between parenchymal cells and mitophagy in liver ischemia-reperfusion injury (LIRI)?\\n- The text does not explicitly state a causal relationship between parenchymal cells and mitophagy in LIRI, but it does mention that mitochondrial dysfunction exacerbates cellular injury in LIRI and that regulating mitophagy during liver I/R can ameliorate LIRI. It also suggests that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI.\\n\\n4. Given the information above, which cause-and-effect relationship is more likely?\\n- C: \"parenchymal\" and \"mitophagy\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "9 = parenchymal, 20 = steatosis\n",
      "(('parenchymal', 'steatosis'), '1. Identify the entities: \"parenchymal\" and \"steatosis\".\\n2. Look for possible causal relationships between the two in the given text or pre-trained knowledge.\\n3. In the text, we can see that mitochondrial dysfunction is recognized as a hallmark of LIRI and exacerbates cellular injury, including injury to both parenchymal and non-parenchymal liver cells. On the other hand, steatosis (the accumulation of fat in the liver) is mentioned as a condition that exacerbates mitochondrial dysfunction. \\n4. There is no direct causal relationship between \"parenchymal\" and \"steatosis\" mentioned in the text. Both are related to mitochondrial dysfunction, which is recognized as a major cause of LIRI.\\n\\nTherefore, the correct answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"parenchymal\" and \"steatosis\".')\n",
      "9 = parenchymal, 21 = aging\n",
      "(('parenchymal', 'aging'), 'Step 1: Identify relevant sentences and entities: \\n\\n- \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n- \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\n\\nEntities: parenchymal, aging, mitochondrial dysfunction, LIRI\\n\\nStep 2: Determine the causal relationships between the entities:\\n\\n- There is a correlation between mitochondrial dysfunction and LIRI.\\n- Targeting mitochondria has been successful in decreasing susceptibility to LIRI in conditions that exacerbate mitochondrial dysfunction, such as aging and steatosis.\\n- There is no direct cause-and-effect relationship mentioned between parenchymal and aging.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"parenchymal\" and \"aging\" are not causally related.')\n",
      "9 = parenchymal, 22 = therapeutic strategies\n",
      "(('parenchymal', 'therapeutic strategies'), '1. The text mentions that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Protecting mitochondria during liver I/R is said to ameliorate LIRI and has been successful in decreasing susceptibility to it.\\n3. Studying mitochondrial dysfunction is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this, it is most likely that \"therapeutic strategies\" cause improvement in \"parenchymal\" damage caused by LIRI. Therefore, the cause-and-effect relationship is: B. \"therapeutic strategies\" causes \"parenchymal\". \\n\\n<Answer>B</Answer>')\n",
      "9 = parenchymal, 23 = patient outcomes\n",
      "10 = non-parenchymal liver cells, 11 = mitochondrial dysfunction\n",
      "(('non-parenchymal liver cells', 'mitochondrial dysfunction'), '1. What is liver ischemia-reperfusion injury (LIRI)?\\n- LIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation. \\n- It is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n\\n2. What is the role of mitochondria in liver I/R?\\n- Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death. \\n- Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n- A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\n3. What is the relationship between \"non-parenchymal liver cells\" and \"mitochondrial dysfunction\"?\\n- The text states that \"although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n- This suggests that \"mitochondrial dysfunction\" causes injury to both parenchymal and non-parenchymal liver cells, rather than the other way around.\\n- Therefore, the more likely cause-and-effect relationship is B: \"mitochondrial dysfunction\" causes \"non-parenchymal liver cells\".\\n\\n<Answer>B</Answer>')\n",
      "10 = non-parenchymal liver cells, 12 = glucose metabolism\n",
      "(('non-parenchymal liver cells', 'glucose metabolism'), '1. The text states that \"mitochondria play a major role in glucose metabolism\" and that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\", suggesting that mitochondrial dysfunction affects glucose metabolism and leads to cellular injury during LIRI.\\n2. The text also states that \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\", suggesting that mitochondrial dysfunction affects both parenchymal and non-parenchymal liver cells during LIRI.\\n3. However, the text does not provide any explicit cause-and-effect relationship between \"non-parenchymal liver cells\" and \"glucose metabolism\".\\n\\n<Answer>C</Answer> - \"non-parenchymal liver cells\" and \"glucose metabolism\" are not causally related.')\n",
      "10 = non-parenchymal liver cells, 13 = energy production\n",
      "(('non-parenchymal liver cells', 'energy production'), '1. From the given text, the role of mitochondria in liver ischemia-reperfusion injury (LIRI) is discussed.\\n2. Mitochondria are vital for various functions including energy production, glucose metabolism, ROS signaling, calcium homeostasis and cell death.\\n3. Mitochondrial dysfunction is recognized as a hallmark of LIRI.\\n4. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n5. The text also mentions non-parenchymal liver cells as being affected by LIRI.\\n6. There is no direct mention of a causal relationship between \"non-parenchymal liver cells\" and \"energy production\".\\n\\nTherefore, the answer is <Answer>C</Answer> \"non-parenchymal liver cells\" and \"energy production\" are not causally related.')\n",
      "10 = non-parenchymal liver cells, 14 = reactive oxygen species (ROS) signaling\n",
      "(('non-parenchymal liver cells', 'reactive oxygen species (ROS) signaling'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n\\n2. It is also stated that \"mitochondria play a major role in... reactive oxygen species (ROS) signaling\" and that \"protecting mitochondria... during liver I/R ameliorates LIRI.\"\\n\\n3. There is no direct causal relationship mentioned between \"non-parenchymal liver cells\" and \"reactive oxygen species (ROS) signaling.\" \\n\\nBased on the information in the text, it is most likely that D: there is a common factor that is the cause for both \"non-parenchymal liver cells\" and \"reactive oxygen species (ROS) signaling\". This common factor is likely the mitochondrial dysfunction that occurs during Liver I/R.')\n",
      "10 = non-parenchymal liver cells, 15 = calcium homeostasis\n",
      "(('non-parenchymal liver cells', 'calcium homeostasis'), 'Step 1: Identify the entities involved\\n- \"non-parenchymal liver cells\"\\n- \"calcium homeostasis\"\\n\\nStep 2: Look for clues in the text\\n- The text states that \"mitochondria play a major role in ... calcium homeostasis \" and that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\"\\n- The text also states that \"the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood\"\\n\\nStep 3: Apply causal reasoning\\n- There is evidence to suggest that mitochondrial dysfunction exacerbates LIRI and that mitochondria play a major role in calcium homeostasis.\\n- However, it is not clear from the text which entity is the cause and which is the effect, or whether there is a common factor contributing to both.\\n- Therefore, we cannot determine a clear cause-and-effect relationship between \"non-parenchymal liver cells\" and \"calcium homeostasis\".\\n\\n<Answer>C</Answer>')\n",
      "10 = non-parenchymal liver cells, 16 = cell death\n",
      "(('non-parenchymal liver cells', 'cell death'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\" \\n2. The text identifies \"mitochondrial dysfunction\" as a hallmark of LIRI that exacerbates cellular injury. \\n3. The text notes that \"mitochondria play a major role...in cell death\".\\n4. The text suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\", indicating that mitigation of mitochondrial dysfunction can result in lessened cell death.\\n\\nTherefore, based on the text and pre-trained knowledge, the cause-and-effect relationship between \"non-parenchymal liver cells\" and \"cell death\" is likely <Answer>C</Answer>: they are not causally related.')\n",
      "10 = non-parenchymal liver cells, 17 = mitochondrial biogenesis\n",
      "(('non-parenchymal liver cells', 'mitochondrial biogenesis'), '1. Identify the entities involved:\\n\\n- \"non-parenchymal liver cells\"\\n- \"mitochondrial biogenesis\"\\n\\n2. Look for clues in the text about their relationship:\\n\\n- The text mentions that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n- The text also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\n3. Based on the clues, which cause-and-effect relationship is more likely?\\n\\n- Mitochondrial biogenesis causes non-parenchymal liver cells: There is no evidence in the text to support this relationship.\\n- Non-parenchymal liver cells cause mitochondrial biogenesis: There is no evidence in the text to support this relationship.\\n- Non-parenchymal liver cells and mitochondrial biogenesis are not causally related: While there is no direct evidence in the text to support this relationship, the text does mention that protecting mitochondria during liver I/R can ameliorate LIRI, which suggests that there could be some relationship between non-parenchymal liver cells and mitochondrial biogenesis.\\n- There is a common factor that is the cause for both non-parenchymal liver cells and mitochondrial biogenesis: This relationship is also not supported by the text.\\n\\nTherefore, the answer is: <Answer>C</Answer>, non-parenchymal liver cells and mitochondrial biogenesis are not causally related.')\n",
      "10 = non-parenchymal liver cells, 18 = fission/fusion\n",
      "(('non-parenchymal liver cells', 'fission/fusion'), '1. What is the causal relationship between \"non-parenchymal liver cells\" and \"fission/fusion\"?\\n2. What information in the given text supports or refutes each possible answer?\\n\\n1. Causal relationship: The text does not provide clear information about the causal relationship between \"non-parenchymal liver cells\" and \"fission/fusion\".\\n2. Information in the text: The text explains that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Furthermore, the text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI. However, there is no clear information on whether \"non-parenchymal liver cells\" causes \"fission/fusion\", or vice versa, or if they are not causally related, or if there is a common factor causing both.\\n\\n<Answer>C</Answer>')\n",
      "10 = non-parenchymal liver cells, 19 = mitophagy\n",
      "(('non-parenchymal liver cells', 'mitophagy'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" - this implies that mitophagy is related to LIRI.\\n2. The text also mentions that \"the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood\" and that mitochondrial dysfunction is implicated in exacerbating cellular injury - this implies that non-parenchymal liver cells are also related to LIRI, but does not explicitly mention a relationship with mitophagy.\\n3. There is no stated or implied causal relationship between non-parenchymal liver cells and mitophagy in the text.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"non-parenchymal liver cells\" and \"mitophagy\" are not causally related.')\n",
      "10 = non-parenchymal liver cells, 20 = steatosis\n",
      "(('non-parenchymal liver cells', 'steatosis'), 'Step 1: Identify the cause-and-effect relationship mentioned in the text.\\nThe text discusses the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells that are associated with liver ischemia-reperfusion injury (LIRI). It also mentions that conditions such as steatosis exacerbate mitochondrial dysfunction, which is a hallmark of LIRI. Based on this information, it is possible that steatosis causes or exacerbates non-parenchymal liver cell injury in the context of LIRI.\\n\\nStep 2: Check for any conflicting information in the text.\\nThere is no information in the text that conflicts with the possibility that steatosis causes or exacerbates non-parenchymal liver cell injury in the context of LIRI.\\n\\nStep 3: Check for any additional information that supports or contradicts the possible cause-and-effect relationship.\\nThe text mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI. It also suggests that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI. These findings support the possibility that steatosis exacerbates non-parenchymal liver cell injury in the context of LIRI.\\n\\nStep 4: Choose the most likely cause-and-effect relationship based on the information in the text.\\nBased on the information in the text, it is most likely that steatosis exacerbates non-parenchymal liver cell injury in the context of LIRI.\\n\\n<Answer>B</Answer>')\n",
      "10 = non-parenchymal liver cells, 21 = aging\n",
      "(('non-parenchymal liver cells', 'aging'), 'Step 1: Review the text and identify relevant information.\\n\\nThe text explains that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\" This suggests that both non-parenchymal liver cells and aging are conditions that can exacerbate mitochondrial dysfunction and increase susceptibility to LIRI.\\n\\nStep 2: Use pre-trained knowledge to eliminate unlikely causal relationships.\\n\\nSince non-parenchymal liver cells are not typically associated with aging, it is unlikely that \"non-parenchymal liver cells\" causes \"aging\".\\n\\nStep 3: Consider the remaining options and choose the most likely causal relationship.\\n\\nOption D suggests that there is a common factor that is the cause for both \"non-parenchymal liver cells\" and \"aging\". While this is possible, the text specifically mentions that mitochondrial dysfunction is a hallmark of both conditions and can exacerbate cellular injury. This suggests that \"mitochondrial dysfunction\" is the more likely common factor that causes both \"non-parenchymal liver cells\" and \"aging\".\\n\\n<Answer>D</Answer>')\n",
      "10 = non-parenchymal liver cells, 22 = therapeutic strategies\n",
      "(('non-parenchymal liver cells', 'therapeutic strategies'), '1. The text mentions \"non-parenchymal liver cells\" and \"therapeutic strategies\" as separate entities.\\n2. There is no explicit mention of a causal relationship between \"non-parenchymal liver cells\" and \"therapeutic strategies\".\\n3. The text discusses the importance of developing new therapeutic strategies to improve patient outcomes in the context of liver ischemia-reperfusion injury.\\n4. The text also mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during liver ischemia-reperfusion injury, which is important for the development of new therapeutic strategies.\\n5. Therefore, it is more likely that \"therapeutic strategies\" are a potential solution for mitigating the effects of liver ischemia-reperfusion injury, rather than \"non-parenchymal liver cells\" causing \"therapeutic strategies\".\\n\\n<Answer>B</Answer>')\n",
      "10 = non-parenchymal liver cells, 23 = patient outcomes\n",
      "(('non-parenchymal liver cells', 'patient outcomes'), '1. The text states that liver ischemia-reperfusion injury (LIRI) causes complications in different clinical settings such as liver resection and transplantation.\\n2. The text further explains that damage from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\\n3. The text discusses how mitochondrial dysfunction exacerbates cellular injury during LIRI, and how protecting mitochondria during liver I/R can ameliorate LIRI.\\n4. The text also mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for developing new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this information, it is most likely that option D is the correct answer: there is a common factor that is the cause for both \"non-parenchymal liver cells\" and \"patient outcomes\". LIRI, which causes damage to both parenchymal and non-parenchymal liver cells, is a major risk factor for poor patient outcomes after liver surgery or transplantation. Therefore, the two entities are related through the causal pathway of LIRI.')\n",
      "11 = mitochondrial dysfunction, 12 = glucose metabolism\n",
      "(('mitochondrial dysfunction', 'glucose metabolism'), '1. The text states that mitochondria play a major role in glucose metabolism, among other cellular functions.\\n2. The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. Furthermore, protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI, which suggests a causative relationship between mitochondrial dysfunction and LIRI.\\n4. There is no direct statement in the text that \"glucose metabolism\" causes \"mitochondrial dysfunction\".\\n\\nTherefore, based on the given text and pre-trained knowledge, the most likely cause-and-effect relationship is that \"mitochondrial dysfunction\" causes problems in \"glucose metabolism\".\\n<Answer>A</Answer>')\n",
      "11 = mitochondrial dysfunction, 13 = energy production\n",
      "(('mitochondrial dysfunction', 'energy production'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n2. The text also notes that \"A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n3. Based on these statements, it is reasonable to conclude that \"mitochondrial dysfunction\" causes cellular injury during LIRI and that preserving mitochondrial health is essential for maintaining cellular activity and liver integrity during liver I/R.\\n4. It is also clear that energy production is one of the major functions of mitochondria and that targeting mitochondria can decrease susceptibility to LIRI.\\n5. However, the text does not provide any evidence to suggest that \"energy production\" causes \"mitochondrial dysfunction.\" In fact, the text suggests the opposite - that preserving mitochondrial health is necessary for maintaining energy production and cellular activity.\\n6. Therefore, the answer is <Answer>A</Answer>: \"mitochondrial dysfunction\" causes \"energy production.\"')\n",
      "11 = mitochondrial dysfunction, 14 = reactive oxygen species (ROS) signaling\n",
      "(('mitochondrial dysfunction', 'reactive oxygen species (ROS) signaling'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n2. The text also states that \"mitochondria play a major role in reactive oxygen species (ROS) signaling.\"\\n3. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI.\\n\\nTherefore, based on the given text and pre-trained knowledge, it is more likely that \"mitochondrial dysfunction\" causes \"reactive oxygen species (ROS) signaling\". \\n\\n<Answer>A</Answer>')\n",
      "11 = mitochondrial dysfunction, 15 = calcium homeostasis\n",
      "(('mitochondrial dysfunction', 'calcium homeostasis'), '1. The text states that \"Mitochondria play a major role in... calcium homeostasis and cell death.\"\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\".\\n3. This suggests that there is a causal relationship between mitochondrial dysfunction and calcium homeostasis, but it is not clear which one causes the other.\\n\\nTherefore, the answer is <Answer>D</Answer>. There may be a common factor that causes both mitochondrial dysfunction and calcium homeostasis to become disrupted during liver ischemia/reperfusion injury.')\n",
      "11 = mitochondrial dysfunction, 16 = cell death\n",
      "(('mitochondrial dysfunction', 'cell death'), 'Step 1: Identify the entities involved:\\n- \"mitochondrial dysfunction\"\\n- \"cell death\"\\n\\nStep 2: Look for clues in the text about a causal relationship between the entities:\\n- \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\"\\n- Mitochondria play a major role in multiple cellular processes, including \"cell death\"\\n\\nStep 3: Determine the possible causal relationships:\\nBased on the information provided in the text, it is more likely that \"mitochondrial dysfunction\" causes \"cell death\" rather than the other way around.\\n\\nStep 4: Final answer:\\n<Answer>A</Answer>')\n",
      "11 = mitochondrial dysfunction, 17 = mitochondrial biogenesis\n",
      "(('mitochondrial dysfunction', 'mitochondrial biogenesis'), '1. The text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\", indicating that mitochondrial biogenesis can have a protective effect against LIRI.\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI\".\\n3. Based on the above, it is more likely that \"mitochondrial dysfunction\" causes \"mitochondrial biogenesis\", meaning that the body increases mitochondrial biogenesis in response to mitochondrial dysfunction in an attempt to protect against LIRI.\\n\\nTherefore, the answer is <Answer>A</Answer>.')\n",
      "11 = mitochondrial dysfunction, 18 = fission/fusion\n",
      "(('mitochondrial dysfunction', 'fission/fusion'), '1. The text states that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI) that exacerbates cellular injury.\\n2. The text also mentions that mitochondria play a major role in fission/fusion, among other processes.\\n3. The text suggests that regulating fission/fusion can protect mitochondria and ameliorate LIRI.\\n\\nBased on this information, it is more likely that \"fission/fusion\" causes \"mitochondrial dysfunction\". \\n\\n<Answer>B</Answer>')\n",
      "11 = mitochondrial dysfunction, 19 = mitophagy\n",
      "(('mitochondrial dysfunction', 'mitophagy'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n2. The text also mentions the diverse roles of mitochondria in glucose metabolism, energy production, ROS signaling, calcium homeostasis, and cell death.\\n3. The text specifically highlights the role of mitophagy in protecting mitochondria during liver I/R.\\n\\nBased on the above information, it is more likely that:\\nA. \"mitochondrial dysfunction\" causes \"mitophagy\"\\n\\n<Answer>A</Answer>')\n",
      "11 = mitochondrial dysfunction, 20 = steatosis\n",
      "(('mitochondrial dysfunction', 'steatosis'), '1. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" (LIRI: liver ischemia-reperfusion injury)\\n2. The text suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI\" (I/R: ischemia/reperfusion)\\n3. The text also states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis...has been successful in decreasing their susceptibility to LIRI\"\\n4. The above statements suggest that mitochondrial dysfunction is a cause of LIRI, and that targeting factors that exacerbate mitochondrial dysfunction can help decrease susceptibility to LIRI.\\n\\nTherefore, the more likely cause-and-effect relationship is:\\n\\n<Answer>B</Answer> \"steatosis\" causes \"mitochondrial dysfunction\".')\n",
      "11 = mitochondrial dysfunction, 21 = aging\n",
      "(('mitochondrial dysfunction', 'aging'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\" (indicating a causal relationship between mitochondrial dysfunction and LIRI).\\n\\n2. The text also mentions that \"targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI\" (indicating a link between mitochondrial dysfunction and aging).\\n\\n3. However, the text does not provide evidence that aging is causing mitochondrial dysfunction, and in fact, the sentence could be interpreted as suggesting the opposite: that mitochondrial dysfunction is contributing to the aging process.\\n\\n4. Additionally, the text implies that aging and mitochondrial dysfunction may share a common factor that exacerbates their relationship: \"conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging\".\\n\\nBased on this information, the most likely cause-and-effect relationship is:\\n\\nD. there is a common factor that is the cause for both \"mitochondrial dysfunction\" and \"aging\"\\n\\n<Answer>D</Answer>')\n",
      "11 = mitochondrial dysfunction, 22 = therapeutic strategies\n",
      "(('mitochondrial dysfunction', 'therapeutic strategies'), '1. The text states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. \\n2. The text also states that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n3. Furthermore, the text mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nConsidering the above information, it is more likely that option D is correct, i.e., there is a common factor that is the cause for both \"mitochondrial dysfunction\" and \"therapeutic strategies.\" This common factor is liver ischemia/reperfusion injury (LIRI) itself, which causes mitochondrial dysfunction and also prompts the development of therapeutic strategies aimed at preserving mitochondrial health during liver I/R.\\n\\n<Answer>D</Answer>')\n",
      "11 = mitochondrial dysfunction, 23 = patient outcomes\n",
      "(('mitochondrial dysfunction', 'patient outcomes'), '1. The text mentions that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI).\\n2. LIRI is a major cause of the development of complications in different clinical settings and is associated with higher morbidity and mortality after surgery.\\n3. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI and improve patient outcomes.\\n4. There is no mention that patient outcomes cause mitochondrial dysfunction.\\n\\nBased on these points, it is more likely that mitochondrial dysfunction causes patient outcomes, specifically the development of complications and higher morbidity and mortality after surgery due to LIRI. \\n\\nTherefore, the answer is <Answer>A</Answer>, \"mitochondrial dysfunction\" causes \"patient outcomes\".')\n",
      "12 = glucose metabolism, 13 = energy production\n",
      "(('glucose metabolism', 'energy production'), 'First, we need to understand the roles of glucose metabolism and energy production in the context of liver ischemia-reperfusion injury (LIRI). According to the given text, mitochondria play a major role in both glucose metabolism and energy production, as well as other cellular processes that are associated with LIRI. Mitochondrial dysfunction is recognized as a hallmark of LIRI, and preserving mitochondrial health is essential to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n\\nNext, we need to consider the options: \\n\\nA. \"glucose metabolism\" causes \"energy production\"\\nB. \"energy production\" causes \"glucose metabolism\"\\nC. \"glucose metabolism\" and \"energy production\" are not causally related\\nD. there is a common factor that is the cause for both \"glucose metabolism\" and \"energy production\"\\n\\nBased on the information provided in the text, it is clear that glucose metabolism and energy production are causally related in the context of LIRI. Mitochondria play a major role in glucose metabolism, which is a process that produces energy (ATP) by breaking down glucose. Therefore, glucose metabolism causes energy production, and not the other way around. Option A is therefore the correct answer.\\n\\n<Answer>A</Answer>')\n",
      "12 = glucose metabolism, 14 = reactive oxygen species (ROS) signaling\n",
      "(('glucose metabolism', 'reactive oxygen species (ROS) signaling'), '1. The text states that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n4. Therefore, it is more likely that mitochondrial dysfunction caused by liver ischemia-reperfusion injury exacerbates both \"glucose metabolism\" and \"reactive oxygen species (ROS) signaling.\"\\n\\n<Answer>D</Answer>')\n",
      "12 = glucose metabolism, 15 = calcium homeostasis\n",
      "(('glucose metabolism', 'calcium homeostasis'), 'Step 1: The text states that \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\" This suggests that both glucose metabolism and calcium homeostasis are processes regulated by mitochondria.\\n\\nStep 2: The text also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" This suggests that maintaining healthy mitochondria can help prevent damage during liver ischemia/reperfusion injury.\\n\\nStep 3: There is no further information in the text specifically linking glucose metabolism and calcium homeostasis or suggesting a causal relationship between the two.\\n\\nTherefore, the most likely answer is that \"glucose metabolism\" and \"calcium homeostasis\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "12 = glucose metabolism, 16 = cell death\n",
      "(('glucose metabolism', 'cell death'), 'Step 1: Identify the entities related to the cause-and-effect relationship in the text\\n\\nIn the text, the entities related to the cause-and-effect relationship are \"glucose metabolism\" and \"cell death.\"\\n\\nStep 2: Look for clues or evidence indicating a cause-and-effect relationship between the identified entities\\n\\nThe text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\" Mitochondria play a major role in glucose metabolism, energy production, and cell death. Study suggests that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\" These clues provide evidence that there is a relationship between mitochondrial dysfunction and cellular injury, including cell death, during LIRI.\\n\\nStep 3: Determine the direction of the cause-and-effect relationship based on the evidence\\n\\nBased on the evidence, mitochondrial dysfunction can exacerbate cellular injury, which can cause cell death. There is no evidence to suggest that glucose metabolism directly causes cell death, but rather it is a process that is regulated by mitochondria.\\n\\n<Answer>B</Answer>')\n",
      "12 = glucose metabolism, 17 = mitochondrial biogenesis\n",
      "(('glucose metabolism', 'mitochondrial biogenesis'), 'Step 1: The text states that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n\\nStep 2: The text also states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n\\nStep 3: From the information in the text, it is not clear which entity causes the other, or if they are causally related at all.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"glucose metabolism\" and \"mitochondrial biogenesis\" are not causally related.')\n",
      "12 = glucose metabolism, 18 = fission/fusion\n",
      "(('glucose metabolism', 'fission/fusion'), '1. The text states that mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death and that different roles of mitochondria make it essential to preserve their health during liver ischemia/reperfusion (I/R). \\n\\n2. The text also states that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n\\n3. However, the text does not provide any specific indication of a causal relationship between \"glucose metabolism\" and \"fission/fusion\".\\n\\n4. Given that both \"glucose metabolism\" and \"fission/fusion\" are roles of mitochondria and the text emphasizes the importance of preserving mitochondrial health in order to maintain cellular activity and liver integrity during LIRI, it is likely that both \"glucose metabolism\" and \"fission/fusion\" are affected by mitochondrial dysfunction, rather than one causing the other. \\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"glucose metabolism\" and \"fission/fusion\".')\n",
      "12 = glucose metabolism, 19 = mitophagy\n",
      "(('glucose metabolism', 'mitophagy'), '1. Glucose metabolism and mitophagy are both mentioned as playing a role in preserving mitochondrial health during liver I/R.\\n2. The text states that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n3. However, there is no explicit causal relationship mentioned between glucose metabolism and mitophagy.\\n\\nTherefore, the most likely answer is:\\n\\n<Answer>C</Answer> Glucose metabolism and mitophagy are not causally related.')\n",
      "12 = glucose metabolism, 20 = steatosis\n",
      "(('glucose metabolism', 'steatosis'), '1. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n2. The text also states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\n3. Based on these statements, it is more likely that \"steatosis\" causes \"glucose metabolism\", rather than the other way around.\\n4. This is supported by the fact that the text specifically mentions steatosis (among other conditions) as a potential cause of mitochondrial dysfunction, and suggests that targeting mitochondria in such conditions can help prevent cellular injury.\\n\\nTherefore, the answer is <Answer>B</Answer>: \"steatosis\" causes \"glucose metabolism\".')\n",
      "12 = glucose metabolism, 21 = aging\n",
      "(('glucose metabolism', 'aging'), 'Step 1: Identify the entities \\n- \"glucose metabolism\" \\n- \"aging\"\\n\\nStep 2: Look for clues in the text \\n- The text mentions that mitochondria play a major role in glucose metabolism, energy production, ROS signaling, calcium homeostasis and cell death. \\n- The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI. \\n\\nStep 3: Analyze the cause-and-effect relationship \\n- The text does not provide any explicit information about a cause-and-effect relationship between \"glucose metabolism\" and \"aging\". \\n- There is evidence that both \"glucose metabolism\" and \"aging\" can exacerbate mitochondrial dysfunction, but there is no information suggesting a direct causal relationship between the two. \\n\\n<Answer>C</Answer> \"glucose metabolism\" and \"aging\" are not causally related.')\n",
      "12 = glucose metabolism, 22 = therapeutic strategies\n",
      "(('glucose metabolism', 'therapeutic strategies'), '1. The text mentions that there is a need to develop new therapeutic strategies to improve patient outcomes in liver ischemia-reperfusion injury (LIRI).\\n2. The text also mentions that mitochondria play a major role in glucose metabolism, energy production, and cellular activity during liver ischemia/reperfusion (I/R).\\n3. Additionally, it is suggested that protecting mitochondria during liver I/R can ameliorate LIRI.\\n4. However, there is no direct mention of a causal relationship between \"glucose metabolism\" and \"therapeutic strategies.\"\\n\\nTherefore, the most likely answer is <Answer>C</Answer>: \"glucose metabolism\" and \"therapeutic strategies\" are not causally related.')\n",
      "12 = glucose metabolism, 23 = patient outcomes\n",
      "(('glucose metabolism', 'patient outcomes'), '1. The text states that mitochondria play a major role in glucose metabolism, energy production, and cell death during liver ischemia/reperfusion (I/R).\\n2. The text also states that protecting mitochondria during liver I/R can ameliorate liver ischemia-reperfusion injury (LIRI).\\n3. The text further emphasizes the importance of studying mitochondrial dysfunction to understand the underlying mechanisms of cellular damage during LIRI, which is crucial for developing new therapeutic strategies aimed at improving patient outcomes.\\n\\nTherefore, based on the text and pre-trained knowledge, it is more likely that D: there is a common factor that is the cause for both \"glucose metabolism\" and \"patient outcomes\". Both glucose metabolism and patient outcomes could be influenced by mitochondrial health and dysfunction during liver I/R.')\n",
      "13 = energy production, 14 = reactive oxygen species (ROS) signaling\n",
      "(('energy production', 'reactive oxygen species (ROS) signaling'), '1. \"Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n2. \"Although the mechanisms leading to the injury of parenchymal and non-parenchymal liver cells are not yet fully understood, mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. \"A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n4. \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\"\\n\\nBased on the text and pre-trained knowledge, it is more likely that \"reactive oxygen species (ROS) signaling\" causes \"energy production\". This is because mitochondrial dysfunction exacerbates cellular injury during LIRI, and ROS signaling is known to be associated with cellular damage. Therefore, ROS signaling is more likely to be the cause of a decrease in energy production rather than the other way around.\\n\\n<Answer>B</Answer>')\n",
      "13 = energy production, 15 = calcium homeostasis\n",
      "(('energy production', 'calcium homeostasis'), '1. The text states that mitochondria play a major role in energy production, calcium homeostasis, and cell death.\\n2. The text also states that mitochondrial dysfunction exacerbates cellular injury during liver ischemia/reperfusion.\\n3. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n4. The text indicates that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the above analysis, option C seems to be the correct answer, as the text does not suggest a causal relationship between \"energy production\" and \"calcium homeostasis\".')\n",
      "13 = energy production, 16 = cell death\n",
      "(('energy production', 'cell death'), '1. The text states that mitochondria play a major role in energy production, as well as in cell death.\\n2. The text also states that mitochondrial dysfunction is associated with cellular injury and exacerbates liver ischemia-reperfusion injury (LIRI).\\n3. Protecting mitochondria during liver I/R has been shown to ameliorate LIRI.\\n\\nBased on these pieces of information, it is more likely that mitochondrial dysfunction, which affects both energy production and cell death, is the cause of LIRI, rather than \"energy production\" being the cause of \"cell death\".\\n\\nTherefore, the answer is: <Answer>D</Answer> There is a common factor that is the cause for both \"energy production\" and \"cell death\".')\n",
      "13 = energy production, 17 = mitochondrial biogenesis\n",
      "(('energy production', 'mitochondrial biogenesis'), 'Step 1: \\nThe text mentions that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n\\nStep 2: \\nThe text mentions that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n\\nStep 3:\\nBased on the information from the text, it is more likely that \"mitochondrial biogenesis\" causes \"energy production\", as the text highlights that regulating mitochondrial biogenesis can help protect mitochondria during liver ischemia-reperfusion injury, and mitochondria play a major role in energy production.\\n\\nTherefore, the answer is <Answer>B</Answer>.')\n",
      "13 = energy production, 18 = fission/fusion\n",
      "(('energy production', 'fission/fusion'), '1. The text mentions that mitochondria play a major role in energy production, among other functions.\\n2. The text also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n3. It is not stated in the text that \"energy production\" causes \"fission/fusion\" or vice versa.\\n4. It is also not stated in the text that there is a common factor that is the cause for both \"energy production\" and \"fission/fusion\".\\n5. Therefore, the most likely answer is that \"energy production\" and \"fission/fusion\" are not causally related.\\n\\n<Answer>C</Answer>')\n",
      "13 = energy production, 19 = mitophagy\n",
      "(('energy production', 'mitophagy'), '1. The text states that mitochondria play a major role in both energy production and mitophagy.\\n2. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI, but it does not suggest that protecting one specific mitochondrial function is more important than protecting another.\\n3. The text does not provide any explicit or implicit information suggesting one causal relationship between energy production and mitophagy over the other.\\n\\nTherefore, the most appropriate answer is: \\n\\n<Answer>C</Answer> \"energy production\" and \"mitophagy\" are not causally related.')\n",
      "13 = energy production, 20 = steatosis\n",
      "(('energy production', 'steatosis'), 'Step 1: Identify the causal entities in the text and their causal relationship.\\n- Causal entity 1: energy production\\n- Causal entity 2: steatosis\\n- Causal relationship: The text mentions that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\" This suggests that steatosis exacerbates mitochondrial dysfunction and increases susceptibility to LIRI.\\n\\nStep 2: Determine the causal direction between the entities based on your pre-trained knowledge.\\n- Energy production is a function of properly functioning mitochondria.\\n- Steatosis is a condition characterized by excessive fat accumulation in the liver.\\n- It is unlikely that energy production causes steatosis, as steatosis is not a direct consequence of mitochondrial activity.\\n- On the other hand, it is plausible that steatosis causes mitochondrial dysfunction and impairs energy production, as excess fat accumulation in the liver can disrupt mitochondrial function.\\n\\nStep 3: Combine the causal relationship from the text and your pre-trained knowledge to reach a final answer.\\n- Causal entity 1: energy production\\n- Causal entity 2: steatosis\\n- Causal relationship: Steatosis causes mitochondrial dysfunction and impairs energy production.\\n- <Answer>B</Answer> \"steatosis\" causes \"energy production\"')\n",
      "13 = energy production, 21 = aging\n",
      "(('energy production', 'aging'), '1. We are asked to determine which cause-and-effect relationship is more likely between \"energy production\" and \"aging\" based on the given text.\\n2. The text mentions that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI) and exacerbates cellular injury. Mitochondria play a major role in energy production among other cellular processes. The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing susceptibility to LIRI. However, there is no mention in the text that \"energy production\" causes \"aging\".\\n3. From the information given in the text, it is more likely that there is a causal relationship between \"aging\" and \"energy production\" rather than the other way around. The text suggests that mitochondria play a major role in cellular processes including energy production and that dysfunction in mitochondria exacerbates cellular injury. It also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing susceptibility to LIRI, suggesting that aging is a risk factor for mitochondrial dysfunction and subsequent cellular injury.\\n4. Therefore, the answer is <Answer>B</Answer>: \"aging\" causes \"energy production\".')\n",
      "13 = energy production, 22 = therapeutic strategies\n",
      "(('energy production', 'therapeutic strategies'), 'Step 1: \\n\\nThe text mentions that mitochondria play a major role in energy production, as well as in the development of new therapeutic strategies aimed at improving patient outcomes, but it does not provide any clear causal relationship between these two entities. \\n\\nStep 2: \\n\\nWhile it is possible that mitochondrial function and energy production can be a factor in the development of new therapeutic strategies for liver ischemia-reperfusion injury, it is also possible that these two entities are not directly related and that there is a common factor that is the cause for both. \\n\\nStep 3: \\n\\nTherefore, based on the given text, the most likely answer is that \"energy production\" and \"therapeutic strategies\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "13 = energy production, 23 = patient outcomes\n",
      "(('energy production', 'patient outcomes'), '1. The text mentions that mitochondrial dysfunction exacerbates cellular injury during liver ischemia/reperfusion (I/R).\\n2. Mitochondria play a major role in energy production.\\n3. The text suggests that protecting mitochondria during liver I/R can ameliorate LIRI.\\n4. The text also suggests that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the above information, it can be inferred that mitochondrial dysfunction (which can affect energy production) is a cause of poor patient outcomes during liver ischemia/reperfusion injury. Therefore, the more likely cause-and-effect relationship is: \"energy production\" (which is impacted by mitochondrial dysfunction) causes \"patient outcomes\". \\n\\n<Answer>A</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 15 = calcium homeostasis\n",
      "(('reactive oxygen species (ROS) signaling', 'calcium homeostasis'), '1. The text states that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death.\"\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text suggests that protecting mitochondria during liver I/R ameliorates LIRI.\\n4. Therefore, it is likely that mitochondrial dysfunction, which is recognized as a hallmark of LIRI, causes both \"reactive oxygen species (ROS) signaling\" and \"calcium homeostasis\" to become disrupted during liver I/R.\\n\\n<Answer>D</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 16 = cell death\n",
      "(('reactive oxygen species (ROS) signaling', 'cell death'), '1. The text states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in reactive oxygen species (ROS) signaling and cell death, among other functions.\\n3. Protecting mitochondria during liver I/R ameliorates LIRI.\\n4. Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on these pieces of information, it is more likely that \"reactive oxygen species (ROS) signaling\" causes \"cell death\". \\n\\n<Answer>A</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 17 = mitochondrial biogenesis\n",
      "(('reactive oxygen species (ROS) signaling', 'mitochondrial biogenesis'), 'Step 1: Identify the entities\\n- \"reactive oxygen species (ROS) signaling\"\\n- \"mitochondrial biogenesis\"\\n\\nStep 2: Look for clues in the text\\n- The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n- The text also mentions that mitochondria play a major role in reactive oxygen species (ROS) signaling.\\n\\nStep 3: Determine the cause-and-effect relationship\\n- Based on the clues in the text, it is more likely that \"mitochondrial biogenesis\" leads to \"reactive oxygen species (ROS) signaling\" because mitochondrial dysfunction exacerbates cellular injury, and mitochondria play a major role in ROS signaling. Therefore, promoting mitochondrial health through biogenesis could reduce ROS signaling and ameliorate LIRI.\\n\\n<Answer>B</Answer> \"mitochondrial biogenesis\" causes \"reactive oxygen species (ROS) signaling\"')\n",
      "14 = reactive oxygen species (ROS) signaling, 18 = fission/fusion\n",
      "(('reactive oxygen species (ROS) signaling', 'fission/fusion'), 'Step 1: Identify the entities and their relationships in the text.\\n\\nThe text mentions two entities - \"reactive oxygen species (ROS) signaling\" and \"fission/fusion\" - and how protecting mitochondria by regulating them can ameliorate liver ischemia-reperfusion injury (LIRI). However, the text does not explicitly state a cause-and-effect relationship between these entities.\\n\\nStep 2: Apply prior knowledge and logical reasoning.\\n\\nBoth \"reactive oxygen species (ROS) signaling\" and \"fission/fusion\" are processes that occur within mitochondria. It is possible that one process may cause or exacerbate the other, but it is also possible that they are independent processes that are both affected by the same underlying factor (e.g. oxidative stress). Without further evidence, it is not possible to determine which cause-and-effect relationship is more likely.\\n\\n<Answer>D</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 19 = mitophagy\n",
      "(('reactive oxygen species (ROS) signaling', 'mitophagy'), '1. Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in reactive oxygen species (ROS) signaling and mitophagy.\\n3. A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n4. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on the given text, it can be inferred that \"mitophagy\" plays a role in ameliorating LIRI and \"reactive oxygen species (ROS) signaling\" is one of the functions of mitochondria. Therefore, the more likely cause-and-effect relationship is:\\n\\nB. \"mitophagy\" causes \"reactive oxygen species (ROS) signaling\"\\n\\n<Answer>B</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 20 = steatosis\n",
      "(('reactive oxygen species (ROS) signaling', 'steatosis'), '1. The text mentions that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in reactive oxygen species (ROS) signaling, among other functions.\\n3. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI.\\n\\nBased on these statements, it is more likely that option D is correct, and there is a common factor that causes both \"reactive oxygen species (ROS) signaling\" and \"steatosis\". Specifically, mitochondrial dysfunction may be the common factor that leads to both conditions.')\n",
      "14 = reactive oxygen species (ROS) signaling, 21 = aging\n",
      "(('reactive oxygen species (ROS) signaling', 'aging'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\", and \"The diverse roles of mitochondria make it essential to preserve mitochondrial health in order to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R)\".\\n2. The text also states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI\".\\n3. Therefore, it is more likely that there is a causal relationship between \"aging\" and \"reactive oxygen species (ROS) signaling\", as aging is identified as one of the conditions that exacerbates mitochondrial dysfunction, and targeting mitochondria during aging has been successful in decreasing susceptibility to LIRI.\\n\\n<Answer>B</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 22 = therapeutic strategies\n",
      "(('reactive oxygen species (ROS) signaling', 'therapeutic strategies'), '1. The text states that \"reactive oxygen species (ROS) signaling\" is one of the diverse roles of mitochondria. \\n2. The text also suggests that studying mitochondrial dysfunction in liver I/R is important for the development of new therapeutic strategies. \\n\\nBased on the above information, it is more likely that option D is the correct answer, where there is a common factor (mitochondrial dysfunction) that is the cause for both \"reactive oxygen species (ROS) signaling\" and \"therapeutic strategies\".\\n\\n<Answer>D</Answer>')\n",
      "14 = reactive oxygen species (ROS) signaling, 23 = patient outcomes\n",
      "(('reactive oxygen species (ROS) signaling', 'patient outcomes'), '1. The text mentions that liver ischemia-reperfusion injury (LIRI) is a major cause of complications in liver resection and liver transplantation.\\n2. The text also highlights that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n3. The text goes on to discuss the various roles of mitochondria, including reactive oxygen species (ROS) signaling, and the importance of preserving mitochondrial health to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R). \\n4. The text notes that protecting mitochondria during liver I/R has been successful in decreasing susceptibility to LIRI. \\n5. Finally, the text emphasizes that studying mitochondrial dysfunction is important for developing new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this information, it is more likely that \"reactive oxygen species (ROS) signaling\" exacerbates cellular injury and is not the cause of \"patient outcomes\". Therefore, the answer is <Answer>A</Answer>.')\n",
      "15 = calcium homeostasis, 16 = cell death\n",
      "(('calcium homeostasis', 'cell death'), 'Step 1: The text states that mitochondria play a major role in calcium homeostasis, energy production, ROS signaling, and cell death.\\n\\nStep 2: The text also states that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury. Therefore, it is reasonable to infer that mitochondrial dysfunction can lead to calcium dysregulation and cell death.\\n\\nStep 3: Given that the text highlights the importance of preserving mitochondrial health to maintain cellular activity and liver integrity during LIRI, it is likely that calcium homeostasis and cell death are causally related, with mitochondrial dysfunction serving as the root cause.\\n\\n<Answer>A</Answer> \"calcium homeostasis\" causes \"cell death\".')\n",
      "15 = calcium homeostasis, 17 = mitochondrial biogenesis\n",
      "(('calcium homeostasis', 'mitochondrial biogenesis'), '1. The text states that \"mitochondria play a major role in calcium homeostasis\". \\n\\n2. The text also states that \"regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n\\n3. Based on the above, it can be inferred that \"mitochondrial biogenesis\" is likely to have a causal effect on \"calcium homeostasis\" because if mitochondria play a role in calcium homeostasis, and regulating mitochondrial biogenesis improves liver I/R (which involves calcium homeostasis), then it is reasonable to assume that mitochondrial biogenesis has a causal effect on calcium homeostasis.\\n\\nTherefore, the more likely cause-and-effect relationship is: B. \"mitochondrial biogenesis\" causes \"calcium homeostasis\".\\n\\n<Answer>B</Answer>')\n",
      "15 = calcium homeostasis, 18 = fission/fusion\n",
      "(('calcium homeostasis', 'fission/fusion'), 'Step 1: Identify the entities and their descriptions.\\n- \"Calcium homeostasis\": one of the roles of mitochondria.\\n- \"Fission/fusion\": another role of mitochondria.\\n\\nStep 2: Analyze the text for any causal language that connects these entities.\\n- The text explains that \"mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis and cell death\".\\n- It also explains that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n- However, there is no explicit causal language connecting \"calcium homeostasis\" and \"fission/fusion\".\\n\\nStep 3: Consider any plausible explanations for their relationship.\\n- The text does not provide any explanation for a causal relationship between \"calcium homeostasis\" and \"fission/fusion\".\\n\\nTherefore, the most likely answer is that \"calcium homeostasis\" and \"fission/fusion\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "15 = calcium homeostasis, 19 = mitophagy\n",
      "(('calcium homeostasis', 'mitophagy'), 'Step 1: Identify the entities\\n- \"Calcium homeostasis\": the maintenance of a stable calcium concentration in a cell or tissue\\n- \"Mitophagy\": a process of removing damaged mitochondria from cells\\n\\nStep 2: Identify the relevant information in the text\\n- The text mentions that mitochondria play a role in calcium homeostasis, suggesting that calcium homeostasis is downstream of mitochondrial function.\\n- The text also mentions that regulating mitophagy during liver reperfusion can ameliorate liver ischemia-reperfusion injury (LIRI), suggesting that mitophagy is upstream of LIRI.\\n\\nStep 3: Determine the causal relationship\\n- Based on the information in the text, \"mitophagy\" is more likely to cause \"calcium homeostasis\" because the text suggests that mitochondrial dysfunction can lead to LIRI, and regulating mitophagy can improve LIRI. Mitophagy is a process of removing damaged mitochondria, suggesting that mitophagy is upstream of mitochondrial health and function. If mitophagy is impaired, damaged mitochondria may persist and contribute to calcium dysregulation and other downstream effects.\\n\\n<Answer>B</Answer>')\n",
      "15 = calcium homeostasis, 20 = steatosis\n",
      "(('calcium homeostasis', 'steatosis'), '1. We are asked to identify the cause-and-effect relationship between \"calcium homeostasis\" and \"steatosis\" based on the given text.\\n2. The text mentions that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI), which exacerbates cellular injury. Mitochondria play a major role in calcium homeostasis and other cellular functions such as energy production and cell death.\\n3. The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing susceptibility to LIRI. This suggests that steatosis exacerbates mitochondrial dysfunction, which in turn exacerbates cellular injury during LIRI.\\n4. However, the text does not mention any causal relationship between calcium homeostasis and steatosis.\\n5. Therefore, the most likely cause-and-effect relationship in this case is: B. \"steatosis\" causes \"calcium homeostasis\".\\n6. <Answer>B</Answer>')\n",
      "15 = calcium homeostasis, 21 = aging\n",
      "(('calcium homeostasis', 'aging'), '1. The text states that mitochondrial dysfunction is recognized as a hallmark of liver ischemia-reperfusion injury (LIRI).\\n2. Mitochondria play a major role in calcium homeostasis and are essential to maintain cellular activity and liver integrity during liver ischemia/reperfusion (I/R).\\n3. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nThese statements suggest that there is a possible causal relationship between aging and calcium homeostasis, mediated by the role of mitochondria in LIRI. Therefore, the answer is <Answer>B</Answer>: \"aging\" causes \"calcium homeostasis\".')\n",
      "15 = calcium homeostasis, 22 = therapeutic strategies\n",
      "(('calcium homeostasis', 'therapeutic strategies'), '1. The text mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"mitochondria play a major role in calcium homeostasis and cell death\".\\n2. It also mentions that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\" and that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes\".\\n3. The text does not provide any causal relationship between \"calcium homeostasis\" and \"therapeutic strategies\". They are mentioned as separate but related topics.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"calcium homeostasis\" and \"therapeutic strategies\" are not causally related.')\n",
      "15 = calcium homeostasis, 23 = patient outcomes\n",
      "(('calcium homeostasis', 'patient outcomes'), '1. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in calcium homeostasis.\\n3. The text suggests that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n4. The text also mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on this information, it is more likely that D: there is a common factor that is the cause for both \"calcium homeostasis\" and \"patient outcomes\" since both are affected by mitochondrial dysfunction which is a hallmark of LIRI and can exacerbate cellular injury. Protecting mitochondria and studying its dysfunction are suggested to ameliorate LIRI and improve patient outcomes. However, the text does not provide enough evidence to support a direct causal relationship between \"calcium homeostasis\" and \"patient outcomes\". \\n\\n<Answer>D</Answer>')\n",
      "16 = cell death, 17 = mitochondrial biogenesis\n",
      "(('cell death', 'mitochondrial biogenesis'), '1. The text mentions that mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n2. The text also mentions that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\nBased on these two pieces of information, it is more likely that \"mitochondrial biogenesis\" is a cause of preventing \"cell death\" during liver ischemia/reperfusion injury, rather than the other way around. \\n\\nTherefore, the answer is <Answer>B</Answer>: \"mitochondrial biogenesis\" causes \"cell death\".')\n",
      "16 = cell death, 18 = fission/fusion\n",
      "(('cell death', 'fission/fusion'), '1. The text states that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in cell death.\\n3. The text suggests that protecting mitochondria by regulating fission/fusion during liver I/R ameliorates LIRI.\\n4. The text suggests that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI.\\n\\nBased on the above information, the more likely cause-and-effect relationship is that \"fission/fusion\" causes \"cell death\". \\n\\nTherefore, the answer is <Answer>B</Answer>.')\n",
      "16 = cell death, 19 = mitophagy\n",
      "(('cell death', 'mitophagy'), '1. What is Liver ischemia-reperfusion injury (LIRI)?\\n- LIRI is a major cause of the development of complications in different clinical settings such as liver resection and liver transplantation.\\n\\n2. What is the hallmark of LIRI that exacerbates cellular injury?\\n- Mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\\n\\n3. What are the diverse roles of mitochondria?\\n- Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death.\\n\\n4. What do a growing body of studies suggest with regards to protecting mitochondria during liver I/R?\\n- A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\\n\\n5. What is the goal of studying mitochondrial dysfunction in LIRI?\\n- Studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI, which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\nBased on the information given, the more likely cause-and-effect relationship is:\\nD. There is a common factor that is the cause for both \"cell death\" and \"mitophagy\". This is because both \"cell death\" and \"mitophagy\" are mentioned as processes that result from mitochondrial dysfunction, which is recognized as a hallmark of LIRI. Mitochondria play a major role in various cellular processes, including glucose metabolism, energy production, ROS signaling, and calcium homeostasis. Dysfunction in any of these processes can lead to cellular damage and ultimately cell death or mitophagy. Therefore, there may be a common factor, such as mitochondrial dysfunction, that is the cause of both processes.')\n",
      "16 = cell death, 20 = steatosis\n",
      "(('cell death', 'steatosis'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\", and \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" So, LIRI is linked with mitochondrial dysfunction.\\n2. The text mentions that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\" So, steatosis exacerbates mitochondrial dysfunction.\\n\\nTherefore, it is more likely that \"steatosis\" causes \"cell death\". \\n\\n<Answer>B</Answer>')\n",
      "16 = cell death, 21 = aging\n",
      "(('cell death', 'aging'), 'Step 1: Identify the entities and their roles\\n- \"Cell death\": a process that exacerbates cellular injury\\n- \"Aging\": a condition that exacerbates mitochondrial dysfunction\\n\\nStep 2: Determine the causal direction based on common knowledge and the given text\\n- The text states that \"cell death\" exacerbates cellular injury, which suggests that it is an effect rather than a cause of a condition.\\n- The text also states that \"aging\" exacerbates mitochondrial dysfunction, which suggests that it is a cause rather than an effect of a condition.\\n- Therefore, \"aging\" is more likely to cause \"cell death\".\\n\\n<Answer>B</Answer>')\n",
      "16 = cell death, 22 = therapeutic strategies\n",
      "(('cell death', 'therapeutic strategies'), 'Step 1: Identify the causal entities and their relationship in the text.\\n\\nCausal entities: \"cell death\" and \"therapeutic strategies\"\\nRelationship: The text does not explicitly state a causal relationship between \"cell death\" and \"therapeutic strategies\".\\n\\nStep 2: Consider the context and background knowledge.\\n\\nThe text discusses the mechanisms of liver ischemia-reperfusion injury and the role of mitochondria in cellular injury. It also highlights the importance of protecting mitochondria during liver ischemia/reperfusion (I/R) in order to maintain cellular activity and liver integrity. The text does not provide any indication of a direct causal relationship between \"cell death\" and \"therapeutic strategies\".\\n\\nStep 3: Choose the most likely answer based on steps 1 and 2.\\n\\nAnswer: <Answer>C</Answer> \"cell death\" and \"therapeutic strategies\" are not causally related.')\n",
      "16 = cell death, 23 = patient outcomes\n",
      "(('cell death', 'patient outcomes'), '1. The text states that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n2. The text also states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. The text further states that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n\\nBased on this information, it is most likely that option D, there is a common factor that is the cause for both \"cell death\" and \"patient outcomes\", is the correct answer. The common factor is likely to be liver ischemia-reperfusion injury (LIRI) itself, which is known to cause both damage to cellular structures such as mitochondria (which can lead to cell death) and negative outcomes for patients such as higher morbidity and mortality. \\n\\n<Answer>D</Answer>')\n",
      "17 = mitochondrial biogenesis, 18 = fission/fusion\n",
      "(('mitochondrial biogenesis', 'fission/fusion'), '1. The text mentions that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n2. The text also mentions that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury.\"\\n3. From these two statements, we can infer that the relationship between mitochondrial biogenesis and fission/fusion is not a causal one, but rather both processes are important in protecting mitochondria and preventing mitochondrial dysfunction that leads to LIRI.\\n4. Therefore, the correct answer is <Answer>C</Answer>: \"mitochondrial biogenesis\" and \"fission/fusion\" are not causally related.')\n",
      "17 = mitochondrial biogenesis, 19 = mitophagy\n",
      "(('mitochondrial biogenesis', 'mitophagy'), 'Step 1: Identify the entities involved\\nThe entities involved are \"mitochondrial biogenesis\" and \"mitophagy\".\\n\\nStep 2: Look for clues in the text\\nThe text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\" This suggests that both mitochondrial biogenesis and mitophagy are important in protecting the mitochondria and preventing liver ischemia-reperfusion injury.\\n\\nStep 3: Consider known causal relationships\\nMitochondrial biogenesis refers to the process of generating new mitochondria. Mitophagy, on the other hand, is the process of removing damaged or dysfunctional mitochondria. While these two processes are related to the health of mitochondria, there is no direct causal relationship between them.\\n\\nStep 4: Consider alternative explanations\\nIt is possible that there is a common factor that causes both mitochondrial biogenesis and mitophagy. For example, a cellular stress response may trigger both processes.\\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"mitochondrial biogenesis\" and \"mitophagy\".')\n",
      "17 = mitochondrial biogenesis, 20 = steatosis\n",
      "(('mitochondrial biogenesis', 'steatosis'), 'Step 1: Identify the entities and their roles in the text:\\n- \"mitochondrial biogenesis\": mentioned as a potential strategy to protect mitochondria during liver ischemia/reperfusion (I/R) and decrease susceptibility to liver ischemia-reperfusion injury (LIRI).\\n- \"steatosis\": mentioned as a condition that exacerbates mitochondrial dysfunction and increases susceptibility to LIRI.\\n\\nStep 2: Determine the direction of causality:\\n- The text suggests that protecting mitochondria by regulating mitochondrial biogenesis may ameliorate LIRI, while conditions that exacerbate mitochondrial dysfunction (such as steatosis) increase susceptibility to LIRI.\\n- Therefore, it is more likely that \"steatosis\" causes \"mitochondrial dysfunction\" and increases susceptibility to LIRI, rather than the other way around.\\n\\n<Answer>B</Answer>')\n",
      "17 = mitochondrial biogenesis, 21 = aging\n",
      "(('mitochondrial biogenesis', 'aging'), 'Step 1: The text states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\" This suggests that both mitochondrial dysfunction and aging are conditions that can exacerbate the risk of LIRI. \\n\\nStep 2: However, the text does not provide any evidence or indication that mitochondrial biogenesis causes aging or that aging causes mitochondrial biogenesis. \\n\\nStep 3: Therefore, the most likely answer is C: \"mitochondrial biogenesis\" and \"aging\" are not causally related. \\n\\n<Answer>C</Answer>')\n",
      "17 = mitochondrial biogenesis, 22 = therapeutic strategies\n",
      "(('mitochondrial biogenesis', 'therapeutic strategies'), '1. The text mentions that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n2. The text also mentions that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n3. Therefore, it is more likely that \"mitochondrial biogenesis\" is a factor that can be targeted as a part of \"therapeutic strategies\" for improving outcomes in conditions where mitochondrial dysfunction causes LIRI.\\n4. This implies that there is a causal relationship between \"mitochondrial biogenesis\" and \"therapeutic strategies\", with \"mitochondrial biogenesis\" being a factor that contributes to \"therapeutic strategies.\"\\n\\nTherefore, the answer is <Answer>A</Answer>: \"mitochondrial biogenesis\" causes \"therapeutic strategies\".')\n",
      "17 = mitochondrial biogenesis, 23 = patient outcomes\n",
      "(('mitochondrial biogenesis', 'patient outcomes'), 'Step 1: Identify relevant sentences and entities.\\n\\nThe text discusses the role of mitochondria in liver ischemia-reperfusion injury (LIRI) and the potential for regulating mitochondrial biogenesis to ameliorate LIRI and improve patient outcomes.\\n\\nStep 2: Use background knowledge to eliminate incorrect answers.\\n\\nIt is unlikely that \"patient outcomes\" cause \"mitochondrial biogenesis\" as mitochondrial biogenesis is a natural cellular process that occurs to maintain mitochondrial health. \\n\\nStep 3: Determine the direction of causality.\\n\\nThere is evidence that regulating mitochondrial biogenesis can ameliorate LIRI and improve patient outcomes. Therefore, it is more likely that \"mitochondrial biogenesis\" affects \"patient outcomes\".\\n\\n<Answer>A</Answer>')\n",
      "18 = fission/fusion, 19 = mitophagy\n",
      "(('fission/fusion', 'mitophagy'), '1. The text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n2. This suggests that fission/fusion and mitophagy are both involved in protecting mitochondria during liver ischemia/reperfusion.\\n3. The text does not provide any indication of a causal relationship between fission/fusion and mitophagy.\\n4. Therefore, it is most likely that fission/fusion and mitophagy are not causally related, but rather both contribute to protecting mitochondria against LIRI.\\n\\n<Answer>C</Answer>')\n",
      "18 = fission/fusion, 20 = steatosis\n",
      "(('fission/fusion', 'steatosis'), '1. The text mentions that mitochondrial dysfunction is a hallmark of liver ischemia-reperfusion injury (LIRI).\\n2. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death.\\n3. Protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n4. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI.\\n\\nFrom the text, it is clear that \"fission/fusion\" and \"steatosis\" are not causally related and there is a common factor that is the cause for both of them. The text states that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing their susceptibility to LIRI, which implies that both \"fission/fusion\" and \"steatosis\" are caused by mitochondrial dysfunction. Therefore, the correct answer is <Answer>D</Answer>.')\n",
      "18 = fission/fusion, 21 = aging\n",
      "(('fission/fusion', 'aging'), '1. The text describes that mitochondrial dysfunction is a hallmark of LIRI that exacerbates cellular injury.\\n2. Mitochondria play a major role in glucose metabolism, energy production, reactive oxygen species (ROS) signaling, calcium homeostasis, and cell death.\\n3. A growing body of studies suggest that protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion, and mitophagy during liver I/R ameliorates LIRI.\\n4. Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n\\nFrom the given information, we can infer that \"fission/fusion\" and \"aging\" are both conditions that exacerbate mitochondrial dysfunction and increase susceptibility to LIRI. However, there is no evidence to support a causal relationship between the two.\\n\\nTherefore, the answer is <Answer>C</Answer>: \"fission/fusion\" and \"aging\" are not causally related.')\n",
      "18 = fission/fusion, 22 = therapeutic strategies\n",
      "(('fission/fusion', 'therapeutic strategies'), '1. The text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n2. The text also states that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n\\nBased on these statements, it is more likely that \"fission/fusion\" and \"therapeutic strategies\" are not causally related but are both potential approaches for mitigating the effects of LIRI. Therefore, the answer is <Answer>C</Answer>: \"fission/fusion\" and \"therapeutic strategies\" are not causally related.')\n",
      "18 = fission/fusion, 23 = patient outcomes\n",
      "(('fission/fusion', 'patient outcomes'), '1. Identify the entities: \"fission/fusion\" and \"patient outcomes\"\\n2. Look for causal language linking the entities to each other or to other entities in the text.\\n3. Are there any mentions of one entity causing the other or vice versa?\\n\\nBased on the text and pre-trained knowledge, there is no direct causal relationship between \"fission/fusion\" and \"patient outcomes\" mentioned. The text discusses the importance of protecting mitochondria during liver I/R to ameliorate LIRI and improve patient outcomes, and mentions that regulating mitochondrial fission/fusion is one way to protect them. However, it does not explicitly state whether or not fission/fusion has a causal effect on patient outcomes. It is possible that there is a common factor that contributes to both fission/fusion and patient outcomes (e.g. the severity of liver I/R injury), but this is not mentioned in the text.\\n\\nTherefore, the answer is <Answer>D</Answer>: there is a common factor that is the cause for both \"fission/fusion\" and \"patient outcomes\".')\n",
      "19 = mitophagy, 20 = steatosis\n",
      "(('mitophagy', 'steatosis'), 'Step 1: Identify the causal relationship between \"mitophagy\" and \"steatosis\" from the text. \\n\\nThe text states that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis..\". This suggests that \"steatosis\" is a condition that can exacerbate mitochondrial dysfunction, including mitophagy. \\n\\nStep 2: Formulate the causal relationship \\n\\nTherefore, the causal relationship is: \"steatosis\" causes \"mitochondrial dysfunction\" which can exacerbate \"mitophagy\". \\n\\nAnswer: <Answer>B</Answer>')\n",
      "19 = mitophagy, 21 = aging\n",
      "(('mitophagy', 'aging'), '1. The text states that \"mitochondrial dysfunction is recognized as a hallmark of LIRI that exacerbates cellular injury\" and that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI\".\\n\\n2. The text also mentions that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI\".\\n\\n3. While the text suggests a causal link between mitochondrial dysfunction and LIRI, it does not provide clear evidence for a causal relationship between mitophagy and aging.\\n\\n4. Therefore, it is most likely that option C: \"mitophagy\" and \"aging\" are not causally related, is the correct answer.\\n\\n<Answer>C</Answer>')\n",
      "19 = mitophagy, 22 = therapeutic strategies\n",
      "(('mitophagy', 'therapeutic strategies'), '1. The text states that \"protecting mitochondria by regulating mitochondrial biogenesis, fission/fusion and mitophagy during liver I/R ameliorates LIRI.\"\\n2. The text also states that \"studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI which is important for the development of new therapeutic strategies aimed at improving patient outcomes.\"\\n\\nBased on this information, it is more likely that \"therapeutic strategies\" cause \"mitophagy\", as the text suggests that developing new therapeutic strategies aimed at improving patient outcomes is important, and studying mitochondrial dysfunction is key to this aim. Additionally, the text mentions that protecting mitochondria through mitophagy is an effective way to ameliorate LIRI, which supports the idea that therapeutic strategies that involve mitophagy can help improve patient outcomes.\\n\\nTherefore, the correct answer is <Answer>B</Answer>: \"therapeutic strategies\" causes \"mitophagy\".')\n",
      "19 = mitophagy, 23 = patient outcomes\n",
      "(('mitophagy', 'patient outcomes'), '1. The text mentions that preserving mitochondrial health during liver ischemia/reperfusion (I/R) can ameliorate liver ischemia-reperfusion injury (LIRI).\\n2. The text also mentions that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\\n3. The text further mentions that studying mitochondrial dysfunction will help understand the underlying mechanisms of cellular damage during LIRI and develop new therapeutic strategies aimed at improving patient outcomes.\\n\\nTherefore, it is more likely that mitigating mitophagy (that helps preserve mitochondrial health) would improve patient outcomes rather than the other way around. \\n\\n<Answer> A </Answer>')\n",
      "20 = steatosis, 21 = aging\n",
      "(('steatosis', 'aging'), '1. The text mentions that \"targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\" This suggests that both steatosis and aging can worsen mitochondrial dysfunction, which in turn exacerbates liver ischemia-reperfusion injury (LIRI).\\n\\n2. However, the text does not provide any evidence to suggest that steatosis causes aging or vice versa. It only suggests that both conditions can worsen mitochondrial dysfunction, which is a known risk factor for LIRI.\\n\\n3. Therefore, the most likely cause-and-effect relationship between steatosis and aging in the context of LIRI is that there is a common factor that worsens both conditions, rather than one causing the other.\\n\\n<Answer>D</Answer>')\n",
      "20 = steatosis, 22 = therapeutic strategies\n",
      "(('steatosis', 'therapeutic strategies'), '1. Identify the entities: \"steatosis\" and \"therapeutic strategies\". \\n2. Look for causal language: \"has been successful in decreasing their susceptibility to LIRI\" suggests a causal relationship between the two entities. \\n3. Determine the direction of the causal relationship: the sentence indicates that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis, has been successful in decreasing susceptibility to LIRI. This suggests that \"therapeutic strategies\" (targeting mitochondria) cause a decrease in susceptibility to LIRI in conditions such as \"steatosis\". \\n4. Choose the answer: B. \"therapeutic strategies\" causes \"steatosis\". \\n\\n<Answer>B</Answer>')\n",
      "20 = steatosis, 23 = patient outcomes\n",
      "(('steatosis', 'patient outcomes'), '1. The text mentions that steatosis and aging exacerbate mitochondrial dysfunction during liver ischemia/reperfusion injury (LIRI).\\n2. The text also states that protecting mitochondria during liver I/R can ameliorate LIRI.\\n3. The text does not provide any direct causal relationship between \"steatosis\" and \"patient outcomes.\"\\n\\nTherefore, the most likely cause-and-effect relationship is D: there is a common factor that is the cause for both \"steatosis\" and \"patient outcomes.\" This factor could be a pre-existing condition or a complication arising from LIRI itself. However, the text does not provide enough information to determine this common factor. \\n\\n<Answer>D</Answer>')\n",
      "21 = aging, 22 = therapeutic strategies\n",
      "(('aging', 'therapeutic strategies'), '1. The text mentions that \"Targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as steatosis and aging, has been successful in decreasing their susceptibility to LIRI.\", which suggests a relationship between aging and the effectiveness of therapeutic strategies in decreasing susceptibility to LIRI. \\n2. However, this does not necessarily mean that aging causes therapeutic strategies or that therapeutic strategies cause aging. \\n3. It is possible that there is a common factor that contributes to both aging and the effectiveness of therapeutic strategies in decreasing susceptibility to LIRI, such as the overall health of the liver. \\n\\n<Answer>D</Answer>')\n",
      "21 = aging, 23 = patient outcomes\n",
      "(('aging', 'patient outcomes'), '1. The text mentions that mitochondrial dysfunction is recognized as a hallmark of liver ischemia-reperfusion injury (LIRI) that exacerbates cellular injury.\\n\\n2. It also states that targeting mitochondria in conditions that exacerbate mitochondrial dysfunction, such as aging, has been successful in decreasing susceptibility to LIRI.\\n\\n3. Furthermore, the article highlights the importance of studying the role of mitochondria in liver I/R for the development of new therapeutic strategies aimed at improving patient outcomes.\\n\\n4. There is no direct causation mentioned between \"aging\" and \"patient outcomes\".\\n\\nBased on the information presented, it is more likely that there is a common factor that is the cause for both \"aging\" and \"patient outcomes\".<Answer>D</Answer>')\n",
      "22 = therapeutic strategies, 23 = patient outcomes\n",
      "(('therapeutic strategies', 'patient outcomes'), '1. The text mentions \"new therapeutic strategies aimed at improving patient outcomes.\"\\n2. It also mentions that \"Damage arising from LIRI is a major risk factor for early graft rejection and is associated with higher morbidity and mortality after surgery.\"\\n3. Additionally, the text discusses how protecting mitochondria during liver I/R ameliorates LIRI.\\n4. Based on this information, it is more likely that \"therapeutic strategies\" cause \"patient outcomes\" (improved outcomes after liver surgery) by ameliorating LIRI and decreasing the risk of graft rejection and negative health outcomes. \\n\\n<Answer>A</Answer>')\n",
      "Edges:\n",
      "[(('Liver ischemia-reperfusion injury (LIRI)', 'complications'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'clinical settings'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'liver resection'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'liver transplantation'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'graft rejection'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'morbidity'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'mortality'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'mechanisms'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'parenchymal'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'non-parenchymal liver cells'), 'C'), (('Liver ischemia-reperfusion injury (LIRI)', 'mitochondrial dysfunction'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'energy production'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'reactive oxygen species (ROS) signaling'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'calcium homeostasis'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'cell death'), 'A'), (('Liver ischemia-reperfusion injury (LIRI)', 'mitochondrial biogenesis'), 'D'), (('Liver ischemia-reperfusion injury (LIRI)', 'fission/fusion'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'mitophagy'), 'D'), (('Liver ischemia-reperfusion injury (LIRI)', 'therapeutic strategies'), 'B'), (('Liver ischemia-reperfusion injury (LIRI)', 'patient outcomes'), 'A'), (('complications', 'clinical settings'), 'D'), (('complications', 'liver resection'), 'C'), (('complications', 'liver transplantation'), 'B'), (('complications', 'graft rejection'), 'A'), (('complications', 'morbidity'), 'D'), (('complications', 'mortality'), 'A'), (('complications', 'mechanisms'), 'C'), (('complications', 'parenchymal'), 'B'), (('complications', 'non-parenchymal liver cells'), 'C'), (('complications', 'mitochondrial dysfunction'), 'B'), (('complications', 'glucose metabolism'), 'A'), (('complications', 'energy production'), 'B'), (('complications', 'reactive oxygen species (ROS) signaling'), 'B'), (('complications', 'calcium homeostasis'), 'C'), (('complications', 'cell death'), 'C'), (('complications', 'mitochondrial biogenesis'), 'C'), (('complications', 'fission/fusion'), 'C'), (('complications', 'mitophagy'), 'B'), (('complications', 'steatosis'), 'B'), (('complications', 'aging'), 'D'), (('complications', 'therapeutic strategies'), 'C'), (('complications', 'patient outcomes'), 'A'), (('clinical settings', 'liver resection'), 'A'), (('clinical settings', 'liver transplantation'), 'A'), (('clinical settings', 'graft rejection'), 'B'), (('clinical settings', 'morbidity'), 'A'), (('clinical settings', 'mortality'), 'A'), (('clinical settings', 'mechanisms'), 'C'), (('clinical settings', 'parenchymal'), 'C'), (('clinical settings', 'non-parenchymal liver cells'), 'D'), (('clinical settings', 'mitochondrial dysfunction'), 'A'), (('clinical settings', 'glucose metabolism'), 'D'), (('clinical settings', 'energy production'), 'B'), (('clinical settings', 'reactive oxygen species (ROS) signaling'), 'C'), (('clinical settings', 'calcium homeostasis'), 'C'), (('clinical settings', 'cell death'), 'D'), (('clinical settings', 'mitochondrial biogenesis'), 'C'), (('clinical settings', 'fission/fusion'), 'C'), (('clinical settings', 'mitophagy'), 'D'), (('clinical settings', 'steatosis'), 'D'), (('clinical settings', 'aging'), 'D'), (('clinical settings', 'patient outcomes'), 'A'), (('liver resection', 'liver transplantation'), 'C'), (('liver resection', 'graft rejection'), 'A'), (('liver resection', 'morbidity'), 'A'), (('liver resection', 'mortality'), 'A'), (('liver resection', 'mechanisms'), 'D'), (('liver resection', 'parenchymal'), 'D'), (('liver resection', 'non-parenchymal liver cells'), 'B'), (('liver resection', 'mitochondrial dysfunction'), 'C'), (('liver resection', 'glucose metabolism'), 'C'), (('liver resection', 'energy production'), 'C'), (('liver resection', 'reactive oxygen species (ROS) signaling'), 'B'), (('liver resection', 'calcium homeostasis'), 'C'), (('liver resection', 'mitochondrial biogenesis'), 'B'), (('liver resection', 'fission/fusion'), 'C'), (('liver resection', 'mitophagy'), 'C'), (('liver resection', 'steatosis'), 'B'), (('liver resection', 'aging'), 'C'), (('liver resection', 'therapeutic strategies'), 'C'), (('liver resection', 'patient outcomes'), 'A'), (('liver transplantation', 'graft rejection'), 'A'), (('liver transplantation', 'morbidity'), 'D'), (('liver transplantation', 'mortality'), 'C'), (('liver transplantation', 'mechanisms'), 'C'), (('liver transplantation', 'parenchymal'), 'B'), (('liver transplantation', 'non-parenchymal liver cells'), 'C'), (('liver transplantation', 'mitochondrial dysfunction'), 'C'), (('liver transplantation', 'glucose metabolism'), 'C'), (('liver transplantation', 'energy production'), 'C'), (('liver transplantation', 'reactive oxygen species (ROS) signaling'), 'B'), (('liver transplantation', 'calcium homeostasis'), 'C'), (('liver transplantation', 'cell death'), 'B'), (('liver transplantation', 'mitochondrial biogenesis'), 'A'), (('liver transplantation', 'fission/fusion'), 'C'), (('liver transplantation', 'mitophagy'), 'A'), (('liver transplantation', 'steatosis'), 'B'), (('liver transplantation', 'aging'), 'B'), (('liver transplantation', 'therapeutic strategies'), 'B'), (('liver transplantation', 'patient outcomes'), 'B'), (('graft rejection', 'morbidity'), 'A'), (('graft rejection', 'mortality'), 'C'), (('graft rejection', 'mechanisms'), 'B'), (('graft rejection', 'parenchymal'), 'B'), (('graft rejection', 'non-parenchymal liver cells'), 'C'), (('graft rejection', 'mitochondrial dysfunction'), 'B'), (('graft rejection', 'glucose metabolism'), 'A'), (('graft rejection', 'energy production'), 'B'), (('graft rejection', 'reactive oxygen species (ROS) signaling'), 'B'), (('graft rejection', 'calcium homeostasis'), 'B'), (('graft rejection', 'cell death'), 'B'), (('graft rejection', 'mitochondrial biogenesis'), 'C'), (('graft rejection', 'fission/fusion'), 'C'), (('graft rejection', 'mitophagy'), 'B'), (('graft rejection', 'steatosis'), 'B'), (('graft rejection', 'aging'), 'C'), (('graft rejection', 'therapeutic strategies'), 'D'), (('morbidity', 'mortality'), 'D'), (('morbidity', 'mechanisms'), 'C'), (('morbidity', 'parenchymal'), 'D'), (('morbidity', 'non-parenchymal liver cells'), 'C'), (('morbidity', 'mitochondrial dysfunction'), 'B'), (('morbidity', 'glucose metabolism'), 'B'), (('morbidity', 'energy production'), 'B'), (('morbidity', 'reactive oxygen species (ROS) signaling'), 'B'), (('morbidity', 'cell death'), 'B'), (('morbidity', 'fission/fusion'), 'D'), (('morbidity', 'mitophagy'), 'B'), (('morbidity', 'steatosis'), 'B'), (('morbidity', 'aging'), 'D'), (('morbidity', 'therapeutic strategies'), 'C'), (('morbidity', 'patient outcomes'), 'B'), (('mortality', 'mechanisms'), 'B'), (('mortality', 'parenchymal'), 'B'), (('mortality', 'non-parenchymal liver cells'), 'B'), (('mortality', 'mitochondrial dysfunction'), 'B'), (('mortality', 'glucose metabolism'), 'D'), (('mortality', 'energy production'), 'B'), (('mortality', 'reactive oxygen species (ROS) signaling'), 'B'), (('mortality', 'calcium homeostasis'), 'C'), (('mortality', 'cell death'), 'B'), (('mortality', 'mitochondrial biogenesis'), 'B'), (('mortality', 'fission/fusion'), 'B'), (('mortality', 'steatosis'), 'D'), (('mortality', 'aging'), 'D'), (('mortality', 'therapeutic strategies'), 'B'), (('mortality', 'patient outcomes'), 'B'), (('mechanisms', 'parenchymal'), 'A'), (('mechanisms', 'non-parenchymal liver cells'), 'A'), (('mechanisms', 'mitochondrial dysfunction'), 'B'), (('mechanisms', 'glucose metabolism'), 'C'), (('mechanisms', 'energy production'), 'A'), (('mechanisms', 'reactive oxygen species (ROS) signaling'), 'A'), (('mechanisms', 'calcium homeostasis'), 'C'), (('mechanisms', 'cell death'), 'A'), (('mechanisms', 'mitochondrial biogenesis'), 'C'), (('mechanisms', 'fission/fusion'), 'C'), (('mechanisms', 'mitophagy'), 'B'), (('mechanisms', 'steatosis'), 'B'), (('mechanisms', 'therapeutic strategies'), 'A'), (('mechanisms', 'patient outcomes'), 'A'), (('parenchymal', 'non-parenchymal liver cells'), 'C'), (('parenchymal', 'glucose metabolism'), 'B'), (('parenchymal', 'energy production'), 'D'), (('parenchymal', 'reactive oxygen species (ROS) signaling'), 'C'), (('parenchymal', 'calcium homeostasis'), 'C'), (('parenchymal', 'cell death'), 'C'), (('parenchymal', 'mitochondrial biogenesis'), 'C'), (('parenchymal', 'mitophagy'), 'C'), (('parenchymal', 'steatosis'), 'D'), (('parenchymal', 'aging'), 'C'), (('parenchymal', 'therapeutic strategies'), 'B'), (('non-parenchymal liver cells', 'mitochondrial dysfunction'), 'B'), (('non-parenchymal liver cells', 'glucose metabolism'), 'C'), (('non-parenchymal liver cells', 'energy production'), 'C'), (('non-parenchymal liver cells', 'calcium homeostasis'), 'C'), (('non-parenchymal liver cells', 'cell death'), 'C'), (('non-parenchymal liver cells', 'mitochondrial biogenesis'), 'C'), (('non-parenchymal liver cells', 'fission/fusion'), 'C'), (('non-parenchymal liver cells', 'mitophagy'), 'C'), (('non-parenchymal liver cells', 'steatosis'), 'B'), (('non-parenchymal liver cells', 'aging'), 'D'), (('non-parenchymal liver cells', 'therapeutic strategies'), 'B'), (('mitochondrial dysfunction', 'glucose metabolism'), 'A'), (('mitochondrial dysfunction', 'energy production'), 'A'), (('mitochondrial dysfunction', 'reactive oxygen species (ROS) signaling'), 'A'), (('mitochondrial dysfunction', 'calcium homeostasis'), 'D'), (('mitochondrial dysfunction', 'cell death'), 'A'), (('mitochondrial dysfunction', 'mitochondrial biogenesis'), 'A'), (('mitochondrial dysfunction', 'fission/fusion'), 'B'), (('mitochondrial dysfunction', 'mitophagy'), 'A'), (('mitochondrial dysfunction', 'steatosis'), 'B'), (('mitochondrial dysfunction', 'aging'), 'D'), (('mitochondrial dysfunction', 'therapeutic strategies'), 'D'), (('mitochondrial dysfunction', 'patient outcomes'), 'A'), (('glucose metabolism', 'energy production'), 'A'), (('glucose metabolism', 'reactive oxygen species (ROS) signaling'), 'D'), (('glucose metabolism', 'calcium homeostasis'), 'C'), (('glucose metabolism', 'cell death'), 'B'), (('glucose metabolism', 'mitochondrial biogenesis'), 'C'), (('glucose metabolism', 'fission/fusion'), 'D'), (('glucose metabolism', 'mitophagy'), 'C'), (('glucose metabolism', 'steatosis'), 'B'), (('glucose metabolism', 'aging'), 'C'), (('glucose metabolism', 'therapeutic strategies'), 'C'), (('energy production', 'reactive oxygen species (ROS) signaling'), 'B'), (('energy production', 'cell death'), 'D'), (('energy production', 'mitochondrial biogenesis'), 'B'), (('energy production', 'fission/fusion'), 'C'), (('energy production', 'mitophagy'), 'C'), (('energy production', 'steatosis'), 'B'), (('energy production', 'aging'), 'B'), (('energy production', 'therapeutic strategies'), 'C'), (('energy production', 'patient outcomes'), 'A'), (('reactive oxygen species (ROS) signaling', 'calcium homeostasis'), 'D'), (('reactive oxygen species (ROS) signaling', 'cell death'), 'A'), (('reactive oxygen species (ROS) signaling', 'mitochondrial biogenesis'), 'B'), (('reactive oxygen species (ROS) signaling', 'fission/fusion'), 'D'), (('reactive oxygen species (ROS) signaling', 'mitophagy'), 'B'), (('reactive oxygen species (ROS) signaling', 'aging'), 'B'), (('reactive oxygen species (ROS) signaling', 'therapeutic strategies'), 'D'), (('reactive oxygen species (ROS) signaling', 'patient outcomes'), 'A'), (('calcium homeostasis', 'cell death'), 'A'), (('calcium homeostasis', 'mitochondrial biogenesis'), 'B'), (('calcium homeostasis', 'fission/fusion'), 'C'), (('calcium homeostasis', 'mitophagy'), 'B'), (('calcium homeostasis', 'steatosis'), 'B'), (('calcium homeostasis', 'aging'), 'B'), (('calcium homeostasis', 'therapeutic strategies'), 'C'), (('calcium homeostasis', 'patient outcomes'), 'D'), (('cell death', 'mitochondrial biogenesis'), 'B'), (('cell death', 'fission/fusion'), 'B'), (('cell death', 'steatosis'), 'B'), (('cell death', 'aging'), 'B'), (('cell death', 'therapeutic strategies'), 'C'), (('cell death', 'patient outcomes'), 'D'), (('mitochondrial biogenesis', 'fission/fusion'), 'C'), (('mitochondrial biogenesis', 'mitophagy'), 'D'), (('mitochondrial biogenesis', 'steatosis'), 'B'), (('mitochondrial biogenesis', 'aging'), 'C'), (('mitochondrial biogenesis', 'therapeutic strategies'), 'A'), (('mitochondrial biogenesis', 'patient outcomes'), 'A'), (('fission/fusion', 'mitophagy'), 'C'), (('fission/fusion', 'steatosis'), 'D'), (('fission/fusion', 'aging'), 'C'), (('fission/fusion', 'therapeutic strategies'), 'C'), (('fission/fusion', 'patient outcomes'), 'D'), (('mitophagy', 'steatosis'), 'B'), (('mitophagy', 'aging'), 'C'), (('mitophagy', 'therapeutic strategies'), 'B'), (('steatosis', 'aging'), 'D'), (('steatosis', 'therapeutic strategies'), 'B'), (('steatosis', 'patient outcomes'), 'D'), (('aging', 'therapeutic strategies'), 'D'), (('aging', 'patient outcomes'), 'D'), (('therapeutic strategies', 'patient outcomes'), 'A')]\n",
      "--\n",
      "Nodes:\n",
      "['Liver ischemia-reperfusion injury (LIRI)', 'complications', 'clinical settings', 'liver resection', 'liver transplantation', 'graft rejection', 'morbidity', 'mortality', 'mechanisms', 'parenchymal', 'non-parenchymal liver cells', 'mitochondrial dysfunction', 'energy production', 'reactive oxygen species (ROS) signaling', 'calcium homeostasis', 'cell death', 'mitochondrial biogenesis', 'fission/fusion', 'mitophagy', 'therapeutic strategies', 'patient outcomes', 'glucose metabolism', 'steatosis', 'aging']\n",
      "--\n",
      "Processed Edges:\n",
      "[('Liver ischemia-reperfusion injury (LIRI)', 'complications'), ('Liver ischemia-reperfusion injury (LIRI)', 'clinical settings'), ('liver resection', 'Liver ischemia-reperfusion injury (LIRI)'), ('liver transplantation', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'graft rejection'), ('Liver ischemia-reperfusion injury (LIRI)', 'morbidity'), ('Liver ischemia-reperfusion injury (LIRI)', 'mortality'), ('mechanisms', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'parenchymal'), ('mitochondrial dysfunction', 'Liver ischemia-reperfusion injury (LIRI)'), ('energy production', 'Liver ischemia-reperfusion injury (LIRI)'), ('reactive oxygen species (ROS) signaling', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'calcium homeostasis'), ('Liver ischemia-reperfusion injury (LIRI)', 'cell death'), ('mitochondrial biogenesis', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'mitochondrial biogenesis'), ('fission/fusion', 'Liver ischemia-reperfusion injury (LIRI)'), ('mitophagy', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'mitophagy'), ('therapeutic strategies', 'Liver ischemia-reperfusion injury (LIRI)'), ('Liver ischemia-reperfusion injury (LIRI)', 'patient outcomes'), ('clinical settings', 'complications'), ('complications', 'clinical settings'), ('liver transplantation', 'complications'), ('complications', 'graft rejection'), ('morbidity', 'complications'), ('complications', 'morbidity'), ('complications', 'mortality'), ('parenchymal', 'complications'), ('mitochondrial dysfunction', 'complications'), ('complications', 'glucose metabolism'), ('energy production', 'complications'), ('reactive oxygen species (ROS) signaling', 'complications'), ('mitophagy', 'complications'), ('steatosis', 'complications'), ('aging', 'complications'), ('complications', 'aging'), ('complications', 'patient outcomes'), ('clinical settings', 'liver resection'), ('clinical settings', 'liver transplantation'), ('graft rejection', 'clinical settings'), ('clinical settings', 'morbidity'), ('clinical settings', 'mortality'), ('non-parenchymal liver cells', 'clinical settings'), ('clinical settings', 'non-parenchymal liver cells'), ('clinical settings', 'mitochondrial dysfunction'), ('glucose metabolism', 'clinical settings'), ('clinical settings', 'glucose metabolism'), ('energy production', 'clinical settings'), ('cell death', 'clinical settings'), ('clinical settings', 'cell death'), ('mitophagy', 'clinical settings'), ('clinical settings', 'mitophagy'), ('steatosis', 'clinical settings'), ('clinical settings', 'steatosis'), ('aging', 'clinical settings'), ('clinical settings', 'aging'), ('clinical settings', 'patient outcomes'), ('liver resection', 'graft rejection'), ('liver resection', 'morbidity'), ('liver resection', 'mortality'), ('mechanisms', 'liver resection'), ('liver resection', 'mechanisms'), ('parenchymal', 'liver resection'), ('liver resection', 'parenchymal'), ('non-parenchymal liver cells', 'liver resection'), ('reactive oxygen species (ROS) signaling', 'liver resection'), ('mitochondrial biogenesis', 'liver resection'), ('steatosis', 'liver resection'), ('liver resection', 'patient outcomes'), ('liver transplantation', 'graft rejection'), ('morbidity', 'liver transplantation'), ('liver transplantation', 'morbidity'), ('parenchymal', 'liver transplantation'), ('reactive oxygen species (ROS) signaling', 'liver transplantation'), ('cell death', 'liver transplantation'), ('liver transplantation', 'mitochondrial biogenesis'), ('liver transplantation', 'mitophagy'), ('steatosis', 'liver transplantation'), ('aging', 'liver transplantation'), ('therapeutic strategies', 'liver transplantation'), ('patient outcomes', 'liver transplantation'), ('graft rejection', 'morbidity'), ('mechanisms', 'graft rejection'), ('parenchymal', 'graft rejection'), ('mitochondrial dysfunction', 'graft rejection'), ('graft rejection', 'glucose metabolism'), ('energy production', 'graft rejection'), ('reactive oxygen species (ROS) signaling', 'graft rejection'), ('calcium homeostasis', 'graft rejection'), ('cell death', 'graft rejection'), ('mitophagy', 'graft rejection'), ('steatosis', 'graft rejection'), ('therapeutic strategies', 'graft rejection'), ('graft rejection', 'therapeutic strategies'), ('mortality', 'morbidity'), ('morbidity', 'mortality'), ('parenchymal', 'morbidity'), ('morbidity', 'parenchymal'), ('mitochondrial dysfunction', 'morbidity'), ('glucose metabolism', 'morbidity'), ('energy production', 'morbidity'), ('reactive oxygen species (ROS) signaling', 'morbidity'), ('cell death', 'morbidity'), ('fission/fusion', 'morbidity'), ('morbidity', 'fission/fusion'), ('mitophagy', 'morbidity'), ('steatosis', 'morbidity'), ('aging', 'morbidity'), ('morbidity', 'aging'), ('patient outcomes', 'morbidity'), ('mechanisms', 'mortality'), ('parenchymal', 'mortality'), ('non-parenchymal liver cells', 'mortality'), ('mitochondrial dysfunction', 'mortality'), ('glucose metabolism', 'mortality'), ('mortality', 'glucose metabolism'), ('energy production', 'mortality'), ('reactive oxygen species (ROS) signaling', 'mortality'), ('cell death', 'mortality'), ('mitochondrial biogenesis', 'mortality'), ('fission/fusion', 'mortality'), ('steatosis', 'mortality'), ('mortality', 'steatosis'), ('aging', 'mortality'), ('mortality', 'aging'), ('therapeutic strategies', 'mortality'), ('patient outcomes', 'mortality'), ('mechanisms', 'parenchymal'), ('mechanisms', 'non-parenchymal liver cells'), ('mitochondrial dysfunction', 'mechanisms'), ('mechanisms', 'energy production'), ('mechanisms', 'reactive oxygen species (ROS) signaling'), ('mechanisms', 'cell death'), ('mitophagy', 'mechanisms'), ('steatosis', 'mechanisms'), ('mechanisms', 'therapeutic strategies'), ('mechanisms', 'patient outcomes'), ('glucose metabolism', 'parenchymal'), ('energy production', 'parenchymal'), ('parenchymal', 'energy production'), ('steatosis', 'parenchymal'), ('parenchymal', 'steatosis'), ('therapeutic strategies', 'parenchymal'), ('mitochondrial dysfunction', 'non-parenchymal liver cells'), ('steatosis', 'non-parenchymal liver cells'), ('aging', 'non-parenchymal liver cells'), ('non-parenchymal liver cells', 'aging'), ('therapeutic strategies', 'non-parenchymal liver cells'), ('mitochondrial dysfunction', 'glucose metabolism'), ('mitochondrial dysfunction', 'energy production'), ('mitochondrial dysfunction', 'reactive oxygen species (ROS) signaling'), ('calcium homeostasis', 'mitochondrial dysfunction'), ('mitochondrial dysfunction', 'calcium homeostasis'), ('mitochondrial dysfunction', 'cell death'), ('mitochondrial dysfunction', 'mitochondrial biogenesis'), ('fission/fusion', 'mitochondrial dysfunction'), ('mitochondrial dysfunction', 'mitophagy'), ('steatosis', 'mitochondrial dysfunction'), ('aging', 'mitochondrial dysfunction'), ('mitochondrial dysfunction', 'aging'), ('therapeutic strategies', 'mitochondrial dysfunction'), ('mitochondrial dysfunction', 'therapeutic strategies'), ('mitochondrial dysfunction', 'patient outcomes'), ('glucose metabolism', 'energy production'), ('reactive oxygen species (ROS) signaling', 'glucose metabolism'), ('glucose metabolism', 'reactive oxygen species (ROS) signaling'), ('cell death', 'glucose metabolism'), ('fission/fusion', 'glucose metabolism'), ('glucose metabolism', 'fission/fusion'), ('steatosis', 'glucose metabolism'), ('reactive oxygen species (ROS) signaling', 'energy production'), ('cell death', 'energy production'), ('energy production', 'cell death'), ('mitochondrial biogenesis', 'energy production'), ('steatosis', 'energy production'), ('aging', 'energy production'), ('energy production', 'patient outcomes'), ('calcium homeostasis', 'reactive oxygen species (ROS) signaling'), ('reactive oxygen species (ROS) signaling', 'calcium homeostasis'), ('reactive oxygen species (ROS) signaling', 'cell death'), ('mitochondrial biogenesis', 'reactive oxygen species (ROS) signaling'), ('fission/fusion', 'reactive oxygen species (ROS) signaling'), ('reactive oxygen species (ROS) signaling', 'fission/fusion'), ('mitophagy', 'reactive oxygen species (ROS) signaling'), ('aging', 'reactive oxygen species (ROS) signaling'), ('therapeutic strategies', 'reactive oxygen species (ROS) signaling'), ('reactive oxygen species (ROS) signaling', 'therapeutic strategies'), ('reactive oxygen species (ROS) signaling', 'patient outcomes'), ('calcium homeostasis', 'cell death'), ('mitochondrial biogenesis', 'calcium homeostasis'), ('mitophagy', 'calcium homeostasis'), ('steatosis', 'calcium homeostasis'), ('aging', 'calcium homeostasis'), ('patient outcomes', 'calcium homeostasis'), ('calcium homeostasis', 'patient outcomes'), ('mitochondrial biogenesis', 'cell death'), ('fission/fusion', 'cell death'), ('steatosis', 'cell death'), ('aging', 'cell death'), ('patient outcomes', 'cell death'), ('cell death', 'patient outcomes'), ('mitophagy', 'mitochondrial biogenesis'), ('mitochondrial biogenesis', 'mitophagy'), ('steatosis', 'mitochondrial biogenesis'), ('mitochondrial biogenesis', 'therapeutic strategies'), ('mitochondrial biogenesis', 'patient outcomes'), ('steatosis', 'fission/fusion'), ('fission/fusion', 'steatosis'), ('patient outcomes', 'fission/fusion'), ('fission/fusion', 'patient outcomes'), ('steatosis', 'mitophagy'), ('therapeutic strategies', 'mitophagy'), ('aging', 'steatosis'), ('steatosis', 'aging'), ('therapeutic strategies', 'steatosis'), ('patient outcomes', 'steatosis'), ('steatosis', 'patient outcomes'), ('therapeutic strategies', 'aging'), ('aging', 'therapeutic strategies'), ('patient outcomes', 'aging'), ('aging', 'patient outcomes'), ('therapeutic strategies', 'patient outcomes')]\n",
      "--\n",
      "Liver ischemia-reperfusion injury (LIRI) -> complications\n",
      "Liver ischemia-reperfusion injury (LIRI) -> clinical settings\n",
      "Liver ischemia-reperfusion injury (LIRI) <- liver resection\n",
      "Liver ischemia-reperfusion injury (LIRI) <- liver transplantation\n",
      "Liver ischemia-reperfusion injury (LIRI) -> graft rejection\n",
      "Liver ischemia-reperfusion injury (LIRI) -> morbidity\n",
      "Liver ischemia-reperfusion injury (LIRI) -> mortality\n",
      "Liver ischemia-reperfusion injury (LIRI) <- mechanisms\n",
      "Liver ischemia-reperfusion injury (LIRI) -> parenchymal\n",
      "Liver ischemia-reperfusion injury (LIRI)   non-parenchymal liver cells\n",
      "Liver ischemia-reperfusion injury (LIRI) <- mitochondrial dysfunction\n",
      "Liver ischemia-reperfusion injury (LIRI) None glucose metabolism\n",
      "Liver ischemia-reperfusion injury (LIRI) <- energy production\n",
      "Liver ischemia-reperfusion injury (LIRI) <- reactive oxygen species (ROS) signaling\n",
      "Liver ischemia-reperfusion injury (LIRI) -> calcium homeostasis\n",
      "Liver ischemia-reperfusion injury (LIRI) -> cell death\n",
      "Liver ischemia-reperfusion injury (LIRI) <-> mitochondrial biogenesis\n",
      "Liver ischemia-reperfusion injury (LIRI) <- fission/fusion\n",
      "Liver ischemia-reperfusion injury (LIRI) <-> mitophagy\n",
      "Liver ischemia-reperfusion injury (LIRI) ? steatosis\n",
      "Liver ischemia-reperfusion injury (LIRI) <- therapeutic strategies\n",
      "Liver ischemia-reperfusion injury (LIRI) -> patient outcomes\n",
      "complications <-> clinical settings\n",
      "complications   liver resection\n",
      "complications <- liver transplantation\n",
      "complications -> graft rejection\n",
      "complications <-> morbidity\n",
      "complications -> mortality\n",
      "complications   mechanisms\n",
      "complications <- parenchymal\n",
      "complications   non-parenchymal liver cells\n",
      "complications <- mitochondrial dysfunction\n",
      "complications -> glucose metabolism\n",
      "complications <- energy production\n",
      "complications <- reactive oxygen species (ROS) signaling\n",
      "complications   calcium homeostasis\n",
      "complications   cell death\n",
      "complications   mitochondrial biogenesis\n",
      "complications   fission/fusion\n",
      "complications <- mitophagy\n",
      "complications <- steatosis\n",
      "complications <-> aging\n",
      "complications   therapeutic strategies\n",
      "complications -> patient outcomes\n",
      "clinical settings -> liver resection\n",
      "clinical settings -> liver transplantation\n",
      "clinical settings <- graft rejection\n",
      "clinical settings -> morbidity\n",
      "clinical settings -> mortality\n",
      "clinical settings   mechanisms\n",
      "clinical settings   parenchymal\n",
      "clinical settings <-> non-parenchymal liver cells\n",
      "clinical settings -> mitochondrial dysfunction\n",
      "clinical settings <-> glucose metabolism\n",
      "clinical settings <- energy production\n",
      "clinical settings   reactive oxygen species (ROS) signaling\n",
      "clinical settings   calcium homeostasis\n",
      "clinical settings <-> cell death\n",
      "clinical settings   mitochondrial biogenesis\n",
      "clinical settings   fission/fusion\n",
      "clinical settings <-> mitophagy\n",
      "clinical settings <-> steatosis\n",
      "clinical settings <-> aging\n",
      "clinical settings -> patient outcomes\n",
      "liver resection   liver transplantation\n",
      "liver resection -> graft rejection\n",
      "liver resection -> morbidity\n",
      "liver resection -> mortality\n",
      "liver resection <-> mechanisms\n",
      "liver resection <-> parenchymal\n",
      "liver resection <- non-parenchymal liver cells\n",
      "liver resection   mitochondrial dysfunction\n",
      "liver resection   glucose metabolism\n",
      "liver resection   energy production\n",
      "liver resection <- reactive oxygen species (ROS) signaling\n",
      "liver resection   calcium homeostasis\n",
      "liver resection ? cell death\n",
      "liver resection <- mitochondrial biogenesis\n",
      "liver resection   fission/fusion\n",
      "liver resection   mitophagy\n",
      "liver resection <- steatosis\n",
      "liver resection   aging\n",
      "liver resection   therapeutic strategies\n",
      "liver resection -> patient outcomes\n",
      "liver transplantation -> graft rejection\n",
      "liver transplantation <-> morbidity\n",
      "liver transplantation   mortality\n",
      "liver transplantation   mechanisms\n",
      "liver transplantation <- parenchymal\n",
      "liver transplantation   non-parenchymal liver cells\n",
      "liver transplantation   mitochondrial dysfunction\n",
      "liver transplantation   glucose metabolism\n",
      "liver transplantation   energy production\n",
      "liver transplantation <- reactive oxygen species (ROS) signaling\n",
      "liver transplantation   calcium homeostasis\n",
      "liver transplantation <- cell death\n",
      "liver transplantation -> mitochondrial biogenesis\n",
      "liver transplantation   fission/fusion\n",
      "liver transplantation -> mitophagy\n",
      "liver transplantation <- steatosis\n",
      "liver transplantation <- aging\n",
      "liver transplantation <- therapeutic strategies\n",
      "liver transplantation <- patient outcomes\n",
      "graft rejection -> morbidity\n",
      "graft rejection   mortality\n",
      "graft rejection <- mechanisms\n",
      "graft rejection <- parenchymal\n",
      "graft rejection   non-parenchymal liver cells\n",
      "graft rejection <- mitochondrial dysfunction\n",
      "graft rejection -> glucose metabolism\n",
      "graft rejection <- energy production\n",
      "graft rejection <- reactive oxygen species (ROS) signaling\n",
      "graft rejection <- calcium homeostasis\n",
      "graft rejection <- cell death\n",
      "graft rejection   mitochondrial biogenesis\n",
      "graft rejection   fission/fusion\n",
      "graft rejection <- mitophagy\n",
      "graft rejection <- steatosis\n",
      "graft rejection   aging\n",
      "graft rejection <-> therapeutic strategies\n",
      "graft rejection ? patient outcomes\n",
      "morbidity <-> mortality\n",
      "morbidity   mechanisms\n",
      "morbidity <-> parenchymal\n",
      "morbidity   non-parenchymal liver cells\n",
      "morbidity <- mitochondrial dysfunction\n",
      "morbidity <- glucose metabolism\n",
      "morbidity <- energy production\n",
      "morbidity <- reactive oxygen species (ROS) signaling\n",
      "morbidity ? calcium homeostasis\n",
      "morbidity <- cell death\n",
      "morbidity ? mitochondrial biogenesis\n",
      "morbidity <-> fission/fusion\n",
      "morbidity <- mitophagy\n",
      "morbidity <- steatosis\n",
      "morbidity <-> aging\n",
      "morbidity   therapeutic strategies\n",
      "morbidity <- patient outcomes\n",
      "mortality <- mechanisms\n",
      "mortality <- parenchymal\n",
      "mortality <- non-parenchymal liver cells\n",
      "mortality <- mitochondrial dysfunction\n",
      "mortality <-> glucose metabolism\n",
      "mortality <- energy production\n",
      "mortality <- reactive oxygen species (ROS) signaling\n",
      "mortality   calcium homeostasis\n",
      "mortality <- cell death\n",
      "mortality <- mitochondrial biogenesis\n",
      "mortality <- fission/fusion\n",
      "mortality <-> steatosis\n",
      "mortality <-> aging\n",
      "mortality <- therapeutic strategies\n",
      "mortality <- patient outcomes\n",
      "mechanisms -> parenchymal\n",
      "mechanisms -> non-parenchymal liver cells\n",
      "mechanisms <- mitochondrial dysfunction\n",
      "mechanisms   glucose metabolism\n",
      "mechanisms -> energy production\n",
      "mechanisms -> reactive oxygen species (ROS) signaling\n",
      "mechanisms   calcium homeostasis\n",
      "mechanisms -> cell death\n",
      "mechanisms   mitochondrial biogenesis\n",
      "mechanisms   fission/fusion\n",
      "mechanisms <- mitophagy\n",
      "mechanisms <- steatosis\n",
      "mechanisms -> therapeutic strategies\n",
      "mechanisms -> patient outcomes\n",
      "parenchymal   non-parenchymal liver cells\n",
      "parenchymal ? mitochondrial dysfunction\n",
      "parenchymal <- glucose metabolism\n",
      "parenchymal <-> energy production\n",
      "parenchymal   reactive oxygen species (ROS) signaling\n",
      "parenchymal   calcium homeostasis\n",
      "parenchymal   cell death\n",
      "parenchymal   mitochondrial biogenesis\n",
      "parenchymal None fission/fusion\n",
      "parenchymal   mitophagy\n",
      "parenchymal <-> steatosis\n",
      "parenchymal   aging\n",
      "parenchymal <- therapeutic strategies\n",
      "non-parenchymal liver cells <- mitochondrial dysfunction\n",
      "non-parenchymal liver cells   glucose metabolism\n",
      "non-parenchymal liver cells   energy production\n",
      "non-parenchymal liver cells ? reactive oxygen species (ROS) signaling\n",
      "non-parenchymal liver cells   calcium homeostasis\n",
      "non-parenchymal liver cells   cell death\n",
      "non-parenchymal liver cells   mitochondrial biogenesis\n",
      "non-parenchymal liver cells   fission/fusion\n",
      "non-parenchymal liver cells   mitophagy\n",
      "non-parenchymal liver cells <- steatosis\n",
      "non-parenchymal liver cells <-> aging\n",
      "non-parenchymal liver cells <- therapeutic strategies\n",
      "non-parenchymal liver cells ? patient outcomes\n",
      "mitochondrial dysfunction -> glucose metabolism\n",
      "mitochondrial dysfunction -> energy production\n",
      "mitochondrial dysfunction -> reactive oxygen species (ROS) signaling\n",
      "mitochondrial dysfunction <-> calcium homeostasis\n",
      "mitochondrial dysfunction -> cell death\n",
      "mitochondrial dysfunction -> mitochondrial biogenesis\n",
      "mitochondrial dysfunction <- fission/fusion\n",
      "mitochondrial dysfunction -> mitophagy\n",
      "mitochondrial dysfunction <- steatosis\n",
      "mitochondrial dysfunction <-> aging\n",
      "mitochondrial dysfunction <-> therapeutic strategies\n",
      "mitochondrial dysfunction -> patient outcomes\n",
      "glucose metabolism -> energy production\n",
      "glucose metabolism <-> reactive oxygen species (ROS) signaling\n",
      "glucose metabolism   calcium homeostasis\n",
      "glucose metabolism <- cell death\n",
      "glucose metabolism   mitochondrial biogenesis\n",
      "glucose metabolism <-> fission/fusion\n",
      "glucose metabolism   mitophagy\n",
      "glucose metabolism <- steatosis\n",
      "glucose metabolism   aging\n",
      "glucose metabolism   therapeutic strategies\n",
      "glucose metabolism ? patient outcomes\n",
      "energy production <- reactive oxygen species (ROS) signaling\n",
      "energy production ? calcium homeostasis\n",
      "energy production <-> cell death\n",
      "energy production <- mitochondrial biogenesis\n",
      "energy production   fission/fusion\n",
      "energy production   mitophagy\n",
      "energy production <- steatosis\n",
      "energy production <- aging\n",
      "energy production   therapeutic strategies\n",
      "energy production -> patient outcomes\n",
      "reactive oxygen species (ROS) signaling <-> calcium homeostasis\n",
      "reactive oxygen species (ROS) signaling -> cell death\n",
      "reactive oxygen species (ROS) signaling <- mitochondrial biogenesis\n",
      "reactive oxygen species (ROS) signaling <-> fission/fusion\n",
      "reactive oxygen species (ROS) signaling <- mitophagy\n",
      "reactive oxygen species (ROS) signaling ? steatosis\n",
      "reactive oxygen species (ROS) signaling <- aging\n",
      "reactive oxygen species (ROS) signaling <-> therapeutic strategies\n",
      "reactive oxygen species (ROS) signaling -> patient outcomes\n",
      "calcium homeostasis -> cell death\n",
      "calcium homeostasis <- mitochondrial biogenesis\n",
      "calcium homeostasis   fission/fusion\n",
      "calcium homeostasis <- mitophagy\n",
      "calcium homeostasis <- steatosis\n",
      "calcium homeostasis <- aging\n",
      "calcium homeostasis   therapeutic strategies\n",
      "calcium homeostasis <-> patient outcomes\n",
      "cell death <- mitochondrial biogenesis\n",
      "cell death <- fission/fusion\n",
      "cell death ? mitophagy\n",
      "cell death <- steatosis\n",
      "cell death <- aging\n",
      "cell death   therapeutic strategies\n",
      "cell death <-> patient outcomes\n",
      "mitochondrial biogenesis   fission/fusion\n",
      "mitochondrial biogenesis <-> mitophagy\n",
      "mitochondrial biogenesis <- steatosis\n",
      "mitochondrial biogenesis   aging\n",
      "mitochondrial biogenesis -> therapeutic strategies\n",
      "mitochondrial biogenesis -> patient outcomes\n",
      "fission/fusion   mitophagy\n",
      "fission/fusion <-> steatosis\n",
      "fission/fusion   aging\n",
      "fission/fusion   therapeutic strategies\n",
      "fission/fusion <-> patient outcomes\n",
      "mitophagy <- steatosis\n",
      "mitophagy   aging\n",
      "mitophagy <- therapeutic strategies\n",
      "mitophagy None patient outcomes\n",
      "steatosis <-> aging\n",
      "steatosis <- therapeutic strategies\n",
      "steatosis <-> patient outcomes\n",
      "aging <-> therapeutic strategies\n",
      "aging <-> patient outcomes\n",
      "therapeutic strategies -> patient outcomes\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sample = df['abstract'].sample().values[0]\n",
    "print(f'{sample}\\n')\n",
    "\n",
    "causal_discovery_pipeline(sample, use_text_in_causal_discovery=True, use_LLM_pretrained_knowledge_in_causal_discovery=True, reverse_edge_for_variable_check=False, optimize_found_entities=True, use_text_in_entity_optimization=True, verbose=True)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
